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ABSTRACT 
Hypochlorous acid (HOCl) is a neutrophil-derived oxidant that is used to 
kill invading pathogens. Since HOCl reacts indiscriminately with biological 
molecules, such as amino acids, excess or misplaced production of HOCl can 
cause host tissue damage. Methionine (Met), one of only two naturally 
occurring sulfur amino acids, reacts fast with HOCl making it one of the first 
targets. The mechanism for this reaction is not well known but is assumed to go 
through a chlorosulfonium intermediate to form methionine sulfoxide (MetO), 
and then methionine sulfone (MetO2). 
The first chapter of this dissertation introduces topics which will help the 
reader understand the significance of the research that is described herein. The 
second chapter presents the new method, which we called inhibitory titrations 
(IT). IT is an expansion of the competition method that is commonly used for 
measuring rate constants of fast reactions. IT tries to minimize assumptions that 
can create problems when indirectly measuring rate constants by: 1) making 
use of all the data collected (the rate constant measured using just the 50% 
inhibition point can underestimate the rate constant compared to that which fits 
all of the data); and 2) consideration of the stoichiometry of the reaction, which 
was important for accurately fitting data, especially when over-oxidation is 
possible. Our data shows that taking the stoichiometry of the reaction into 
consideration produces a better fit of the experimental data than assuming the 
reaction has a 1:1 stoichiometry. Without consideration of the rate law for the 
xxvii 
 
reaction, one may derive a first order rate constant from a second order 
reaction, leading to a misrepresentative rate constant. 
The third chapter examines thioether reactions with HOCl with the 
expectation that a chlorosulfonium intermediate could be characterized. In 
general, HOCl reacts with thioethers, at neutral pH, with a second order rate 
constant of 106-108 M-1s-1, consistent with those reported in literature. The 
reactions studied did not show definitive evidence for the formation of a 
chlorosulfonium ion intermediate. However, the observed product, 
dehydromethionine (DHM), formed in the reaction of Met with HOCl (studied in 
greater detail in the fourth chapter), gives insight into the identity of the 
intermediate. Due to the hypothesized method by which DHM is formed, from 
intramolecular attack followed by ring closure, a halosulfonium intermediate can 
account for the formation of the DHM product. 
The fourth chapter describes an investigation of the reaction of free Met, 
peptide bound Met, and protein bound Met, by various two electron oxidants. 
Oxidation of Met, which has a free amine, can form either MetO or DHM, a 
potential biomarker of oxidative stress. Different oxidants form different 
percentages of DHM. Two electron oxidants that react through oxygen transfer 
do not produce DHM, while halogenating species (but not the 
pseudohypohalous acid HOSCN) that react through a halide cation (X+, where 
X = I, Br, or Cl) transfer, produce a significant amount of DHM. The 
halogenating agents can be grouped by the yields of DHM they produce, where 
chlorinating agents produce around 43% DHM, brominating agents 
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approximately 75%, and iodinating agents close to 100% DHM. The percentage 
of DHM formed is related to the type of halosulfonium that is formed, whether it 
is a chlorosulfonium, bromosulfonium, or iodosulfonium species. Comparing 
analogous halosulfonium species, the stability towards hydrolysis is I > Br > Cl, 
reflecting the trend observed in the yields of DHM. The ease of formation along 
with the high kinetic stability of DHM at neutral pH, which in the absence of 
catalysts has a half life of over 600 days, shows the high potential for DHM as a 
biomarker of protein oxidation by halogenating agents. 
The fifth chapter is a summary of important findings of this research 
along with recommended future experiments. Overall, the dissertation examines 
fast (k = 106-108 M-1s-1) reactions of HOCl and related oxidants with biologically 
relevant molecules. 
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Chapter 1: Introduction: Production of Reactive Oxygen Species by the Human 
Immune System  
1.1 Immune system 
 The immune system protects the body from infection. It is comprised of 
two components, the innate (non-specific) immune system and the adaptive 
(specific) immune system. The innate response, the body’s first defense, 
responds to pathogens generically (i.e. non-specific) (discussed in more detail 
below). If a pathogen evades the innate immune system, the body’s second line 
of defense is the adaptive immune system. The adaptive immune system 
protects against re-exposure to the same pathogens by “remembering” what 
pathogens it has already been exposed to and how to combat them (1). 
 
 
1.1.1 Innate immune system 
The innate immune system provides defense against infection through a 
non-specific response to pathogens. The epithelial surface (i.e. skin) is one part 
of the innate immune system. It serves as the first line of defense by forming a 
physical barrier to prevent pathogens from entering the body. When a pathogen 
successfully enters the body, such as through a cut, the body’s inflammatory 
response (inflammation) is activated. At the location of inflammation, chemicals, 
such as histamine, are released. These chemicals cause blood vessels to leak 
fluid into the infected area, causing swelling which helps in the isolation of the 
pathogen(s). In addition, these chemicals attract white blood cells (leukocytes). 
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Leukocytes, which normally are found in the blood, migrate to the inflamed 
tissue through a process known as chemotaxis (the directed movement of a cell 
along a chemical concentration gradient) (1). 
 
Table 1.1: Properties of leukocytes 
Type 
Approx. % 
in adults Main function 
Neutrophil 54-62% phagocytosis; destroy pathogenic bacteria 
Eosinophil 1-3% 
destroy parasitic worms; regulate allergic 
inflammatory responses 
Basophil <1% 
release histamine during immune reactions to 
promote inflammation 
Lymphocyte 25-33% destroy virus-infected cells and tumor cells 
Monocyte 3-7% 
migrate from the bloodstream to other tissues in 
which they become macrophages (phagocytosis of 
cellular debris and pathogens) 
 
1.2 Leukocytes 
Leukocytes can be divided into two categories by looking for the 
presence of granules (defined as any structure barely visible by light 
microscopy). These two categories are granulocytes and agranulocytes (1-3). 
Granulocytes, which account for approximately 70% of all white blood cells, are 
characterized by the appearance of granules in their cytoplasm. Granules are 
membrane-bound enzymes that act primarily in the digestion of engulfed 
(phagocytized) foreign particles. The three types of granulocytes are 
neutrophils, basophils, and eosinophils. Agranulocytes, on the other hand, are 
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leukocytes which are characterized by what appears to be the absence of 
granules in their cytoplasm. Types of agranulocytes include lymphocytes and 
monocytes (also known as macrophages after they migrate from the 
bloodstream and enter tissue). Each leukocyte plays its own role in the human 
immune system and thus has different properties (table 1.1) (2-4). 
 
1.2.1 Neutrophils 
Neutrophils are the most abundant leukocyte in blood, accounting for 54-
62% of all leukocytes (1,4-5). It is a small cell that has a diameter of 
approximately 9-10 µm. Neutrophils are often referred to as the first line of 
leukocyte defense since it is the first defensive cell type to be recruited to an 
infection site during the beginning stages of inflammation, usually arriving within 
the first hour of the onset of inflammation. A non-activated neutrophil circulates 
in the blood stream and once it is activated, it migrates out of the blood stream 
and into the infected tissue (chemotaxis). Activated neutrophils are phagocytes, 
whose primary function is to kill small microorganisms, such as fungi and 
bacteria (5). 
 Neutrophils have both nonoxidative and oxidative mechanisms for 
destroying pathogens (6). Specific granules (i.e. secondary granules), part of 
the nonoxidative antimicrobial mechanism, contain cytotoxic molecules, namely 
enzymes (e.g. lysozyme) and antimicrobial peptides (e.g. lactoferrin), which are 
released during a process called degranulation. These cytotoxic molecules help 
kill pathogens by inhibiting growth (lactoferrin aids in depriving bacteria of iron 
which is needed for cellular growth) and by solubilizing the bacteria’s cellular 
 wall thereby making it more accessible to the oxidativ
oxidative antimicrobial mechanism contains two key components, the NADPH 
(nicotinamide adenine dinucleotide phosphate) oxidase system and 
myeloperoxidase (MPO). The NADPH oxidase system (discussed in more detail 
below) is contained throughout the cytoplasm and plasma 
neutrophil (8). MPO is found in azurophil granules. Azurophil (primary) granules 
play a role in killing and digesting pathogens through phagocytosis 
 
Figure 1.1: Illustration of phagocytosis
 
1.3 Phagocytosis 
Phagocytes (e.g. neutrophils, macrophages) engulf foreign material (e.g. 
bacteria, viruses, and dead or damaged cells) through a process called
phagocytosis (5). Phagocytosis involves several steps (figure 1.1), which 
includes the white blood cell (WBC) identifying and tracking down the foreign 
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material (through receptors on the surface which detect foreign material), 
engulfing it, digesting it, and eliminating the waste. A single WBC is capable of 
engulfing many microbes, with each of these phagocytic events resulting in the 
formation of a phagosome. 
 
1.4 Respiratory burst 
Prior to the phagocytosis of the particle, the phagocyte (e.g. neutrophils) 
begins to consume oxygen in a process called the respiratory burst (oxidative 
burst). During the respiratory burst, oxygen is consumed to form reduced 
oxygen which will be used to kill the microorganism(s). The respiratory burst 
involves the activation of the enzyme NADPH oxidase, which catalyzes the one 
electron reduction of oxygen (O2), using NADPH as an electron donor, forming 
large quantities of superoxide (O2-) (figure 1.2). Superoxide, a reactive oxygen 
species (ROS), serves as the starting point in a cascade of reactive species 
that are derived from O2-. The superoxide can disproportionate to give hydrogen 
peroxide (H2O2) and oxygen (a reaction that is catalyzed by superoxide 
dismutase, SOD). H2O2 is a powerful oxidizer but kinetically stable. H2O2 can be 
converted into more reactive ROS such as hydroxyl radical (•OH) (10). In 
addition, H2O2 serves as a substrate for the peroxidase enzymes [e.g. MPO] (5-
6,8-9,11-12). 
 
 Figure 1.2: Production of ROS during neutrophillic oxidative bursts
 
1.5 Peroxidases and the production of 
Mammalian peroxidases (PO) are enzymes that catalyze the oxidation of 
halides (or pseudo halide SCN
OHX 2+−
Eosinophil peroxidase (found in eosinophils
milk, lung, and other mucosa
MPO (found in neutrophils and macrophages
The ability of a PO to catalyze the oxidation of halides depends on two factors, 
the bioavailability of the halide and the redox potential of the peroxidase 
MPO is unique amongst other mammalian PO in that it is the only naturally 
6 
ROS 
-) by H2O2 (1.1).  
OHOX 2Enzyme2 + → −  (X=Cl, Br, I, or SCN)
), lactoperoxidase (found in breast 
), thyroid peroxidase (found in the
) are examples of mammalian PO. 
 
 
   (1.1) 
 thyroid), and 
(13). 
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occurring enzyme capable of catalyzing (under physiological conditions) the 
oxidation of chloride by H2O2 to form hypochlorous acid (HOCl) (13-14). 
Chloride is accepted to be the major substrate for MPO due to the presence of 
high concentrations in the blood which ranges from 100-140 mM (iodide < 1 µM; 
bromide = 20-100 µM; thiocyanate = 20-120 µM)  (14). HOCl is believed to play 
an important role in inflammation and has been linked to many inflammatory 
diseases such as atherosclerosis, arthritis, asthma, emphysema, cystic fibrosis, 
and periodontitis (15-18). HOCl is several orders of magnitude more cytotoxic 
than H2O2 and it is non-specific (it reacts with a large variety of functional 
groups). When left unchecked, HOCl can destroy host tissue as well as its 
pathogenic target (14,16-18). 
 
1.5.1 Reactive oxygen species 
 Reactive oxygen species (ROS) that are produced by phagocytes are 
implicated in host tissue damage that occurs during both acute and chronic 
inflammation (19). A cascade of ROS begins with the production of superoxide 
(O2-.) by NADPH oxidase, which is normally dormant in phagocytes but is 
activated during an oxidative burst (respiratory burst) (11,20). NADPH oxidase, 
a membrane bound enzyme complex found in the membrane of a phagosome, 
generates superoxide by transferring electrons from NADPH inside the cell 
across the membrane and coupling these to molecular oxygen to produce the 
superoxide (1.2) (20). 
2O2NADPH+ +−+ ++ HO2NADP 2     (1.2) 
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A majority of the superoxide disproportionates to yield H2O2 and molecular 
oxygen in a reaction that is efficiently catalyzed by superoxide dismutase (SOD) 
(1.3) (21-22).  
−++→+−• OH22O2H2OO2H22O2     (1.3) 
H2O2, though being kinetically inert, is a powerful oxidant (13) which phagocytes 
use, with the assistance of peroxidases (23), to produce more effective killing 
agents (24). 
 ROS oxidize both proteins and lipid components of low-density 
lipoprotein (LDL). Superoxide is relatively nonreactive with respect to protein 
components, but instead is highly reactive towards lipids (25). In contrast, the 
hypohalous acids [e.g. HOCl and hypobromous acid (HOBr)] are more reactive 
towards proteins and less reactive towards lipids (13,26-27). The pseudo-
hypohalite, hypothiocyanite (OSCN-), in contrast to these other ROS mentioned, 
is a mild oxidant that appears to react selectively with sulfhydryl groups, such 
as cysteine and its derivatives (13,28). 
 
1.6 Antioxidants 
Despite the apparent correlation between oxidative stress and 
inflammatory diseases, antioxidant strategies, both dietary (29) and 
pharmaceutical (18), have exhibited poor performance in limiting 
atherosclerosis in humans (30). Most antioxidants that have been investigated 
in great detail, for example vitamin E, have been chosen because it inhibits the 
oxidation of LDL by one electron oxidants in vitro. One electron oxidants are 
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typically radical species. There is also evidence that two electron oxidants, such 
as the ROS HOCl and reactive nitrogen species (RNS) peroxynitrite, play a 
significant role in LDL damage (31). Since there are a variety of different 
oxidants, including ROS, RNS, and reactive sulfur species (RSS), which play a 
role in oxidation of LDL, possibly contributing to atherosclerosis, there is 
considerable interest in determining the role that endogenous antioxidants 
(scavengers) play in moderating these oxidants (13,32). For HOCl and HOBr, 
the most effective scavengers are organosulfur compounds, in particular, 
methionine (Met) (33) and cysteine (Cys) (18,34) derivatives. These derivatives 
include glutathione (GSH), a small tripeptide which exhibits millimolar 
concentration in human cells (35), as well as the macromolecule human serum 
albumin (HSA), a protein bearing a single Cys group on its surface and six Met 
groups, which in blood plasma has a concentration around 600 µM (13).  
 
1.7 Summary of chapters 
This dissertation is comprised of several projects that have been 
progressively built off one another. Though the chapters follow a general theme, 
they are written to be independent of each other and as such each chapter 
contains its own introduction of relevant concepts, experimental design, 
interpretation, and conclusions. 
Chapter one has been a general introduction to some of the basic 
concepts that will aid the reader in understanding the research presented later 
and its importance. The goal of this chapter was to help the reader understand 
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where the oxidants studied in these research projects are derived from and the 
importance of their study. 
Chapter two presents the development of a method we call inhibitory 
titration, which we have used to measure the rate constants of fast reactions in 
solution. Ideally, rate constants should be measured under conditions of 
interest; however, this is not always practical. Historically, measuring rate 
constants of fast reactions has been problematic. Difficulties include the fact 
that the time required to get complete mixing of the reactants is often longer 
than the reaction time, so turbulent (i.e. complete) mixing does not occur. In 
addition, the instrumentation needed to monitor fast reactions is not always 
available (e.g. it is not possible to monitor a reaction with a half-life of µs when 
instrumental time resolution is on the order of ms). Techniques used in the past 
for fast reactions in solution include the competition reaction method and pH 
extrapolation. The competition reaction method uses the rate constant of a 
known reaction to obtain the rate constant for other reactions if competition 
conditions can be arranged. By measuring the proportions of competition 
reactants and/or products that remain after reaction, the rate constant can be 
found for the reaction of interest. For reactions which are pH dependent, 
changing the pH may slow down the reaction enough to use concentrations in 
which the rates are measurable, and then the rate constant at the pH of interest 
can be computed by extrapolation. Anytime the rate constant is measured 
under conditions other than that of interest, whether it is through competition 
reactions, pH extrapolation, etc., experimental assumptions are needed which 
11 
 
may cause inaccuracy in the computed rate constant (e.g. when using pH 
extrapolation to compute the rate constant, one assumes that the rate law at the 
pH of interest is the same as it is at the pH of the measurement). Using the 
reaction of thiocyanate with HOCl, for example, the rates that were extrapolated 
from measurements under alkaline conditions (pH extrapolation) (36) and those 
from competition reactions (18,37) were not self-consistent, pointing to a 
potential problem with one or both of these techniques. The inhibitory titration 
method that is described herein offers insight into these inconsistencies. 
 Chapter three examines the oxidation of four thioethers [methionine 
(Met), methionine sulfoxide (MetO), dinitrophenyl-methionine (DNPMet), and 
TNBMe (thioether derivative of 5-thio-2-nitrobenzoic acid, TNB)]. Oxidation of 
thioethers by HOCl is believed to occur through a Cl+ transfer from the O of 
HOCl to the sulfur of the thioether, forming a chlorosulfonium ion intermediate 
(CH3-S+(Cl)-R). Though there is no direct evidence for the formation of the 
chlorosulfonium intermediate, it is still widely accepted that oxidation of 
thioethers first forms the chlorosulfonium intermediate which subsequently 
hydrolyzes to form the observed sulfoxide. Studying the reaction of these four 
thioethers with HOCl was done to help understand the mechanism by which 
thioethers are oxidized.  
 Chapter four examines the oxidation of Met by two-electron oxidants, 
forming varying amounts of dehydromethionine (DHM) and MetO. In 1945, 
Lavine (38) identified a Met derivative which he called DHM. He found that 
oxidation of Met with iodine causes Met to form a cyclic (a sulfur-nitrogen bond) 
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derivative that differs from Met (in mass) by a loss of two hydrogens. Due to the 
ease of production and stability at neutral pH, Lavine suggested that DHM has 
biological importance (38). Young et al. (39) later proposed a mechanism by 
which iodine (I2) oxidizes Met through a I+ transfer that ring closes forming 
DHM. Since I2 has limited biological relevance (40), we wanted to investigate 
whether other halogenating agents such as HOCl and HOBr, two biologically 
relevant oxidants, oxidize Met through an analogous mechanism (since HOCl 
has been proposed to occur through a Cl+ transfer (36)) to form DHM. In 
addition, we studied the formation of DHM in peptides and proteins (containing 
an N-terminus Met), in hopes of finding a potential biomarker for hypohalous 
acids. If DHM is formed only by certain oxidants, or particular groups of 
oxidants, identifying DHM would help in understanding which oxidant(s) caused 
damage in hopes of developing preventative measures against destructive 
oxidants. 
 Chapter five is a summary of the important findings of the dissertation 
including suggested future experiments. This chapter helps connect the 
dissertation together in a broad view and bring focus to the importance of the 
work. 
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Chapter 2: Inhibitory Titrations: Development of a Method for Measuring Rate 
Constants of Fast Reactions 
2.1 Introduction 
2.1.1 Rate law 
Studying the kinetics of a chemical reaction aids in understanding the 
mechanism by which a reaction occurs. Investigation of the kinetics includes 
examining how different experimental conditions affect the rate of a chemical 
reaction, thereby helping to understand the intimate chemical mechanism 
though development of a rate law. The rate law describes the disappearance of 
reactants and/or the appearance of products as a function of experimental 
parameters (e.g., pH, temperature, physical state of the reactants, 
concentrations, ionic strength) that influence the rate. For a generic chemical 
reaction aA + bB → yY + zZ, the rate is mathematically expressed by (2.1), 
where r is the rate, k is the rate constant, and m and n are the reaction orders 
(determined experimentally and dependent on the reaction mechanism). 
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Elementary reactions can be unimolecular (e.g. A → C) or bimolecular (e.g., 
homogenous A + A → C or heterogeneous A + B → C); higher orders are 
improbable. This chapter describes the development of a method to measure 
rate constants for fast bimolecular reactions. Bimolecular reactions involve the 
homogenous or heterogeneous reaction of two components, with their rate laws 
expressed in (2.2) and (2.3), respectively. 
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For equations (2.2) and (2.3), k is the second-order rate constant with units of 
inverse concentration inverse time (usually M-1s-1). The rate of a homogenous 
second-order reaction can only be measured if the reactant, A, can be 
produced faster than it reacts with itself. This chapter discusses near diffusion 
controlled (k = 109-1010 M-1s-1) irreversible heterogeneous reactions. To 
accurately measure the rate, the solution (of A and B) must be homogenous 
(i.e. completely mixed). Heterogeneous second-order reactions can be 
measured under second-order conditions ([A] and [B] are of comparable value) 
or pseudo first-order conditions ([A] >> [B] or [A] << [B]). Pseudo first-order 
conditions are unique to heterogeneous systems, and not available for 
homogenous systems. While it is necessary to know the initial concentration of 
A ([A]0) for homogenous systems and heterogeneous systems when [A]0 = [B]0, 
it is not necessary to know [A]0 under pseudo first-order conditions when [A]0 << 
[B]0 (or [B]0 when [A]0 >> [B]0), although it is necessary to know the 
concentration of the reagent in excess. To follow a reaction under pseudo first-
order conditions, there needs to be enough reaction remaining after mixing to 
measure a change in concentration (directly or indirectly, e.g., though change in 
absorbance). 
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2.1.2 Fast reaction detection techniques 
Though the term “fast reaction” is subjective, for the following discussion 
a fast reaction is one for which the half-life is less than one second. A problem 
occurs when measuring rates of fast reactions when the time it takes to mix the 
reactants is comparable or less than the half-life of the reactants (t1/2, the time it 
takes for half of the reactant(s) to be depleted), so that the initial half of the 
reaction cannot be measured accurately. Another potential problem is the time 
resolution of the method that is used to monitor the reaction. For reactants that 
are consumed in a matter of seconds, a technique which can only take data on 
the order of minutes is not appropriate. The faster the reaction, the faster the 
data collection capabilities of the instrument used needs to be in order to follow 
the reaction. Different time domains can be accessed using the available fast 
kinetic techniques (figure 2.1). Figure 2.1 compares some of the kinetic 
methods used for fast reactions, comparing the first order rate constants            
(
2/1t
2lnk = ). Choice of which kinetic method to use depends on the type of 
reaction as well as expected time frame of the reaction. 
Depending on the type of reaction under investigation and the rate 
constant anticipated, it can be useful to compare techniques. Unfortunately, a 
majority of the techniques are for specific applications. For example, if there is 
no fluorescent compound in the reaction being studied, then fluorescent decay 
is not applicable (1). 
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Figure 2.1: Time ranges of various kinetic methods. Time axis given in units of 
log of the first order rate constant (s-1) (1). 
 
Flow techniques (referred to in figure 2.1 as rapid mixing) are the most 
commonly used method for measuring fast reactions and involve rapidly 
delivering two or more solutions (or gases) into a mixing vessel. Stopped-flow is 
a commonly used method that involves using syringes to rapidly mix two (or 
more) reactants, the flow is abruptly stopped (time = zero), and some physical 
property is measured (e.g., absorbance through spectroscopic instrumentation). 
Since stopped-flow methods are limited by the time it takes to homogenously 
mix the solutions (about one millisecond), they are applicable for reactions with 
half-lives on the order of milliseconds or greater (figure 2.1) (1). 
-12-10-8-6-4-20
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Rapid mixing
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Relaxation methods are applicable to reactions that come to equilibrium. 
For reactions which do not reach equilibrium, e.g., oxidation/reductions 
reactions, relaxation methods are not appropriate. Relaxation methods work 
when the reaction equilibrium is disturbed by some external parameter. After 
the disturbance to the equilibrium, there is a time period before the system 
returns to equilibrium, a parameter which is measured. An example of a 
relaxation method is temperature jump (T-jump) in which a sudden change in 
the temperature causes the reaction to reach a new equilibrium; data are 
collected as the reaction reaches a new equilibrium (the rate at which the 
reaction reaches the new equilibrium will dictate which kind of instrument can 
be used to measure the reaction by this method). Half-lives accessible for 
relaxation methods are about 10-9 s to over 1 s (figure 2.1) (1). 
Flash methods use an intense flash of light to photochemically initiate a 
reaction, which is subsequently measured. An example of a flash method is 
when the absorption of light electronically excites a molecule forming a free 
radical which subsequently reacts with other molecules in solution. Reactions 
that have half-lives as small as 10-5 s can be observed by this method (figure 
2.1). Pulse radiolysis is a method similar to flash photolysis. In pulse radiolysis, 
however, instead of a light flash, a pulse of high energy radiation is used to 
initiate the reaction (1). 
Fluorescence methods are applicable to reactions which contain a 
molecule which is capable of fluorescing. Fluorescence quenching is a common 
form of this method and involves studying the rate of reaction of a 
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photochemically excited molecule with another substance, which reduces the 
intensity of the fluorescence, called the quenching molecule. Typically, a 
molecule that is capable of fluorescing is excited by a light pulse lasting less 
than 10-9 s, and the observed intensity of the emitted light is measured. When a 
quenching molecule is added, this competes with the deactivation of the 
fluorescent molecule by other mechanisms that occur even in the absence of 
quencher, such as loss of energy to a solvent. The half-quenching times (i.e. 
the half-life of the reaction between the fluorescent molecule and the quenching 
molecule) are on the order of 10-8 s (figure 2.1), allowing for diffusion controlled 
reactions to be studied by this method, assuming one of the reagents are 
capable of fluorescence (1). 
Electrochemical methods require that one of the species involved in the 
reaction of interest be redox active so that the reaction can be coupled to an 
electrode reaction. This method measures current, which is typically controlled 
by the rate of diffusion of a redox active species to the electrode, but is also 
controlled by the rate at which that species is produced by a chemical reaction 
in solution. Polarography is an example of this method, which measures the 
current that flows in solution as a function of an applied voltage. Since the 
current depends on the diffusion of the electrochemical species through solution 
towards the electrode, the diffusion controlled rate of reaction in which reactants 
meet by diffusion to react with each other cannot be greater than the diffusion 
rate constant (k = 109-1010 M-1s-1) (figure 2.1) (1). 
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Electron-spin resonance (ESR), also known as or paramagnetic 
resonance (EPR), is a process observed with free radicals possessing an 
unpaired electron. In a strong magnetic field the electron aligns with this field, 
either parallel or anti-parallel to the field, both of which differ in energy. If a 
second magnetic field is applied, the electrons can be made to pass from one 
orientation to the other, leading to a peak in the power absorbed. The position, 
structure, and width of the line observed depend on the lifetime of the radical; if 
a reaction occurs which destroys the free radical, thereby changing the lifetime, 
the spectrum is altered. From the observed spectral changes, the rate of the 
reaction can be determined. Rate constants up to about 1010 s-1 have been 
determined (figure 2.1, electron magnetic resonance) (1).  
Nuclear magnetic resonance (NMR) may be exhibited by any compound 
whose molecule contains a nucleus with a spin. The most common nuclei 
include protons (1H and 2H), the common isotopes of nitrogen (14N) and fluorine 
(19F), and also less common isotopes of carbon (13C) and oxygen (17O). NMR is 
analogous to ESR described previously; the spinning nucleus has a magnetic 
moment and a spin orientation associated with it. By applying and modifying a 
second magnetic field the structure of the absorption spectrum and width are 
modified, both of which depend on the lifetime of the nucleus. When the 
environment of the nucleus is altered, such as when the compound undergoes 
a reaction, the spectrum changes. Half-lives accessible are as fast as 10-7 s 
(figure 2.1) (1). 
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2.1.3 Methods used to change t1/2 of a second-order reaction 
Ideally, having the capabilities to measure the rate of a reaction under 
the conditions of interest is ideal but unfortunately desirable conditions may not 
be practical for analysis. Instrumentation to measure fast reactions in solution is 
not commonly found in a majority of laboratories, however, changing 
experimental conditions in order to modify the rate constant can be done. 
Common experimental conditions chosen to vary, which affect the rate, include 
concentration of the reactants, pH, and temperature. Each method chosen has 
its own limitations. 
 
 
 
Figure 2.2: A plot of [A] or pH vs. k. X, Y, and Z points for a generic reaction 
used to point to particular conditions. 
 
k
[A] or 1/[OH-]
X
Y
Z
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Varying the concentration of the reactant(s) is the most common method 
used to change the rate constant. Take the generic example given in Figure 
2.2. In this example, the [A] of interest is at point Y, and gives a certain k. 
Unfortunately, it is not possible to observe the reaction under these conditions 
because [A] is too small to give a change in absorbance which is large enough 
to measure by commonly used instrumentation. By increasing the [A], the rate 
constant also increases, say to point marked with an X. Under these conditions 
suppose the change in absorbance is large enough to observe a change in 
reaction and the rate constant is not too large to measure, making these the 
conditions chosen for analysis. If the [A] is increased to point Z, the rate 
constant also increases. By increasing the [A], there will be a larger change in 
concentration over the course of the reaction, however, the larger the rate 
constant, the more difficult it may be to find an instrument capable of collecting 
the data. Though we were interested in conditions marked by point Y, for 
practical reasons we had to measure the reaction under conditions at point X. 
This is often the situation faced; the conditions under which a reaction is wanted 
to be studied is not practical, and therefore other conditions must be chosen. 
Anytime conditions other than those of interest are studied, there is possible 
error when extrapolating the data. 
For reactions that are pH dependent, changing the pH may slow down 
the reaction enough to use conditions in which the rates are measurable. Using 
extrapolation techniques, it may be possible to estimate the rate constant at the 
pH of interest. Typically, for first-order pH-dependent reactions, every pH unit 
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will change the rate of reaction by an order of magnitude. Using the following 
generic reaction: 
HA −+ + AH     pKa=X 
and 
CHAB →+
 
In this reaction, B reacts with HA, but depending on the pH, there is equilibrium 
between HA and A-. When the pH > X, there is more A- (nonreactive form) and 
therefore less HA is present, which slows down the reaction. Say, for example, 
we want to measure the reaction of B + HA under conditions at point Z (figure 
2.2), however, the rate of the reaction is too fast. Fortunately, the reaction is not 
too fast to measure around point Y. By measuring the rate (and calculating the 
rate constant) under conditions around point Y and plotting 1/[OH-] vs. k, using 
extrapolation we can estimate what the rate constant will be at point Z. 
Extrapolation, while it has been shown to be a good estimator, can be 
problematic. This method often requires extrapolation of the effects of [H+] by 
many orders of magnitude in order to estimate the rates at conditions of 
interest. Also, this method is not practical for measuring all reaction rates if one 
or more of the reactants are unstable under conditions which are suitable for 
measuring the rate. Finally, when one or more reactants have multiple pKa’s, 
changing the pH can complicate the interpretation and extrapolation.   
Another method of changing the rate is by varying the temperature at 
which the reaction is measured at. Generally, by decreasing the temperature of 
the reaction, the rate of the reaction decreases. Temperature also has its own 
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limitations, especially for aqueous solutions in which the minimum temperature 
must be above the freezing point. Also, many instruments are not capable of 
low temperature control. Temperature tends to not have as large of an effect on 
the rate when compared to changing the concentration and/or pH, but is 
another method which can be used to slow down the rate if needed. As when 
changing concentration and pH, by changing the temperature to modify the rate 
to conditions which are observable, those conditions may not be the conditions 
of interest. 
 
2.1.4 Competition reactions 
When the rate constant is known for a reaction, it can be used to obtain 
the rate constant for other reactions if competition conditions can be arranged. 
Take the following generic reactions:  
a
A PkXA →+
 
and 
b
B PkXB →+
 
If kA is known, then by employing conditions in which B is competitive for X, kB 
can be calculated (by measuring the proportions of A, B, Pa, and/or Pb). 
Historically, competition reactions have not been used for fast reactions, 
although there is no reason why they cannot, as long as conditions are chosen 
in which complete mixing can be achieved. Competition reactions can possibly 
have the same issue as others mentioned previously in that conditions in which 
competition is successful might not be conditions of interest. Referring again to 
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figure 2.2, point Y is the conditions of interest for our inhibitor (C), however, we 
need to run the competition reactions under conditions of point Z in order to 
achieve competitive conditions, again facing the potential problem of running 
the experiment under conditions other than what is desired (1).  
Winterbourn has used competition reactions to measure the relative 
rates of reactions of small biological molecules, such as amino acids, with HOCl 
at physiological pH (2). By determining the concentration of the competitive 
biological molecule that inhibits the reaction of HOCl with monochlorodimedone 
(MCD) (chosen as the competing substance) by 50%, a point at which the rates 
of the reaction of HOCl with MCD and the inhibitor are presumably equal, 
Winterbourn was able to measure the relative rates of reactions of biological 
molecules with HOCl (2). Using data collected by Winterbourn (2) along with the 
rate of reaction of HOCl with MCD, Pattison and Davies tried to derive the rate 
constants of the reactions of HOCl with biological molecules (3). However, the 
rates that were extrapolated from measurements made under alkaline 
conditions (4) and those that were derived from the MCD data (2-3) were not 
self-consistent, pointing to a potential problem with one or both of these 
techniques. 
 
2.1.5 Development of the inhibitory titration method 
It is desirable to develop a method to measure the rate of the reaction 
under conditions of interest which utilizes commonly found instrumentation 
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(such as UV-vis or stopped-flow instrumentation), as this would allow research 
groups to investigate reactions which had previously been out of reach. 
Our approach is an extension of the commonly used method of 
competition reactions, with an overall aim to develop a method of measuring 
rates of fast reactions that can be applied to any type of reaction, though our 
particular interest is in biologically relevant reactions. For competition reactions 
used by Winterbourn, for example, the concentration of competitor that is 
required to inhibit the reaction of MCD by HOCl by 50% is used to calculate the 
rates of reaction of HOCl with competitor. Competition reactions typically use 
just this 50% inhibition point, while the rest of the data set remains unused. Our 
method, which is named inhibitory titration (IT), goes one step further and uses 
the whole data set (not just the 50% inhibition point) to fit the data and obtain 
the rate constant. We believe that all of the data is important in accurately 
calculating the rate constant. This is especially important when conditions the 
reaction is being studied under are different from those desired. 
Though our overall goal was to develop a generic method for measuring 
fast reactions, we wanted to investigate a reaction we were interested in to 
validate the IT method. Thus, we used the reaction of SCN- with HOCl. The 
developed method was subsequently used to investigate a new reaction, HSA 
with HOCl. These particular reactions are of interest since members of the 
Ashby research group have demonstrated that HOCl reacts rapidly with 
thiocyanate (SCN-) to give the RSS hypothiocyanite (OSCN-) (5), an 
antimicrobial agent (6). Human plasma contains substantial amounts of SCN- 
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(33±26 µM for non-smokers and 158±51 µM for smokers) (7), an environment in 
which HSA is believed to be the main target of HOCl (5). We believe that in a 
plasma environment, SCN- may be competitive with HSA for HOCl. Having 
accurate rate constants for these reactions may help in modeling the 
partitioning of HOCl in human plasma. 
 
2.2 Experimental methods 
2.2.1 Materials 
All chemicals were A.C.S certified grade or better and were used without 
further purification unless stated otherwise. Water was doubly-distilled in glass. 
Unless otherwise noted, all solutions contain 0.1 M NaCl in 0.1 M phosphate 
buffer at pH 7.4, prepared from Na2HPO4 (used as received from Mallinckrodt). 
Sodium chloride (NaCl) and potassium iodide (KI) were obtained from EMD 
Chemicals. 2-chloro-5,5-dimethyl-1,3-cyclohexanedione (monochlorodimedone, 
MCD), sodium thiosulfate (anhydrous, >98%), sodium thiocyanate (98%), 
potassium dichromate (>99.0%), 2,6-dichlorophenol indophenols sodium salt 
(DCPIP), and Human Serum Albumin (lyophilized powder essentially fatty acid 
free) were all obtained from Sigma-Aldrich. Sodium phosphate dibasic 
anhydrous Na2HPO4 was used as received from Mallinckrodt. Stock solutions of 
hypochlorite (OCl-) were prepared from dilution of commercial bleach (Clorox) 
which had been periodically standardized prior to use. 
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2.2.2 Sample preparation 
2.2.2.1 DCPIP dye 
Stock solutions of DCPIP were prepared from the sodium salt in 0.1 M 
PBS, pH=7.4, [NaCl] = 0.1 M. The concentration of DCPIP was determined 
spectrophotometrically at 600 nm (ε600 = 2.06x104 M-1cm-1) (8). 
 
2.2.2.2 Thiocyanate 
Stock solutions of thiocyanate were prepared from the sodium salt (dried 
in oven for a minimum of 2 hours, then cooled at room temperature in a 
desiccator prior to weighing) in 0.1 M PBS, pH = 7.4, [NaCl] = 0.1 M. 
Concentrations of thiocyanate were determined based on mass of sample, MW 
NaSCN = 81.07 g/mol, and volume of water added (either in volumetric flask or 
with volumetric pipettes).   
 
2.2.2.3 Monochlorodimedone (MCD) 
Stock solutions of MCD were prepared from its salt in 0.1 M PBS, 
pH=7.4, [NaCl] = 0.1 M. The concentration of MCD was determined 
spectrophotometrically at 290 nm (ε290 = 1.99x104 M-1cm-1) (9).  
 
2.2.2.4 Hypochlorous acid 
Stock solutions of HOCl were prepared from dilution of standardized 
commercial bleach into 0.1 M PBS, pH=7.4, [NaCl] = 0.1 M. Approximate 
concentrations of HOCl were determined spectrophotometrically at 292 nm 
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(OCl- ε292 = 350 M-1cm-1) (10), at pH=7.4 there is approximately 50% OCl- and 
50% HOCl). For accurate concentrations, HOCl solutions were titrated with 
MCD (1:1 stoichiometry) spectrophotometrically, observing the disappearance 
of the MCD at 290 nm (ε290 = 1.99x104 M-1cm-1).  
 
2.2.2.5 Human serum albumin (HSA) 
Stock solutions of HSA were prepared from its lyophilized powder into 
0.1 M PBS, pH=7.4, [NaCl] = 0.1 M. Concentrations were determined from 
sample mass (monomer MW = 66,478 g/mol) and known volumes. 
 
2.2.3 Standardization of commercial bleach (hypochlorite) 
The procedure used to standardize hypochlorite stock solutions was 
adapted from a book published by Daniel Harris (11), which consists of first 
standardizing a sodium thiosulfate (Na2S2O3) solution that has been freshly 
prepared, and then using that to standardize the OCl- stock solution. (The 
following uses conditions based on the titration of a stock solution of bleach 
which is 0.4-0.6 M, for concentrations which are higher or lower, the 
concentration of Na2S2O3 (as well as the amount of K2Cr2O7 used to titrate the 
Na2S2O3) needs to be adjusted.  
 
2.2.3.1 Titration of Na2S2O3 
The following solutions were prepared prior to the standardization of 
Na2S2O3: 40 mL of 2.0 M KI (in water, prepared fresh every four hours), 50 mL 
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of a 1:1 (v/v) HCl solution (50% dilution of concentrated HCl into water), and 50 
mL of starch indicator (mix approximately 0.5 g of soluble starch with 2-3 mL of 
water to create a paste, then transfer into 50 mL of boiling water and heat 2-3 
mins until solution is clear, and cool to room temperature). A stock solution of 
approximately 0.1 M Na2S2O3 (0.5-1 L) is prepared from addition of the 
appropriate mass of the salt to water (to prevent bacteria growth, it is important 
to clean the bottle with soap and water, rinsing bottle at least 3 times to rid it of 
residual soap) that is essentially bacteria and CO2 free (achieved by boiling for 
5-10 min., capping, and letting cool to room temperature). Prepare 3-5 
Erlenmeyer flasks with 0.20-0.23 g of K2Cr2O7 (dried in oven for approximately 
2 hours, then cooled at room temperature in a desiccator prior to weighing), add 
approximately 50 mL of water to each sample to dissolve the K2Cr2O7. Prepare 
a burette with the Na2S2O3 solution. To the first K2Cr2O7 sample, add 8 mL of 
2.0 M KI, 10 mL of 1:1 HCl, and titrate immediately with S2O32- until the dark 
red-brown color of I2 has faded to an olive green color. At this time, add 2-3 mL 
of the starch indicator solutions and continue to titrate with S2O32- until the 
purple-black color turns to a pure green, indicating the end point of the titration. 
Repeat for each of the remaining K2Cr2O7 samples. The mechanism for this 
reaction is in (2.4) and (2.5), giving a stoichiometry of 1 Cr2O72-: 6 S2O32-. 
OH7Cr2I3I6H14OCr 232272 ++→++ +−+−     (2.4) 
−−− +→+ I2OSOS2I 2642322            (2.5) 
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2.2.3.2 Titration of bleach 
A diluted bleach solution was prepared by taking 15.0 mL of stock bleach 
and diluting up to 250 mL with water in a volumetric flask (giving a 
concentration of approximately 60 mM, or one around one third of your Na2S2O3 
stock solution). To the Erlenmeyer flasks which contain 50.0 mL bleach sample, 
10 mL glacial acetic acid was added followed by addition of 8 mL of 2.0 M KI. 
The resulting solutions were titrated immediately with the primary standard of 
Na2S2O3 until color fades to a pale yellow. Next add 2 mL of starch solution and 
continue titrating until the sample just becomes colorless. The reaction is 
occurring through the mechanism in (2.6) and (2.7), giving a stoichiometry of 1 
OCl-: 2 S2O32-. 
OHClII2H2OCl 22 ++→++ −−+−           (2.6) 
       
−−− +→+ I2OSOS2I 2642322                    (2.7) 
2.2.4 pH measurements 
The [H+] of the buffered solutions were determined with an Orion Ion 
Analyzer EA920 using an Ag/AgCl combination pH electrode. pH was adjusted 
with NaOH or HCl (made from pellets or concentrated solution, respectively) as 
required. 
 
2.2.5 UV-vis spectroscopy 
Electronic spectra were measured using a HP 8452A diode array 
spectrophotometer with quartz cells calibrated for 1 mm, 2 mm, 1 cm, and 10 
cm path lengths, at 20 ºC. 
 2.2.6 Turbulent mixing of 
HOCl was added drop wise to samples of SCN
 
2.2.7 Biologic instrument
2.2.7.1 General information
A Biologic SFM
a Xe arc lamp and a PMT
system contains two delay
time. It has the capability of single, double, or triple mixing. 
stopped-flow instruments, this instrument drives its syringes individually using 
stepper motors, which allow mixing of solutions to occur in two ways, either by 
continuous flow or interrupted flo
instrument is designed to be used in either stopped
(QF) mode (figure 2.3) 
 
Figure 2.3: Schematic of SFM
samples 
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The instrument contains four syringes (S1-4, figure 2.3), of which two, 
three, or all four can be used. If all four syringes are used, syringes 1 and 2 are 
pushed simultaneously through a DL (delay line). The delay line can be 
modified to create either longer or shorter delay times depending on desired 
aging time of the reaction. The solutions resulting from syringes 1 and 2 is 
mixed with syringe 3 through a second delay line, and finally with syringe 4. In 
stopped-flow configuration, samples are rapidly mixed and pushed through an 
observation cell which allows for direct analysis of absorbance, transmittance, 
or fluorescence on the instrument using the MOS 450. In quench-flow 
configuration, samples are rapidly mixed and collected for analysis by a 
technique which is independent of the SFM-400. A water circulator bath is 
attached, set to 20ºC, encapsulating all SFM syringes, valves, delay lines, and 
cuvettes allowing temperature regulation (12). 
 
2.2.7.2 Quench-flow mode 
A quench-flow experiment designed for a simple reaction of 
CBA →+ Q
 where the reaction is stopped by the addition of a quencher, Q. 
This simple reaction consists of three steps (figure 2.4): a mixing step, an aging 
step, and a quenching step (complex experiments can consist of more steps, 
however, to simplify this discussion, only a three-step setup, the simplest 
quench-flow experiment, will be described) (12).  
 Figure 2.4: Schematic of 
 
The first step is the mixing step, in which A and B are pushed through 
the mixer, by the stepper motors of the syringes, where they are mixed and 
allowed to react to start producing the product C. The second 
step which occurs as the syringes continue to push A and B through the mixer 
and into the delay line. As the samples travel through the delay line, the sample 
ages (i.e. reacts) until it reaches the second mixer. As the sample moves 
through the second mixer it is mixed with the reactant Q, the quencher, which 
quenches (i.e. stops)
analyzed for amount of C produced, or amount of A or B remaining. The 
amount of time allowed for A and B to
defined as total time between the start of the reaction at which A and B combine 
and the quenching of the
syringes are pushed (i.e. flow rate) as well as length of delay line. The t
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simple quench flow setup; M1 and M2 are mixers
step is the 
 the reaction. The sample is then collected and can be 
 react, referred to as the ageing time (
 reaction), depends on both the speed at which 
 
 
aging 
tage, 
age could 
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also depend on the pause time if using interrupted flow. By plotting tage versus 
the results of each sample analyzed, a kinetic trace of the reaction can be 
determined (12). 
 
2.2.7.3 Aging methods for quench-flow 
In quench-flow mode, samples can be aged by one of three means: 
interrupted flow, continuous flow, or pulsed flow. (For stopped-flow experiments, 
the continuous flow method is adopted.) 
 
2.2.7.3.1 Interrupted flow 
 When using interrupted flow as the aging method, the flow of the 
samples is paused for a certain time period, incubating the samples before 
mixing with the quencher. With this type of aging, tage is determined by the 
intermixer volume (delay line volume), the flow rate of the sample into and out 
of the intermixer volume, and the incubation time that the sample waits in the 
intermixer volume (2.8). 
time incubation
volume intermixer through rateflow 
volume intermixert age +=     (2.8) 
This method of aging is typically used for samples which need to be aged 
longer than can be achieved with continuous flow, typically several hundreds of 
ms to several seconds, or longer. With interrupted flow, higher amounts of 
sample are typically needed than in continuous flow, due to the inability of 
recovering the entire sample without contamination. The contamination is due 
to diffusion; though the flow of the samples is stopped during the incubation 
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time, the solution in the delay line is not isolated, it is in contact with solutions A, 
B, and Q, which as the incubation time increases, allows for more time for these 
solutions to diffuse into the intermixer volume, causing unwanted reaction and 
quenching near the mixer interfaces. To try and avoid collection of 
contaminated samples, the leading and ending edge of the intermixer volume 
are thrown out (i.e. partial sample collection). Long delay lines (i.e. delay lines 
that have a higher volume requirement to fill) are used for aging and multiple 
shots are taken in order to collect enough sample for analysis, all of which leads 
to more sample required for the experiment. The longer the incubation time, the 
higher the risk of contamination due to diffusion, causing the need for more 
sample to be discarded (12). 
 
2.2.7.3.2 Continuous flow 
In continuous flow method, just as the name implies, there is no 
interruption in the flow of the sample (no pause from the start of the reaction 
through the sample collection) so tage is determined only by the intermixer 
volume and the total flow rate (2.9). 
volume intermixer through rateflow 
volume intermixert age =    (2.9) 
The time the sample is allowed to age can be adjusted by using a delay line 
which has a larger volume or by changing the flow rate by programming the 
syringes in the driving sequence to either push the solution faster or slower. As 
mentioned previously, the Biologic instrument drives solutions using a stepping 
motor, which unlike the commonly used pneumatic based system, allows for a 
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larger range of flow rates since flow rates are independent of the viscosity and 
temperature of the solutions. Continuous flow is typically used for reactions that 
have a tage from 1 ms up to approximately 200 ms. Unlike interrupted flow, all of 
the sample can be collected and analyzed with minimal risk of contamination 
due to diffusion, since the time period between reaction and quenching is small 
therefore allowing less time for diffusion to occur (12). 
 
 
2.2.7.3.3 Pulsed flow 
Pulsed flow mode is a special aging method that is unique to the Biologic 
instrument, due to the use of stepper motors to drive syringes versus the use of 
pneumatics such as that used in Hi-Tech stopped flow instruments. By making 
a few pulses to fill the delay line (mixing a small volume of solution A and B at a 
time instead of pushing a larger volume all at one time as in continuous flow), 
solutions are turbulently mixed. (Each pulse is essentially a small volume, a 
“plug,” of solution A and B that get pushed through the intermixer volume by the 
next pulse of solution, and as the plug gets pulsed through the delay line it 
ages.) The pulses are followed by a short incubation time and then mixed with a 
quencher. Using this method, tage is determined by the number of pulses used 
to fill the delay line, the flow rate, and the incubation time (2.10). 
( )[ ]1nt
flow DL
Vn
t inc
pulse
age −×+




 ×
=
                        (2.10) 
In (2.10), n = number of pulses; Vpulse= volume of pulse; flow DL = flow rate in 
the delay line; and tinc = incubation time. An advantage of pulsed-flow aging 
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method is in order to achieve a different aging time, only the incubation time 
needs to be modified, the other parameters remain unchanged making varying 
aging times from one sample to the next a quick change. 
 
 
Figure 2.5: Reaction of HOCl (1 mM) with mixtures of MCD (1 mM) and SCN- 
(0-4.6 mM) at pH 7.4 in 0.1 M phosphate and 0.1 M NaCl; percent MCD 
remaining at the end of the reaction (solid circles) 
 
Figure 2.6: Stoichiometry of the reaction of HOCl with SCN- 
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2.3 Results and discussion 
2.3.1 MCD/SCN- competition reaction with HOCl 
Representative data that was collected for the reaction of HOCl with 
MCD in the presence of varying amounts of SCN- are given in figure 2.5. From 
independent experiments we know that SCN- reacts with up to three molar 
equivalents of HOCl. Figure 2.6, a plot of the stoichiometry for the reaction of 
HOCl with SCN- that was calculated from the data, is consistent with the 3:1 
stoichiometry. As can be seen, when the concentration of SCN- is less than the 
concentration of HOCl, more than one molar equivalent of HOCl is consumed. 
However, when [SCN-] >> [HOCl], a stoichiometry of 1:1 is observed.  
 A mathematical program was developed to calculate the absolute rate 
constant for the reaction of HOCl with SCN-. This model makes use of the 
experimental data (see appendix A for complete data set) and our measured 
rate constant for the reaction of MCD with HOCl, 4x106 M-1s-1, a value that is 
comparable to that previously reported (3). To fit the data, we decided on a 
simple model of two parallel second-order reactions, one between HOCl and 
MCD, and one between HOCl with the inhibitor. Since there is no closed 
solution for the simultaneous differential equations that define the reaction 
mechanism of our system, we used Euler’s method to fit the data (13). Using a 
known initial value, Euler’s method takes small steps and integrates them using 
the differential equations in order to produce a numerical value. Figure 2.7 is a 
flowchart of the iterative procedure we used in our program to compute the rate 
constants. 
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START
END
IS
[MCD]calc=[MCD]obs
?
YES
IS
[MCD]calc>[MCD]obs
?
kX = kX - inc kX = kX + inc
YES NO
NO
IS
[HOCl]calc = 0
?
NO
[MCD]calc=[MCD]calc-h*kMCD[MCD][HOCl]
[X]calc=[X]calc-h*kX[X][HOCl]
[HOCl]calc=[HOCl]calc-h*kMCD[MCD]-h*kx*S*[X][HOCl]
YES
 
Figure 2.7: Flowchart of the iterative procedure that was employed to compute 
the rate constants, assuming parallel second-order reactions of HOCl with MCD 
and X (where X = inhibitor). The constant h is the incremental step for numerical 
integration and S is the experimental stoichiometry. 
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To explain, the program (see appendix B for program code) starts by 
taking the calculated MCD (MCDcalc) value (arbitrarily chosen as twice the 
experimental MCD (MCDobs) value for starting the program) and compares it to 
the experimental MCD value. If they are not the same, the program will take the 
rate constant for X and increase it if MCDcalc is greater than MCDobs, or 
decrease the rate constant by the increment if MCDcalc is less than MCDobs. This 
incremental amount is calculated by the percent difference in MCDcalc and 
MCDobs, which allows for smaller steps to be taken as the calculated MCD value 
approaches the experimental MCD value. The program enters an inside loop in 
which it takes the amount of HOCl and runs through the loop, calculating a new 
MCD value each time, until there is no HOCl left. Once all the HOCl is 
consumed, it takes the MCDcalc and repeats the program, comparing that value 
to the MCDobs. To summarize, the program takes a calculated MCD amount, if it 
is not the same as the experimental MCD amount, it changes the rate constant 
for HOCl + X (X = SCN-
 
for these experiments) and goes through and 
recalculates another MCDcalc, until MCDcalc = MCDexp (uses the experimentally 
found amount of MCD to calculate the k for the inhibitor, SCN-). Table 2.1 gives 
the results of the program. 
 
 
  
45 
 
Table 2.1: Program output which includes the data point number (i), the 
experimental [SCN], the experimental %MCD, the %MCD the program 
calculated, and the rate constant the program calculated (does not take 
stoichiometry into account, calculated based on one data point, using [SCN]exp 
and %MCDcalc).  
i [SCN]exp %MCDexp %MCDcalc kSCN calc 
0 6.00E-05 9.6 9.6 1.07E+07 
1 1.10E-04 25.0 25.0 3.29E+07 
2 2.30E-04 43.0 43.0 3.99E+07 
3 3.40E-04 57.8 57.7 5.70E+07 
4 4.60E-04 63.3 63.2 5.08E+07 
5 5.70E-04 67.0 66.9 5.51E+07 
6 6.90E-04 73.0 72.9 5.89E+07 
7 8.00E-04 75.0 75.0 6.71E+07 
8 9.20E-04 78.7 78.6 5.81E+07 
9 1.03E-03 80.6 80.5 6.03E+07 
10 1.14E-03 83.0 82.9 5.73E+07 
11 1.43E-03 88.0 87.9 5.43E+07 
12 1.72E-03 88.5 88.4 4.38E+07 
13 2.00E-03 89.7 89.6 4.06E+07 
14 2.29E-03 91.6 91.5 4.28E+07 
15 2.57E-03 92.4 92.3 4.15E+07 
16 2.86E-03 92.7 92.6 3.82E+07 
17 3.15E-03 93.3 93.2 3.74E+07 
18 3.43E-03 94.2 94.1 3.93E+07 
19 3.72E-03 95.2 95.1 4.30E+07 
20 4.00E-03 95.8 95.7 4.50E+07 
21 4.29E-03 95.4 95.3 3.86E+07 
22 4.58E-03 95.8 95.7 3.92E+07 
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The next step was to develop code which uses a given rate constant to 
calculate a %MCD remaining (see appendix C for full code), and that %MCD 
can be used to fit the experimental data. The code developed has two parts; it 
calculates the %MCD without any consideration of stoichiometry, so assumes 
HOCl reacts with either MCD or SCN-. The code also calculates the %MCD with 
consideration of the possibility of over-oxidation of the SCN- (i.e. HOCl reacts 
with either MCD or SCN-, then HOCl can react with OSCN-, the product of HOCl 
and SCN-, and likewise HOCl can further react with O2SCN-, the product of 
HOCl and OSCN-). Figure 2.8 is a plot of the resulting program output 
(complete data set in appendix D) plotted along with experimental data points 
and stoichiometry. 
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Figure 2.8: Reaction of 1 mM HOCl with mixtures of 1 mM MCD and SCN- (0 -
3.5 mM) at pH 7.4 (100 mM phosphate, 100 mM NaCl). Experimental 
percentage of MCD remaining at the end of the reaction (solid circles); the 
calculated percentages of MCD at the end of the reactions with (solid line) and 
without (dashed line) consideration of the stoichiometry. 
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As can be seen in figure 2.8, at [SCN-] > 1.5 mM, where a stoichiometry of 1:1 
is observed, the simple model in which no stoichiometry is considered (dashed 
line) suffices in the fitting of the data. However, at lower concentrations of SCN-, 
this simple model is not appropriate, but a model which considers three (but not 
two) sequential reaction steps fit all of the data (solid line). From independent 
stopped-flow experiments performed at higher pH, it is known that these three 
sequential reaction steps that SCN- undergoes when oxidized by HOCl are of 
the same order of magnitude. Keeping this in mind, it was found that kX : kXO : 
kXO2 = 1.0 : 0.1 : 0.4 and kSCN = kX = 1.9x107 M-1s-1 satisfactorily fit the data. The 
agreement in the rate constants calculated by our two program methods is 
remarkable. Using our experimental MCD values (first program), we found a kscn 
= 4.5x107 M-1s-1. Using a kscn of 1.9x107 M-1s-1, along with values of kX : kXO : 
kXO2 = 1.0 : 0.1 : 0.4, we were successfully able to fit our experimental data 
(program two). If you compare these two rate constants to kSCN = 2.34(9)x107 M-
1s-1, extrapolated from the rate constants between HOCl and SCN- that was 
measured between pH 10.5-13.8 and extrapolated to pH 7.4 (5), there is even 
more room for excitement. Given that this extrapolation involved a 103 change 
in [H+], there is a remarkable agreement in the rate constant. Also worth 
mentioning is a possible problem in the traditionally used competition reaction 
method (e.g. Winterbourn (2)) which assumes that the pseudo-rate constants 
are equal at the point of 50% inhibition; examining figure 2.8, the 50% inhibition 
point does not correspond to a stoichiometry of 1:1, which was shown to be 
essential in correctly fitting the data. 
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2.3.2 MCD/HSA competition reaction with HOCl 
We studied the reaction of HOCl with the inhibitor HSA. HSA, being a 
protein, has multiple sites of possible reaction with HOCl along with some sites 
being capable of being over-oxidized (i.e. Met groups). Table 2.2 lists some of 
the amino acid residues found in HSA and their (free amino acid) rate constants  
with HOCl; SCN- is added to the table for comparison (3,5,14-16).  
 
Table 2.2: Second-order rate constants for the reactions of HOCl with amino 
acids and lipid components; SCN- added for comparison; *estimated values. 
Moiety # residues in HSA kHOCl (M-1s-1) 
His 16 1.0x105 
Lys 59 5.0x103 
Arg 24 1.8x103 
Asn 17 0.03 
Gln 20 0.03 
Cys* 1 3.0x107 
Met* 6 3.8x107 
Cystine 17 1.6x105 
Tyr 18 44 
Trp 1 1.1x104 
RNH2 1 1.0x105 
Amide 583 10 
SCN-* 0 2.3x107 
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As can be seen in table 2.2, the most reactive residues are the 6 Met 
and 1 Cys residues. Unlike SCN-, which reacts with HOCl through three 
sequential reactions, HSA is capable of undergoing multiple parallel reactions. 
In addition, each subsequent reaction can undergo sequential reactions, 
possibly complicating the analysis of the data and interpretation. The 
procedures that were employed for HSA were done similar to those for SCN-. A 
plot of the data along with calculated stoichiometry is in figure 2.9 (complete 
table of data in appendix E). 
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Figure 2.9: Reaction of 100 µM HOCl with mixtures of 100 µM MCD and HSA 
(0-61 µM) at pH 7.4 (100 mM phosphate, 100 mM NaCl). %MCD remaining 
(squares), stoichiometry of reaction (circles) 
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Table 2.3: Program output which includes the data point number (i), the 
experimental [HSA], the experimental %MCD, the %MCD the program 
calculated, and the rate constant the program calculated (does not take 
stoichiometry into account, calculated based on one data point, using [HSA]exp 
and %MCDcalc) 
i Xexp (M) %MCDexp %MCDCalc kXcalc (M-1s-1) 
0 1.67E-06 11.1 11.1 5.65E+07 
1 3.34E-06 20.1 20.1 9.08E+07 
2 6.68E-06 33.7 33.7 1.19E+08 
3 1.00E-05 40.8 40.8 1.28E+08 
4 1.50E-05 51.9 51.8 1.47E+08 
5 1.80E-05 56.4 56.3 2.07E+08 
6 2.14E-05 60.4 60.3 2.05E+08 
7 2.40E-05 64.1 64 1.74E+08 
8 2.74E-05 66.4 66.3 2.34E+08 
9 3.01E-05 69.7 69.6 2.40E+08 
10 3.34E-05 74.1 74 2.95E+08 
11 3.61E-05 76.3 76.2 2.98E+08 
12 3.94E-05 78.7 78.6 2.77E+08 
13 4.21E-05 82.2 82.1 2.66E+08 
14 4.54E-05 83.8 82.8 3.60E+09 
15 4.34E-05 83.3 83.2 4.76E+08 
16 5.14E-05 91.2 91.1 5.52E+08 
17 6.15E-05 98.3 98.2 2.52E+09 
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As seen in figure 2.9, stoichiometry of up to 7:1 were observed, which is 
consistent with the prediction that Cys-34 and the six Met groups of HSA should 
be the most reactive. Similar to SCN-, the experimental data was fit using the 
first program (no consideration of stoichiometry) (code in appendix F), resulting 
in a rate constant for the reaction of HOCl with HSA, table 2.3. 
Comparing this rate constant to that by SCN- (kSCN = 4.5(9)x107 M-1s-1), 
this is about an order of magnitude faster. The second program (consideration 
of stoichiometry) was used to calculate %MCD remaining in an attempt to 
obtain a better fit of the experimental data, but difficulties were encountered. 
We could not successfully find a model which gave a good fit of the data. We 
started by trying to fit the data using 7 parallel reactions, all with similar rate 
constants, however, there were several run-time errors in the program code, 
which we did not investigate further. Though the SCN- model is not appropriate 
(three consecutive reactions), we were able to successfully get the program to 
run, and so it is included here for discussion. Figure 2.10 gives a plot of the 
experimental data along with some results from fitting the data using the SCN- 
model, which shows how the fit changes with the program conditions. 
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Figure 2.10: Reaction of 100 µM HOCl with 100 µM MCD and varying amounts 
of HSA (0-61 µM) at pH = 7.4 (100 mM phosphate and 100 mM NaCl). 
Experimental %MCD (circles); calculated %MCD using k = 5.5x108 M-1s-1
 
with 
(triangles) and without (diamonds) consideration of stoichiometry; calculated 
%MCD using k = 5.5x107 M-1s-1
 
without consideration of stoichiometry 
(squares); calculated %MCD using k = 5.5x106 M-1s-1
 
without consideration of 
stoichiometry (crosses) 
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In figure 2.10, the circles are the experimental data. Looking at a fit with 
(triangles, figure 2.10) and without (diamonds, figure 2.10) stoichiometry taken 
into account, when stoichiometry is considered, the calculated data more 
closely resembles the experimental. When comparing how changing the rate 
constant affects the fit, we need to compare the k = 5.5x108 M-1s-1 (diamonds, 
figure 2.10), k = 5.5x107 M-1s-1 (squares, figure 2.10), and k = 5.5x106 M-1s-1 
(crosses, figure 2.10). Changing the rate constant from 106 to 108 M-1s-1 did not 
make any depreciable difference (we observed similar behavior when using a 
mathematical program (appendix G and H) to model the kinetics when using 
sulfite as the inhibitor). This shows that by increasing the rate constant between 
HSA and HOCl, the data does not fit better. However, taking stoichiometry into 
account is needed to improve the fit of the data, although HSA is not believed to 
go through subsequent reactions like SCN-. We were unable to successfully 
find a good fit for the data, however it does show the importance of including 
stoichiometry in accurately fitting the data. 
We note there were problems with the reproducibility in this system. 
Depending on the technique used for mixing (slowly pouring reactants together, 
using a hand-mixer, vortexing sample while adding oxidant dropwise, or using 
the quench-flow instrument), results were not reproducible between methods 
(i.e. data obtained from using the hand-mixer gave different results than when 
mixed using quench-flow instrument). Use of the quench-flow instrument to mix 
the reactants gave the most consistent results from one experiment to the next. 
Studying the reaction using different mixing techniques helped us understand 
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the importance of turbulent (or complete) mixing for these very fast reactions. 
When the reactants react faster than they are mixed, a heterogeneous (not 
homogenous) reaction may occur. For larger molecules, like proteins, which are 
capable of reacting with multiple equivalents of HOCl, incomplete mixing will 
affect results.   
  
2.4 Summary and conclusions 
 Measuring rate constants directly under conditions of interest (e.g. 
concentration, pH, and temperature) is ideal, however, sometimes not practical 
due to experimental and instrumental limitations. Researchers have used 
methods such as pH extrapolation (for reactions which are pH dependent, 
changing the pH may slow down the reaction enough to use conditions at which 
the rate constant is measurable, and then use extrapolation to estimate the rate 
constant at the pH of interest) and competition reactions (when the rate 
constant is known for a particular reaction, it can be used to obtain rate 
constant for another reaction if competitive conditions can be employed) to 
indirectly measure rate constants under conditions of interest (1), thus avoiding 
these limitations. Comparison of rate constants from pH extrapolation and 
competition reactions has shown inconstancies (2-4) which needed 
investigating. Our inhibitory titration method has given insight into these 
inconsistencies. 
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Competition reactions typically use the 50% inhibition point for 
measuring rate constant of the competition reaction, while the rest of the data 
set remains unused (i.e. rate constant is calculated from one data point). In 
addition, reactions are typically assumed to be measured under pseudo first 
order conditions (independent of initial concentration), though the rate laws for 
the two competition reactions are sometimes not understood. 
The method that is developed here, inhibitory titration (IT), tries to 
minimize assumptions that can create problems when indirectly measuring rate 
constant. Firstly, IT makes use of all the data collected, not just the 50% 
inhibition point; fitting the complete data set to obtain the rate constant. We 
show that the rate constant measured using just the 50% inhibition point 
underestimates the rate constant compared to that which fits all of the data. In 
addition, consideration of the stoichiometry of the reaction is important for 
accurately fitting data, especially when over-oxidation is possible. Our data 
shows that taking the stoichiometry of the reaction into consideration produces 
a better fit than assuming the reaction has a 1:1 stoichiometry. Without 
consideration of the rate law for the reaction, one may derive a first order rate 
constant from a second order reaction, leading to a misrepresentative rate 
constant. 
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2.5 Future experiments 
• Validation of IT method: A simple system needs to be chosen to validate 
the IT method. We investigated complex systems (biomolecules which 
react with multiple stoichiometry and possible over-oxidation) that were 
of particular interest to us. To show the overall general use of the IT 
method for measuring rate constants of fast reactions, a simple system 
needs to be used. 
o Take the simple system of XOA kA→+  and YOB kB→+ , 
where kA (a known value) and kB are the rate constants of the 
reactions, respectively. Both reactions need to be non-complex 
reactions. The products X and Y cannot be reactive (so a 
stoichiometry between A or B and O is a 1:1) and no reactive 
intermediates can be formed. Also, the mechanisms for the 
reactions needs to be the same under the experimental conditions 
where the competition reaction occurs as well as the conditions at 
which kA and kB are measured independently. The best option is 
to validate the method under the same conditions as kA and kB 
can be independently measured. In addition, kA and kB must be of 
similar orders of magnitude. 
• Additional experiments need to be performed with HOCl and HSA to aid 
in the development of a mathematical program that can fit the data and 
obtain a more accurate rate constant for this reaction. Also, additional 
experiments may help provide insight into the complex reaction which is 
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occurring including how many equivalents of HOCl that HSA is able to 
scavenger. In addition, studying larger biological molecule may help 
understand turbulent mixing issues. 
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Chapter 3: Oxidation of Methionine by Hypochlorous Acid, Search for an 
Intermediate 
 
3.1 Introduction 
3.1.1 Methionine 
Methionine (Met) is one of only two sulfur containing amino acids, with 
Cys being the other. It is an essential amino acid that humans are unable to 
synthesize, so it must be obtained from dietary sources (e.g. nuts, fish, and 
meats). Met can be found as the free amino acid or within proteins. Like Cys, 
Met has several functions including antioxidant defense (1), regulation of 
cellular function through reversible oxidation and reduction (2-5), and 
functioning as a methyl donor, a process which is necessary for the synthesis of 
proteins (6). 
Free Met reacts with adenosine triphosphate (ATP) in a reaction 
catalyzed by methionine adenosyltransferase. The reaction forms S-Adenosyl 
methionine (SAM), a compound which serves as a methyl donor in biochemical 
pathways such as the synthesis of epinephrine and coline (7-8). The majority of 
Met, however, is found within proteins. Met serves as an initiator in protein 
synthesis and is encoded into the N-terminal position of all eukaryotic proteins 
(N-formylmethionine, a Met derivative is encoded at the N-terminal in bacterial 
proteins), though it is sometimes removed by post-translational modification (2). 
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3.1.2 Oxidation of methionine 
Met is oxidized by a host of oxidants, both one and two electron ROS 
(i.e. H2O2, hypohalous acids, ozone, peroxynitrite, superoxide, and 
chloramines) (9). Oxidation occurs over a broad pH range (2). Due to the ease 
of oxidation, Met is believed to play an important role in defending proteins 
against high levels of ROS during times of oxidative stress (9). MPO, the heme 
containing enzyme found in mammalian neutrophils, which catalyzes the 
oxidation of chloride by hydrogen peroxide to form HOCl, contains 36 
methionine residues (10-12). These Mets may offer protection to the MPO, 
which is often in an environment that has a high concentration of oxidants. 
Oxidation of Met forms a mixture of S and R isomers of methionine 
sulfoxide (MetO) (13); further oxidation produces methionine sulfone (MetO2). 
Formation of MetO can be biologically reversed while that to the sulfone is not. 
While free Met can be used as a methyl donor, formation of the sulfoxide 
deprives it of that ability. Protein Met oxidation can have varying consequences 
depending on the location and the extent of oxidation, but Met oxidation is 
mostly thought of as decreasing or inhibiting the activity of the protein. In some 
cases, however, oxidation of protein Met has lead to the activation of the protein 
(i.e. cell signaling) (5). 
Most proteins have Met that is capable of being oxidized. The amount of 
MetO present in protein is believed to be directly related to the severity and 
duration of oxidative stress in diseases. High levels of sulfoxide have been 
found in cataract lens (about 2/3 of total Met is oxidized) as well as rheumatoid 
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arthritis fluid (13-14). In addition, studies have shown a correlation between 
levels of MetO and age-related illnesses such as Alzheimer disease (13-15). 
Oxidation of protein Met to the sulfoxide influences the biological activity of the 
protein and has been proposed to cause protein aggregation and dysfunction 
(16-18). Lavine et al. have compiled a list of proteins and peptides in which the 
activity is altered as a result of Met oxidation (2). Met, when located near the 
active sites of enzymes (e.g. glutamine synthase), acts as a protector during 
times of increased levels of oxidant (14). In vitro experiments have shown that 
oxidation of Met-36 and Met 48 of human stem cell factor (SCF, a protein that 
plays a role in formation of blood cells) alters the tertiary structure and 
ultimately decreases the biological activity (18-19). Studies have been 
performed on the oxidation of α-1-proteinase inhibitor, a serum protein that is 
known to regulate elastase (an enzyme that breaks down elastin, a protein in 
connective tissue) activity and play a role in emphysema of smokers. Oxidation 
of the Met-358 inactivates the protein. Fortunately, activity is restored when the 
oxidized protein is incubated with methionine sulfoxide reductase (Msr) in the 
presence of thioredoxin (20). 
The oxidation of Met to MetO does not always lead to loss of activity. α-
2-macroglobulin, a protease inhibitor (inhibits proteases from breaking down 
proteins) that functions at sites of inflammation where high levels of damaging 
ROS exist, has been shown to scavenge at least 10 equivalents of ROS (21). 
Continuous exposure to oxidants eventually leads to the oxidation of α-2-
macroglobulin’s one tryptophan, causing inactivation (21). Luo et al. stated that 
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Met residues appeared to act as molecular bodyguards, protecting the 
important tryptophan residue (21). Similar results were found with a study of 
glutamine synthetase (an enzyme that plays a role in metabolism of nitrogen by 
catalyzing the formation of glutamine) (22). Levine et al. oxidized glutamine 
synthase with H2O2 and found that 8 of the 16 Met residues in the protein were 
oxidized to MetO. These eight oxidized Mets were located near the surface of 
the protein, lining the entrance to the active site, while the eight unmodified 
Mets were buried (oxidation of the active site is known to cause inactivation of 
glutamine synthetase) (1,22). As with α-2-macroglobulin, activity was 
preserved. Luo et al. suggested that the ability of Met to scavenge oxidizing 
equivalents without loss of activity along with their placement in the protein(s) 
that protects important functional groups helps show the ability of Met to defend 
against oxidants. Furthermore, since oxidation of Met to its sulfoxide can be 
reversed (20), it shows the effective scavenging of more reactive species by 
proteins such as these two mentioned. 
Oxidation of Met residues in proteins tends to increase the surface 
hydrophobicity of the protein (2). Considering that MetO is less hydrophobic 
than Met, this is contrary to what would be predicted. When Met is oxidized to 
MetO, the oxygen perturbs the folding pattern of the protein, exposing more 
hydrophobic resides, causing the hydrophobicity to increase. The more 
extensive the oxidation damage becomes, the more likely the protein will go 
through proteolysis (digestion of proteins by enzymes called proteases) (2, 20-
21). 
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3.1.3 Mechanism of oxidation 
The thioether group of Met is readily oxidized by a large number of 
oxidants. A selected list of oxidants that react with Met appears in a review by 
M.J. Davies (23), and includes hydroxyl radical, ozone, H2O2, HOCl, HOBr, 
chloramines, and peroxynitrite. As previously mentioned, the major product 
from the oxidation of Met, whether it be protein bound or not, has been reported 
as MetO, rarely has sulfone been found in a biological system (5,23). 
The mechanism by which Met is oxidized by oxidants to form its 
sulfoxide is not completely understood. Oxidation of Met by radicals such as 
hydroxyl radical (•OH) is believed to occur with an addition at the sulfur atom to 
form R-•S(OH)-R adduct, which goes through a series of fast reactions to 
eventually form the sulfoxide (15,24). The exact mechanism is not known but it 
is believed that multiple pathways can lead to the sulfoxide product. One theory 
is that the initial adduct reacts with itself forming a dimeric radical cation that 
contains a two centered three-electron bond, a compound believed to be 
stabilized by neighboring resides (24-25). Similarly, a three electron 
intramolecular S-N bond has been proposed, one in which the sulfur and amide 
nitrogen form a 5 member ring (25). It has also been proposed that the adduct 
reacts with other radicals, such as superoxide to give the sulfoxide (23,26). Met 
reacting with two electron oxidants is also believed to form a short-lived adduct, 
though there is no direct evidence (23). Reaction of Met with H2O2 and other 
peroxides is believed to initially form an R-S+(OH)-R species which is rapidly 
deprotonated to give the sulfoxide (23). The reaction of Met with H2O2 is a 
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rather slow reaction (k = 6x10-3 M-1s-1) (23) but can be catalyzed by both copper 
and iron, two biologically relevant metals (although very little free metal ion is 
found in vivo). In the presence of these metals, H2O2 reacts to form •OH (5) 
which oxidizes Met (k = 8x109 M-1s-1) (23). Similar to the uncatalyzed reaction of 
Met with H2O2, reaction with hypohalous acids (e.g. HOCl and HOBr) are likely 
to produce the analogous R-S+(Cl/Br)-R intermediate which rapidly hydrolyzes 
to the sulfoxide (23,27-28). 
Sulfenyl halides (R-S(Cl/Br)] and halosulfonium cations [R-S+(Cl/Br)-R] 
are often suggested to be the intermediates in the oxidation of Cys and Met, 
respectively, though there is little kinetic and mechanistic evidence for their 
involvement (27,29-33). Armesto et al. performed a mechanistic study of the 
reaction of Met (and Cys) with HOCl. Though they were not able to find direct 
evidence of an intermediate, they were able to develop a mechanism, 
supported by their experimental results, in which Met is chlorinated through an 
effective Cl+ transfer from the oxygen of HOCl to the sulfur of Met, forming a 
chlorosulfonium cation. The chlorosulfonium cation then hydrolyzes to form 
MetO. Armesto et al. conclude that a detailed mechanistic study is still needed 
(27). Though discussed in more detail in chapter four, it is worth mentioning a 
study by Hong et al. who examined the iron catalyzed reaction of Met by H2O2 
and found evidence for an azasulfonium intermediate. The azasulfonium of Met, 
referred to in other publications as dehydromethionine (DHM), slowly 
hydrolyzes to the sulfoxide at neutral pH (26,34).    
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3.1.4 Methionine sulfoxide reductase 
Most organisms, whether they are human or bacteria, have methionine 
sulfoxide reductase (Msr), a family of enzymes that catalyze the reduction of 
MetO to Met (3). Since oxidation of Met in proteins can lead to either activation 
or inactivation of their biological activities, Msr serves to repair oxidative 
damage of some proteins. It also plays an important role in the regulation of 
protein activities by facilitating the interconversion of Met residues between 
oxidized and reduced forms. Oxidation of Met forms a mixture of S and R 
isomers of MetO (3.1). MsrA catalyzes the reduction of S-MetO and MsrB the 
reduction of R-MetO. Both MsrA and MsrB catalyze the thioredoxin [Th(SH)2] 
dependent reduction of MetO to Met (3.2). In addition, oxidized thioredoxin 
(THS-S) can be reduced back to thioredoxin by Nicotinamide adenine 
dinucleotide phosphate (NADPH) (3.3). The net reaction is the consumption of 
ROS by NADPH (3.4) (1-3,13,21).  
   
inactiveROSMetOROSMet +→+
     (3.1) 
         )SThS(MetMsr)SH(ThMetO 2 −+ →+    (3.2) 
     
++ +→++− NADP)SH(ThHNADPH)SThS( 2    (3.3) 
                  
inactiveROSNADPHNADPHROS +→++ ++
    (3.4) 
Msr is believed to play a vital role in protection against oxidative stress. 
In studies conducted on mutant strains (modified to remove the Msr gene) of 
mice (35), bacteria (36-38), and yeast (39), lack of the Msr gene made the 
organism more sensitive to oxidative stress versus the wild-type strains (13). In 
addition, over-expression of the Msr gene in human T cells (40), yeast (40), and 
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fruit flies (41), leads to an increase in the resistance in oxidative stress (13). 
Studies have shown a correlation between age-related diseases and the 
amount of Msr present. Stadtman et al. wrote a review article which has shown 
that MsrA in rat tissue declines with age (13). Levels of Msr are lower in 
patients (vs. healthy patients) whom have age-related disease such as 
Alzheimer’s disease (42), emphysema (especially in smokers) (5,43), and 
Parkinson’s disease (44-45). In addition, lower levels of MsrA activity in mice 
led to a 40 % decrease in the life span (13,35), while over-expression lead to an 
almost doubling of the life span (41). 
 
3.2 Experimental methods 
3.2.1 Materials 
All chemicals were A.C.S certified grade or better and were used without 
further purification unless stated otherwise. 18.2 MΩ•cm water, obtained from a 
Millipore Milli-Q A10 ultrapure water purification system, was used for all 
experiments. Unless otherwise noted, all solutions contain 0.1 M NaCl in 0.1 M 
phosphate buffer at pH 7.4, prepared from NaH2PO4•3H2O and Na2HPO4 (used 
as received from Mallinckrodt). Sodium chloride (NaCl), sodium hydroxide 
pellets (NaOH), and potassium iodide (KI) were all obtained from EMD 
Chemicals. 2-chloro-5,5-dimethyl-1,3-cyclohexanedione (monochlorodimedone, 
MCD), sodium thiosulfate (anhydrous, > 98%), potassium dichromate (> 
99.0%), 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB, 99%), sodium sulfite (> 
98%), DL-methionine (> 99%), DL-methionine sulfoxide (> 99%), DL-methionine 
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sulfone (> 99%), DNP-DL-methionine sulfoxide (95%), DNP-DL-methionine 
sulfone (95%), 1-fluoro-2,4-dinitrobenzene (FDNB, > 99%), and iodomethane 
(99%) were all obtained from Sigma-Aldrich. Sodium phosphate dibasic 
anhydrous Na2HPO4 was used as received from Mallinckrodt. Sodium 
hydroxide solution (50% certified) used for preparation of chromatography 
eluents was obtained from fisher chemical. 
 
3.2.2 Sample preparation 
3.2.2.1 Hypochlorous acid 
Stock solutions of NaOCl were prepared by sparging Cl2 into a 0.3 M 
solution of NaOH. The sparging was stopped when the [OCl-] was 
approximately 0.1 M, as determined spectrophotometrically at 292 nm 
(OCl- ε292 = 350 M-1cm-1) (46). Solutions prepared by dilution of stock solution 
into water or buffer were further standardized prior to experimental use. 
Approximate concentrations of HOCl were determined spectrophotometrically at 
292 nm (OCl- ε292 = 350 M-1cm-1) for solutions with pH > 10  (a drop of 
concentrated sodium hydroxide was added to raise pH if needed) (46). For a 
more accurate measurement of concentration, HOCl solutions were titrated with 
MCD (1:1 stoichiometry), spectrophotometrically observing the disappearance 
of the MCD at 290 nm (ε290 = 1.99x104 M-1cm-1) (47) or titrated with Na2S2O3 as 
described in chapter 2. All HOCl stock solutions were titrated prior to reaction. 
To avoid possible issues with reaction of HOCl and buffer (discussed in chapter 
2), all HOCl solutions with concentrations < 25 µM were prepared in water. 
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3.2.2.2 Synthesis of DNPMet 
 Dinitrophenyl-methionine was synthesized similar to the method used by 
Levy et al. (48). In 40 mL (at 40 ºC) of DI water, 2 g DL-Met and 2.5 g Na2CO3 
(pH = 9-10) were added and stirred until mostly dissolved. To the solution, 2.5 g 
1-fluoro-2,4-dinitrobenzene (FDNB) was added. The reaction was allowed to 
continue until there was no more unreacted FDNB, after which the solution was 
acidified with 6 M HCl until yellow. The solution was put in the refrigerator (~ 2 
ºC) overnight. Precipitate was collected and recrystalized twice with 
ether/pentane (dissolve in minimum amount of ether with 4x amount of pentane, 
put on ice, filtered to collect yellow ppt). Yellow precipitate was dried under 
vacuum overnight and then stored in freezer (at -20 ºC). Neither percent yield 
nor purity was determined (NMR data looked free of unreacted Met). 
 
3.2.2.3 Synthesis of TNBMe 
 TNB (5-thio-2-nitrobenzoic acid) was synthesized from dissolving 1 g 
DTNB (Ellman’s reagent) and 0.64 g sodium sulfite (dried in oven overnight) in 
50 mL water. The solution was stirred for about an hour and then acidified with 
HCl and extracted twice with petroleum ether. The organic layer was collected 
and dried over CaCl2. After gravity filtering the organic layer, it was kept in 
refrigerator (~2 ºC) overnight, and the crystals were collected and dried under 
vacuum. TNB was refluxed with CH3I (in about 50mL water) overnight, acidified 
with HCl, and the resulting yellow precipitate was collected by filtration. Neither 
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percent yield nor purity was determined (NMR spectrum looked free of 
unreacted TNB). 
 
3.2.2.4. Methionine studies 
 A 550 µM Met solution (in 100 mM PBS, pH = 7.4) was made by 10.3 mg 
Met in 25 mL buffer, 1:5 dilution with buffer. A 610 µM MetO solution was 
prepared by dissolving 0.0126 g in 25 mL buffer, followed by a 1:5 dilution in 
buffer. A 305 µM MetO2 was prepared by dissolving 0.0138 g in 25 mL buffer, 
followed by a 1:5 dilution in buffer. Absorbance spectra collected using HP 
diode array and 1 cm cell to determine approximate molar absorptivities. 
 
3.2.2.5. TNBMe titration and molar absorptivity 
A stock solution of TNBMe was prepared by 10.3 mg in 100 mL buffer 
(0.05 M PBS, 0.1 M NaCl, pH = 7.4). The UV-vis spectral data were collected 
using HP8452. Molar absorptivity of the TNBMe was calculated using Beer’s 
law (known concentration, path length, and measured absorbance) as well as 
from the titration experiments. A stock solution of 485 µM gave an absorbance 
of 0.493 (0.1 cm cell), giving a calculated value of ε = 10,165 M-1cm-1. For 
titration experiments, HOCl (stock made in 0.1 M NaOH) solutions were 
standardized with sodium thiosulfate, and then diluted into buffer. Various 
aliquots were added to TNBMe solutions and spectra were taken using UV-vis 
diode array (190-820 nm). 
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3.2.3 High performance liquid chromatography (HPLC) 
 A Gilson HPLC was equipped with a 156 UV-vis (dual wavelength), 805 
manometric module, 811b dynamic mixer (1.5 mL mixing chamber), and two 
305 pumps. Eighty microliters of sample was manually injected into a 20 µL 
loop. The data was monochromatically collected at 358 nm, using Gilson 
Unipoint 5.11 software. DNP-Mets were separated on a varian microsorb 100-5, 
C18, 250 x 4.6 mm column using an isocratic gradient of 1.30 mL/min flow rate 
with 80% A (1% acetic acid in water), 20% B (acetonitrile). All eluents were 
prepared using HPLC grade solvents, 18.2 MΩ•cm water, and degassed under 
vacuum (while stirring) for about 30 minutes prior to using. 
 
3.2.4 Ion chromatography (IC) 
 Ion chromatography experiments were performed using a Dionex ICS 
3000. The instrument was equipped with a single pump, electrochemical 
detector with pH/Ag/AgCl reference electrode and gold working electrode 
(either disposable or non-disposable), and an AS autosampler. Samples 
containing mixtures of Met, MetO, and MetO2 were separated on aminopac 
PA10 amino acid column (2 x 250 mm), equipped with a guard column (2 x 50 
mm), and analyzed using Dionex’s Chromeleon chromatography management 
software. The instrumental method used was a modification of Dionex’s 
standard amino acid analysis method for separation of “oxidation products of 
methionine, cysteine, and cystine,” document number 031481-12. All eluents 
used were prepared with 18.2 MΩ•cm water that was degassed by bubbling 
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ultra high purity helium through for 30 minutes prior to using. Sodium hydroxide 
solutions were prepared by diluting a 50% sodium hydroxide solution with 
previously degassed water. To avoid excess carbonate formation, all eluents 
were kept under a blanket of nitrogen. In addition, 50% sodium hydroxide stock 
solutions were discarded every 6 months or when 1/4 of the stock solution 
remained (sodium hydroxide has a high potential of being contaminated with 
carbon dioxide, forming carbonate which increases the noise level). 
 
3.2.5 Biologic instrument 
 The biologic instrument is described in more detail in chapter 2. Briefly, 
experiments were performed in either stopped-flow or quench-flow mode. 
Stopped-flow mode (single mixing) was used for the reactions of MetO with 
HOCl and TNBMe with HOCl. In stopped-flow mode the instrument can either 
be used to observe the kinetic traces (as a function of time) or scan a sample to 
obtain a complete absorbance spectrum (parascan mode). The experiments 
involving reaction of Met or DNPMet with HOCl used quench-flow mode. The 
quench-flow experiments were similar for both reactions and occurred in 
double-mixing mode using a combination of continuous flow (for delay times 
<200 ms) and pulsed flow (delay times > 200 ms). Met (or DNPMet) was mixed 
with HOCl and after a set delay time, the sample was quenched with excess 
sodium sulfite [reacts with HOCl with a k = 109 M-1s-1 (49)]. Met and DNPMet 
were prepared in 200 µM PBS (pH = 7.4) (100 µM after mixing 1:1 with HOCl). 
HOCl was prepared in water instead of buffer [diluted from its initial stock 
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solution (0.1 M OCl- in 0.1 M NaOH)] to avoid possible interaction between 
phosphate and HOCl at these low concentrations (micromolar) (discussed in 
chapter 2). The pH of reacted solution was measured for every other sample to 
ensure that the pH of the sample after reaction was 7.4±0.4. Sulfite, used as the 
quenching agent for the reaction, was prepared fresh (sulfite air oxidizes to 
sulfate, resulting in a loss of its quenching ability) in water. The sulfite used to 
quench the reaction was no more than five times the concentration of HOCl 
used (a large excess of sulfite corrodes the gold electrode and decreases 
sensitivity over time).    
 
3.2.6 Intermediate production 
 Our experiments focus on pseudo-first order conditions. For a simple 
reaction in which no intermediate is formed, we would expect the data to fit to a 
simple first order plot. Any deviation from first order kinetics may be evidence 
for an intermediate being formed. Unfortunately, depending on the experimental 
conditions and properties of the intermediate, non-deviation from first order plot 
does not necessarily mean an intermediate is not being formed. Take the 
following generic reaction: 
IkOA A→+
 
BkI I→
 
To get significant deviation from a first order fit of the data, the second reaction 
needs to be significantly slow with respect to the first reaction (i.e. kA >> kI, 
causing a buildup of I to occur). If kA and kI are similar, then an overall first order 
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plot is observed (as fast as the reaction can produce I, it disappears forming B, 
so no buildup of an intermediate is observed). If kA > kI or kI > kA, either first or 
second order overall may occur. We are hoping for biphasic kinetics 
(combination of two first order plots), which would indicate multiple reactions 
are occurring. Unfortunately, only under a narrow range of experimental 
conditions are biphasic kinetics observed (need approximately a tenfold 
difference in rate constants to see any buildup of an intermediate). Observing 
biphasic kinetics is dependent not just on the rates of reactions, but also on the 
molar absorptivities of the reactants and products, since we are monitoring the 
reaction by either the disappearance of reactant (A) or appearance of product 
(B). If both A and B have distinctive molar absorptivities (εA and εB), we will see 
A disappear and B appear, forming one or more “tight” isosbestic points (the 
wavelength at which the absorptivities of A and B are equal). To observe an 
intermediate form, εA and εI (or εB and εI) need to be different enough so that 
their spectra can be differentiated. Depending on how different the molar 
absorptivities are (between A, I, and B), determines how “tight” the isosbestic 
point is. The less “tight” the isosbestic point is, the more indication that multiple 
species are being formed (50).   
 
3.3  Results and discussion 
 Several reactions were investigated in hopes of finding evidence for a 
chlorosulfonium (or sulfenyl chloride) intermediate buildup. 
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3.3.1 Oxidation of methionine by HOCl 
 Figure 3.1 shows the calculated (from Beer’s law) molar absorptivities of 
Met, MetO, and MetO2. The molar absorptivities are relatively low and 
unfortunately do not produce distinct absorbance spectra (several compounds 
absorb in this region of the spectrum). 
 
 
Figure 3.1: Molar absorptivity as a function of wavelength (in 100 mM PBS, pH 
= 7.4) of Met (circles), MetO (squares), and MetO2 (diamonds).  
 
In addition, the rate constant of the reaction of Met with HOCl at pH = 7 has 
been estimated to be around 3x107 M-1s-1 (28). Due to the low molar absorptivity 
and large rate constant (at neutral pH), it is difficult to directly follow the kinetics 
of a reaction using conventional equipment (i.e. stopped-flow instrument which 
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has a mixing time on the order of ms). Under pseudo-first order conditions, a 
reaction with a half-life of 20 ms (a reasonable half-life for a reaction studied 
using stopped-flow instrument) and rate constant of 3x107 M-1s-1 would need a 
reactant concentration of about 1 µM to be measurable by stopped-flow. A 1 µM 
solution of Met would give a maximum change in absorbance of 2 mAU, too 
small to measure accurately. Increasing the concentration would help increase 
the absorbance change; however, it also speeds up the rate of the reaction. A 
similar situation would be observed for a reaction under second-order 
conditions, giving concentration of each reactant as 1.6 µM. Since direct 
observation of the reaction was not feasible, we utilized the quench flow 
method, quenching the reaction after varying delay times with a reductant. 
Sodium sulfite was chosen as the quenching agent, a compound that reacts 
with HOCl and is presumed to not react with MetO, MetO2, and any 
intermediate that may form. Representative data are shown in figure 3.2 (IC 
chromatogram). 
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Figure 3.2: Representative ion chromatography chromatogram for mixture of 
Met (C), MetO (A), and MetO2 (B). Solutions were made up in 1 mM PBS, pH = 
7.4. 
 
 
Figure 3.3: Reaction of Met (1.5 µM) with HOCl (1.5 µM) in 100 µM PBS, pH = 
7.4, quenched with excess sodium sulfite (9 µM) after various delay times. Data 
was fit to a second order reaction giving k = 4x108 M-1s-1. 
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Figure 3.3 is a representative trace of the reaction of Met with HOCl. The 
trace fits to a second order reaction and gives a k = 4x108 M-1s-1, which is a 
larger than had been previously estimated (55). This difference could be due to 
several factors including different experimental conditions (buffer concentration, 
ionic strength, etc.) and also lack of sufficient data points. As can be seen in 
figure 3.3, under these conditions the reaction is over half way completed 
before our first data point is collected. Ideally, data should be collected so that 
there are more data points near the beginning of the reaction and less towards 
the end, however, the instrument has a limitation as to how fast it can 
mechanically mix solutions. To increase the t1/2, a smaller concentration of 
reactants could be used, however, this is nearing the limits of detection of the 
IC instrument. Although it may be worth investigating further to get a more 
accurate rate constant, this is all a moot point in relation to an intermediate 
formation. Though the reaction does not fit perfectly to a first order reaction, it 
does not appear to be biphasic (biphasic is a combination of two first order 
reactions and can indicate multiple reactions are occurring such as would be 
observed if there was a buildup of an intermediate which subsequently 
underwent a reaction). From the experiments performed, there does not appear 
to be definitive evidence for a buildup of an intermediate. That being said, it is 
worth pointing out that during these studies, we were never able to recover all 
of our oxidizing equivalents. Since equal amounts of HOCl and Met were 
reacted, we would expect all Met to be consumed. In addition, the longer the 
samples aged after collecting, the more Met was detected (figure 3.4). Though 
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this issue of lack of recovering all oxidizing equivalents is worth pursuing 
(discussed further in chapter 4), it does not give conclusive evidence for 
presence of an intermediate. 
 
 
Figure 3.4: Reaction of Met (1.5 µM) with HOCl (1.5 µM) in 100 µM PBS, pH = 
7.4, quenched with excess sodium sulfite (9 µM) after various delay times. 
Samples analyzed within 12 hours of collecting samples (circles), and samples 
analyzed > 24 hours after collecting samples (squares). Data points are 
averages with error bars of three samples. 
 
3.3.2 Oxidation of methionine sulfoxide by HOCl 
The reaction of MetO with HOCl was investigated. Figure 3.5 shows a 
portion of the absorbance spectrum collected for the reaction of MetO with 
HOCl. As shown, there is an increase in the absorbance at about 252 nm, 
characteristic of chloramine formation (51). 
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Figure 3.5: Reaction of MetO (500 µM) with HOCl (50 µM) in 5 mM PBS at pH 
= 7.4. Absorbance spectra (collected via biologic instrument) of reaction (dotted 
line) versus no reaction (solid line). Inset shows an increase in peak at 252 nm. 
 
Neither MetO nor MetO2 have a significant molar absorptivity at 252 nm 
(figure 3.1). Therefore, if the oxidation of MetO formed MetO2, there should not 
be a peak at 252 nm; however a peak is clearly present (figure 3.5). The 
absorbance max for HOCl is 230 nm (292 nm for OCl-), so this does not appear 
to be unreacted oxidant. Additionally, the new species at 252 nm is stable (no 
significant decrease in absorbance after 8 hour period) so it is not likely an 
intermediate. A typical kinetic trace is shown in figure 3.6. 
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Figure 3.6: Reaction of MetO (500 µM) with HOCl (50 µM) in 5 mM PBS at pH 
= 7.4, kinetic trace followed at 254 nm and fit to first order equation giving kobs = 
280 s-1 (calculated k = 5.6x105 M-1s-1). 
 
Though these particular reaction conditions are pushing the limits of the 
instrument (change in absorbance and rate of reaction), the trace clearly fits a 
first order reaction, giving a kobs = 280 s-1 (second order k = 5.6x105 M-1s1, 
calculated using concentration of MetO); similar results were determined under 
second-order conditions (k = 8.4x105 M-1s-1). Experimental studies of MetO + 
HOCl shows no evidence for any intermediate buildup. A somewhat surprising 
result is evidence for the formation of a chloramine, not MetO2, when MetO is 
oxidized by HOCl (the amino group of MetO reacts faster than the sulfoxide 
group). This can help explain why MetO2 is rarely found in a biological system 
(5,23). MetO can be reduced back to Met by use of the enzyme Msr and 
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chloramines can transfer its oxidizing equivalents to another compound 
(forming MetO). MetO2, on the other hand, is a “dead” form of Met, with no 
practical means of reverting back to Met. In vivo, however, this reaction may be 
irrelevant considering a vast majority of Met is protein bound and do not have 
free amino groups which are capable of forming chloramines (unless found at 
the N-terminus of a protein). 
 
3.3.3  Oxidation of DNPMet 
 Dinitrophenyl-methionine (DNPMet), a derivative of Met which has the 
amino group blocked by the dinitrophenyl group, was synthesized. The addition 
of the dinitrophenyl group increases the molar absorptivity of the compound, 
relative to Met. With an increase in the molar absorptivity, it may be possible to 
directly observe the kinetics of the reaction, leaving out the need to quench the 
reaction (important if an intermediate reacts with the quenching agent). Figure 
3.7 shows the absorbance spectra of DNPMet, DNPMetO, and DNPMetO2. 
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Figure 3.7: Absorbance spectra (0.1 cm cell; HP8452A diode array) of DNPMet 
(Solid line, 0.01164 g in 100 mL 0.1 M PBS pH = 7.4), DNPMetO (long dashed 
line, 0.00664 g in 50 mL 0.1 M PBS pH = 7.4), DNPMetO2 (dashed line, 
0.00616 g in 50 mL 0.1 M PBS pH = 7.4). Using Beer’s law, molar absorptivities 
were calculated as DNPMet ε358nm = 1.55x104 M-1cm-1; DNPMetO ε358nm = 
1.74x104 M-1cm-1; DNPMet ε358nm = 1.69x104 M-1cm-1. 
 
As was expected, the addition of the DNP group to the Met increases the 
molar absorptivity, by a factor of around 10. Unfortunately though, the spectrum 
and molar absorptivities between the DNPMet’s are very similar, which could 
still potentially be a problem for directly following the kinetics of the reaction, 
since we monitor the reaction by a change in absorbance. As with Met, our best 
option was to use quench-flow, thereby collecting the samples and analyzing 
offline using another instrument, in this case HPLC with UV-vis detection (since 
the compounds still do have large extinction coefficients). The DNPMet 
derivatives were successfully separated using HPLC (figure 3.8). 
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Figure 3.8: Representative chromatogram of a mixture of DNPMetO (RT = 2.5 
min) and DNPMet (RT = 7.5 min). 
 
The reaction between DNPMet and HOCl was done similarly to that with 
Met and HOCl. The reactants were mixed in equal amounts and then after a 
known delay time, the reaction was quenched with sulfite, collected, and 
analyzed for amounts of DNPMet and DNPMetO remaining. Figure 3.9 
illustrates a representative plot of the kinetic trace of the reaction along with a fit 
to a second-order reaction, k = 5x106 M-1s-1. Unlike what was observed with the 
oxidation of Met by HOCl, we were able to recover all of the HOCl in this 
reaction, but there still does not appear to be any intermediate (a stoichiometric 
conversion of DNPMet to DNPMetO is observed). Though we were not able to 
find any intermediates, this system was straight forward and to the best of the 
author’s knowledge, had not been investigated before. 
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Figure 3.9: Reaction (100 µM PBS, pH = 7.4) of DNPMet (1.2 µM) with HOCl 
(1.2 µM), quenched with excess sodium sulfite (20 µM) after varying delay 
times, fit with rate constant of 5.5 ± 0.3x106 M-1s-1. 
 
3.3.4 Oxidation of TNBMe 
 Still searching for an intermediate, we investigated the oxidation of 
TNBMe with HOCl (scheme 3.1), hoping that an intermediate would be longer 
lived in this system, increasing the chance of observing it. 
 
Scheme 3.1: Proposed mechanism for the oxidation of TNBMe by HOCl, 
forming a chlorosulfonium ion intermediate. 
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TNBMe is a thioether derivative of TNB (5-thio-2-nitrobenzoic acid), a 
compound commonly used for redox titrations. Though TNBMe (and TNB) is 
not biological relevant, it has a distinct advantage over the Met system in that it 
has a large molar absorptivity, allowing for the possibility to directly observe the 
kinetics, instead of reacting and quenching, a process in which an intermediate 
has the possibility of also being quenched. Figure 3.10 shows the titration of 
TNBMe using varying amounts of HOCl. The TNBMe peak at 352 nm 
disappears with the addition of HOCl forming a new peak at 280 nm, which is 
presumed to be the TNBMeO (sulfoxide of TNBMe). 
 
Figure 3.10: Titration of 240 µM TNBMe with 0-500 µM HOCl (pH = 7.4, 0.05 M 
PBS, 0.1 M NaCl). Absorbance spectra taken using HP8452A diode array. 
From top to bottom (at 350 nm), stoichiometry TNBMe:HOCl, 1:0 (∆), 1:0.3 (+), 
1:0.6 (x), 1:0.8 (◊), 1:1(□), 1:2(○). 
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A molar absorptivity, determined using Beer’s law (known concentration 
and pathlength), was found to be ε352 = 1.0x104 M-1cm-1. The molar absorptivity 
was also determined by a plot of [TNBMe] versus absorbance, taken from the 
titration of TNBMe, giving a molar absorptivity of 9.8x103 M-1cm-1 (figure 3.11). 
 
 
Figure 3.11: Plot of [TNBMe] (M, calculated by [TNBMe]0 – [HOCl]0) versus the 
A352 (circles) (using a 0.2 cm cell, data collected on HP8452A diode array), fit 
using linear equation y = 1.9735 x + 0.0336. Using Beer’s law, A = ε*b*c, ε = 
9.8x103 M-1cm-1 was determined. 
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Figure 3.12: Reaction of 50 µM TNBMe with 10 µM HOCl (monitored at 352 
nm). Data fit to first order reaction (solid line), trace from top to bottom (all done 
at pH = 7.4, top four traces (circles and squares) in 180 µM PBS (low buffer), 
bottom two traces (diamonds) in 50 mM PBS (high buffer), and solutions 
prepared with or without Cl- added): (•)kobs = 0.68 s-1 (TNBMe in low buffer, 
HOCl in water); (○)kobs = 0.91 s-1 (TNBMe in low buffer, HOCl in water, 0.1 M Cl-
); (■)kobs = 0.68 s-1 (TNBMe in low buffer, HOCl in low buffer); (□)kobs = 0.91 s-1 
(TNBMe in low buffer, HOCl in low buffer, 0.1 M Cl-); (♦)kobs = 0.58 s-1 (TNBMe 
in high buffer, HOCl made in water, 0.1 M Cl-); (◊)kobs = 0.57 s-1 (TNBMe in high 
buffer, HOCl made in high buffer, 0.1 M Cl-). (Kinetic traces are offset by an 
absorbance of 0.01.)  
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  Reaction of TNBMe with HOCl (under various experimental conditions), 
unfortunately turned up no evidence of formation of an intermediate. Figure 
3.12 gives representative kinetic traces, all of which fit well to a first order 
reaction. As can be seen in figure 3.12, traces have subtle differences though 
all fit very well to a first order reaction. Sample conditions, such as chloride 
addition to modify the ionic strength, changes the rate slightly, but no evidence 
for any build up of an intermediate was obtained. From initial examination of the 
data, it did not appear to make a marked difference on the kinetics as to how 
HOCl was prepared (in buffer or water). Further examination of this, however, 
shows a possible effect of buffer on the reaction (figure 3.13). 
 
 
Figure 3.13: Reaction of 50 µM TNBMe with 10 µM HOCl Data (180 µM PBS, 
pH = 7.4), reaction data collected within 5 min of preparation of reactants 
(squares, bottom) and after 2 h (circles, top), both fit to first order equation 
(solid line); bottom (t < 5 min) kobs = 0.68 s-1; top (t > 2 h) kobs = 1.0 s-1. 
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Figure 3.13 compares reaction data for TNBMe + HOCl within five mins 
of preparation versus allowing the HOCl to age in buffer for around two hours, 
and then reacting with TNBMe. The reaction rate appears to increase as HOCl 
ages in the buffer (further experiments are needed to confirm that the difference 
in rates is more than experimental error). This observation can be explained as 
a slowly forming complex between HOCl and phosphate buffer; the longer the 
HOCl is stored in the buffer, the more complex could form (possibly forming an 
equilibrium although further investigation is necessary to confirm this). This 
HOCl-buffer complex and HOCl may react with TNBMe differently. Similar 
results were observed when both TNBMe and HOCl were prepared in buffer 
which contained chloride (180 µM PBS, 0.1 M Cl-, at pH 7.4) (t < 5 min, kobs = 
0.91; t > 2 hours, kobs = 1.3), but not observed when HOCl was prepared in 
water and reacted with TNBMe (in buffer). 
Though not well represented in literature, inorganic phosphate is known 
to be oxidized by H2O2, forming a compound known as peroxymonophosphoric 
acid (52-53). It is conceivable that an analogous reaction occurs when 
phosphate is in the presence of HOCl. Though the possible formation of a new 
oxidant similar to peroxymonophosphoric acid is exciting and could play a role 
in reactions in which HOCl is stored in phosphate, we did not further investigate 
due to the unlikelihood of this reaction being biologically relevant (the reaction 
between inorganic phosphate and HOCl to form this compound is negligible in a 
biological setting compared to reactions of HOCl with other compounds).  
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3.4 Summary and conclusions 
The rate constants for the reaction of HOCl with Met, MetO, DNPMet, 
and TNBMe have been measured. In general, HOCl reacts with thioethers, at 
neutral pH, with a second order rate constant of 106-108 M-1s-1, consistent with 
those reported in literature (27,54-55). The reactions studied in this chapter 
unfortunately did not show conclusive evidence for the buildup of a 
chlorosulfonium intermediate. No biphasic kinetics was observed. In addition, 
polychromatic studies of the reaction of TNBMe with HOCl showed a “tight” 
isosbestic point, indicating a lack of detectable intermediate (50). 
Taking the reaction of TNBMe with HOCl as an example, we can 
estimate the lifetime of the intermediate, though some assumptions are needed. 
An intermediate would likely have a similar absorbance spectrum to that of 
TNBMe (56). Since no buildup of an intermediate was observed, the rate 
constant for the intermediate must be at least 10 times faster than the reaction 
of TNBMe + HOCl, giving a half life of an intermediate less than 100 ms. With a 
half life of 100 ms at pH = 7, presumed to be the hydrolysis of the intermediate, 
the intermediate should be long enough lived to observe under stopped-flow 
conditions, if the intermediate has a distinguishable molar absorptivities. 
Though there is a lack of direct evidence for the reaction of HOCl with 
thioethers being able to produce a chlorosulfonium ion intermediate, estimated 
lifetimes should be sufficiently long enough to find conditions at which the 
intermediate can be observed. 
 
94 
 
3.5 Future experiments 
 
• Find direct evidence for a chlorosulfonium intermediate 
o Study a simple thioether which has a distinctive spectrum for both 
the thioether and sulfoxide form of the compound. Vary 
experimental conditions to try and find evidence for an 
intermediate 
 Vary pH of reaction to try and find an intermediate 
• Lower pH should increase rate of reaction between 
thioether and HOCl and decrease rate of hydrolysis 
of an intermediate (biggest chance of finding an 
intermediate, however, one must consider solubility 
of the reactants; typically Met is not soluble at pH 
values that are less than its pKa(COOH) 
• Higher pH should decrease rate of reaction between 
thioether and HOCl and increase rate of hydrolysis 
of an intermediate 
 Since rate constants for the reaction of HOCl with 
thioethers are 105-107 M-1s-1, a thioether which has a large 
extinction coefficient will aid in studying the reaction 
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• Study a system which produces the analogous sulfenyl chloride 
intermediate 
o Chlorosulfonium (R-S+(Cl)-CH3) intermediates carry a charge and 
may be shorter lived than their analogous sulfenyl chloride 
intermediates (R-S-Cl); studying sulfenyl chlorides may help in 
finding conditions in which chlorosulfonium ions are more stable 
• Find a method of trapping the chlorosulfonium intermediate allowing it to 
be isolated and characterized 
o Search for chlorosulfonium intermediates in vivo as way of 
identifying which type of oxidant it originated from 
• Determine if the analogous bromosulfonium or iodosulfonium 
intermediates can be formed and isolated 
• Investigate the possible formation of a phosphate-HOCl complex, since a 
large number of studies are performed with HOCl in a buffered system; 
determine if this complex causes any interference in reactions of interest 
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Chapter 4: Oxidation of Methionine by Halogens to Produce the Potential 
Biomarker Dehydromethionine.1 
4.1 Introduction 
4.1.1 Oxidation of proteins 
Virtually all biological molecules (e.g. lipids, DNA, RNA, carbohydrates, 
cholesterol, and proteins) are susceptible to reactive oxidants produced in vivo, 
which include one electron oxidants (e.g. radicals) and two electron oxidants 
(e.g. hypohalites). Reactions of oxidants with biological molecules can cause a 
variety of modifications. These modifications cause different degrees of 
damage, often leading to a loss of function, degradation of the protein, and 
progression of various diseases. Diseases associated with protein damage 
include atherosclerosis, chronic inflammation, and some cancers (1). The 
extent of the damage depends on the rate at which an oxidant reacts with a 
potential target (i.e. concentration of the target and rate constant for reaction of 
oxidant with target) as well as the body’s ability to regulate the extent of the 
reaction. Regulation of reaction depends on several factors such as location of 
target in relation to site of oxidant formation, the availability of oxidant-
scavenging reactions (i.e. antioxidants), occurrence of transfer reactions, and 
ability of the body to repair damage done as a consequence of the reaction. In 
the biological system (e.g. tissue, cellular fluid, and biological fluid such as 
plasma), proteins comprise the majority of the dry weight of cells, up to 70% (2-
                                                          
1
 The work that is described in this chapter has been published: Beal J.L, Foster S.B., 
Ashby M.T. “Hypochlorous Acid Reacts with the N-Terminal Methionines of Proteins to 
Give Dehydromethionine, a Potential Biomarker for Neutrophil-Induced Oxidative 
Stress.” Biochemistry. 2009;48:11142-8. 
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3). The large abundance along with their high reactivity with a variety of 
oxidants makes proteins a major target of oxidants. Different amino acid 
residues of the protein are more or less susceptible to different oxidants. In 
general, Trp, Tyr, His, Met, Cys, Phe, and Arg residues are most reactive 
towards oxidants along with the protein backbone (4).  
 A large number of rate constants are available in the literature for amino 
acids with different oxidants under a variety of different experimental condition. 
This includes a database devoted to solution kinetics (5). Knowledge of the rate 
constant of an oxidant with the various amino acid residues is helpful in 
developing computational models that might be used to predict which sites of a 
protein will undergo oxidation. However, such models must be considered to be 
approximate, since knowledge of rate constants alone do not allow for inclusion 
of other determining factors of reactivity (e.g. location, since amino acids buried 
within the protein will be harder to oxidize then those on the surface). Likewise, 
kinetic data for the oxidation of the protein with a particular oxidant is limited in 
its utility. The constants predict the overall rate of reaction but do not give 
information on selectivity of the oxidant with respect to the different sites of the 
protein (4). 
A variety of techniques have been used to examine the oxidative 
damage of proteins. A recent review by Hawkins et al. (3) points out that most 
of the methods currently employed are chosen based on the ease of use 
instead of the importance, and lead to qualitative data, not quantitative, making 
comparison between different research groups difficult. Oxidized proteins are 
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typically digested into smaller fragments and then separated and analyzed 
using GS/MS, LC/MS, or LC/UV-vis (3,6-7). A few of the more commonly used 
techniques are discussed here. 
Analysis of oxidized proteins through its digestive products is the most 
commonly used method of analysis. Digestion can either be a total, which 
cleaves all amino acid bonds, or enzymatic, which cleaves only certain amino 
acid bonds as determined by the type of enzyme used. 
Total digestion uses elevated temperatures and either strong acidic or 
basic conditions, which hydrolyzes the protein into its individual amino acids. 
Amino acids can then be analyzed directly using Ion Chromatography (8) or 
derivatized with a chromophore, such as o-phthalidialdehyde (OPA), and 
analyzed by HPLC (3). Advantages of this method include high sensitivity 
(micro-molar concentration) and experience of being a well understood method. 
A disadvantage of this method is lack of specificity, so if a protein has two of the 
same amino acid residue, one cannot be distinguished from the other. Another 
disadvantage is that problems exist for analyzing certain amino acids. For 
example Cys and Met are often oxidized during the hydrolysis if care is not 
taken to rid the system of oxygen. Also, some amino acids are unstable during 
hydrolysis conditions (e.g. tryptophane) which can lead to misinterpretation of 
results (3,9). 
Digestion is also done using enzymes that cleave the protein at specific 
peptide bonds. Trypsin, for example, cleaves a peptide bond at the carboxyl 
side of lysine or arginine (except when either is followed by proline). Unlike total 
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digestion, products of enzymatic digestion leave peptides, and not individual 
amino acids. Peptides resulting from the enzyme digestion are typically 
analyzed using LC/MS (10). Enzymatic digestion has the advantage of using 
milder conditions (typically 37 °C and pH = 7.4; Cy s and Met are not likely to be 
oxidized during the enzymatic digestive process), as well as providing specific 
information about which residues are modified (peptides not individual amino 
acids are analyzed) and what modification occurred (based on mass changes). 
A disadvantage of this method is the possible trouble in separation of peptides. 
The more complex (i.e. large number of peptides) and less purified the protein, 
the harder it may be to separate and identify the individual peptides. Also, 
enzymatic digestion itself may be problematic due to some proteins (e.g. 
ubiquitin (Ub) (11)) being resistant to digestion as well as possible self digestion 
of the enzyme resulting in more peptides peaks to separate and possibly 
complicating analysis (3).   
Due to new technological advances, a less common method, yet steadily 
growing field, for analysis of oxidized protein is analysis of the intact 
(undigested) protein. Direct analysis of the oxidized protein would have several 
advantages over digestive methods, including reduced cost in sampling which 
allows for higher through-put in sample analysis. Also, though methods are 
developed in the digestive process to avoid unwanted sample modification (e.g. 
oxidation of Met or Cys), the fewer additional steps during sample preparation 
the less chance of having unwanted modifications to the protein.  Analysis of 
intact oxidized protein is being done using NMR spectroscopy (both 1D and 
106 
 
2D). A major disadvantage of NMR analysis is the low sensitivity of NMR 
spectroscopy (compared to MS). Low sensitivity can be overcome by 
isotopically labeling the protein before analysis; however, labeling leads to 
higher sample costs. NMR spectroscopy has the advantage of high 
reproducibility along with non-destructiveness, so the same sample can be run 
using various NMR sampling techniques without the need to remake samples, 
as well as allowing for analysis of the same sample through additional methods 
such as MS (6,12-13). Intact oxidized proteins are sometimes analyzed by other 
methods such as UV-vis spectroscopy, electron paramagnetic resonance 
(EPR), electrospray ionization (ESI) mass spectrometry, or matrix-assisted laser 
desorption/ionization (MALDI) mass spectrometry; however, these methods 
give information about changes to the protein as a whole, and not to specific 
sites of the protein (3,6). 
Whether proteins are oxidized by radicals or non-radicals, there tends to 
be specific modification to the protein that researchers look for during analysis. 
Select amino acids that are highly susceptible to oxidation include Cys, Tyr, 
Met, and Lys, and are often tested for modification in the protein product. 
Ptolemy et al. (7) and Hawkins et al. (3) have written reviews discussing the 
amino acids that are susceptible to oxidation as well as potential products of 
oxidation. For example Cys, which exists in proteins as either the Cys (-SH) or 
cystine (-S-S-), produces the oxidative products sulfinic and sulfonic acid (14). 
When oxidation of protein occurs by HOCl, Tyr residues are oxidized to 
monochloro-tyrosine or dichloro-tyrosine. 
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4.1.2 Biomarkers of oxidation by halogenating agents 
 Neutrophils, the body’s first line of defense against invading pathogens, 
is a major source of the reactive oxidants and are likely contributors to the 
oxidative damage associated with inflammatory diseases (15). Neutrophils 
possess both oxidative and non-oxidative defense mechanisms. Their oxidative 
defense mechanisms are implicated in the oxidative stress that is associated 
with many inflammatory diseases, including atherosclerosis (16). Activated 
neutrophils generate superoxide and H2O2 at sites of inflammation via a 
respiratory burst (1). In addition, MPO is released. MPO is a heme enzyme that 
utilizes H2O2 to oxidize a variety of substrates, namely halides and pseudo-
halide ions to generate the ROS HOCl, HOBr, and HOSCN (17-18). MPO is 
believed to play a central role in many inflammatory diseases (18-21). Methods 
commonly used to characterize the end products (i.e. targets) of protein 
oxidation were discussed earlier; however, characterization of the specific 
oxidants responsible for a given modification of the biomolcules is far more 
challenging since these reactive oxidants, mainly radicals and ROS, that are 
associated with biomolecular oxidation are extremely short lived, making direct 
measurement of them in vivo extremely challenging (17,22). As a consequence, 
considerable research has gone into identifying suitable biomarkers of specific 
oxidants (15,22). A good biomarker needs to be specific for the reactive species 
studied as well as both chemically and biologically stable. The target of 
oxidation needs to have a high enough concentration and reactivity towards the 
oxidant so that the biomarker can be produced in a large enough quantity to be 
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detected (17). Identification of biomarkers is important in both determining the 
extent of oxidative damage as well as possibly identifying the nature of the 
oxidant that has caused the damage. Biomarkers can provide information that 
would allow for development of antioxidant therapies to prevent further injury, 
possibly preventing, or at very least delaying, the onset of inflammatory 
diseases like atherosclerosis (23). 
Much effort in the last decade has been put into developing potential 
biomarkers that uniquely assesses the possible involvement of MPO in the 
development of inflammatory diseases, in particular the involvement of the ROS 
HOCl (15,17-18,21,24-26). Neutrophilic MPO is the only naturally occurring 
mammalian enzyme that is capable of oxidizing Cl- to HOCl at a significant rate 
under physiological conditions. HOCl is capable of regulating the inflammatory 
response by both stimulating and repressing inflammatory mediators. 
Inflammatory response is critical in the resolution of infection, but 
overstimulation of neutrophils is a likely contributor to host tissue damage. 
Therefore, HOCl can be both beneficial and destructive, which accounts for the 
considerable interest in identifying biomarkers that uniquely assess the 
involvement of HOCl in vivo. A recent review by Winterbourn et al. lists the 
advantages and disadvantages of existing biomarkers for MPO-derived HOCl, 
which include chlorinated tyrosine (3-TyrCl and 3,5-TyrCl2), lipid chlorohydrins, 
5-chlorocytosine, protein carbonyls, and a sulfonamide derivative of glutathione 
(GSA) (15,27). GSA, characterized and discussed in more detail by Harwood et 
al. (28), is of particular interest as an attractive biomarker for HOCl because 
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thiols (e.g. glutathione, the precursor to GSA) are among the first chemical 
targets of HOCl in a biological setting (29). Thioethers are as reactive towards 
HOCl as thiols. For the thioether Met, it has been suggested that the sulfoxide 
(MetO) is the final product of oxidation by hypohalous acids (30-37). Studies 
involving the oxidation of Met by I3-, however, show the formation of an 
intermediate called dehydromethionine (DHM), which is slowly hydrolyzed to 
the expected MetO product (38-45). We suspected that in addition to oxidation 
by triiodide, DHM is formed from the oxidation of Met by other halogenating 
agents such as HOCl and HOBr, which would make it an attractive biomarker 
for oxidation of Met by halogenating agents. 
 
4.1.3 Dehydromethionine 
 Prior to 2009, a literature search for DHM results in a little over a dozen 
papers published, with the latest of which being more then 10 years ago (38-
57). DHM was first identified and isolated in 1945 by Lavine (44) from the 
oxidation of Met with iodine. The product of the reaction was iodine-free and 
differed from Met by the loss of two hydrogens atoms. In addition, Lavine 
discovered that the reaction was reversible, regenerating iodine. Lavine found 
the product (DHM) to be extremely hygroscopic. At pH 7 in aqueous solution, 
DHM slowly hydrolyzes to MetO. Hydrolysis is accelerated by phosphate and 
other buffers, as well as acidic and alkaline conditions. Due to the ease of 
formation of DHM as well as the high stability at neutral pH, Lavine suggested 
that it may have biological importance (44). 
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 Gensch et al. (58) performed a detailed kinetic study of the oxidation of 
Met by iodine to form DHM (4.1). 
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In this study the rate constant for both the forward (formation of DHM) and 
reverse (reduction of DHM) reactions were determined independently. The rate 
constant for the forward reaction, oxidation of Met by iodine, was determined to 
be 6.5x105 M-1s-1, and the rate constant of the reverse reaction is 27 M-3s-1. 
Reaction rates were found to be dependent on the pH, concentration of iodide, 
and buffer concentration. The reaction rate for the forward reaction (in a 
buffered system) was found to increase with an increase in pH (linear between 
pH 4 and 8), which the authors suggested could be due to the involvement in 
the mechanism of the free amino group (with pKa of about 9). In addition, the 
forward reaction rate is found to be inversely dependent on the concentration of 
iodide. Iodine, the reactive form of the oxidant, is only slightly soluble in 
aqueous solutions and instead exists as triiodide (I3-). The higher the iodide 
concentration the more the oxidant exists in the nonreactive form, I3-. The rate 
of the reverse reaction (reduction of DHM), was found to increase with both a 
decrease in pH (pH 0 to 6) and an increase in iodide concentration [as expected 
from the equilibrium reaction shown in (4.1)]. Gensch examined two possible 
mechanisms by which Met oxidation could occur: by iodine attack on either the 
amine or the alkyl sulfide. A mechanism involving Met oxidation through the 
amine was supported by experimental data for the forward reaction but not the 
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reverse reaction. On the other hand, the data supported a mechanism involving 
oxidation through sulfur for the reverse reaction but not the forward reaction 
(58). This was further investigated by Young and Hsieh ten years later (56). 
These authors show that at high buffer concentrations the reaction approaches 
an inverse-squared dependence on iodide concentration; however, at low 
concentrations of buffer, the reaction is inversely dependent on concentration of 
iodide ion. A mechanism that has an inverse-squared dependence on iodide 
can be explained by a simple scheme that involves Met oxidation by iodine to 
form iodosulfonium ion that can either be reduced back to Met by addition of 
iodide or go through ring close (through deprotonated amine) to produce DHM. 
An inverse dependence is due to the iodine-triiodide equilibrium, while the other 
inverse dependence is due to reversal of the reaction by attack of iodide on the 
iodosulfonium ion. Young and Hsieh proposed the mechanism for the formation 
of DHM (4.1) which takes into account their experimental observations, 
including dependence on iodide changes with buffer concentration, buffer 
catalyses the rate of reaction, and the reaction goes to completion rather than 
equilibrium [contrary to findings by Gensch et al. (58)]. Young and Hsieh 
conclude that at high buffer concentrations, the buffer catalyzed formation of the 
tetra-coordinated sulfurane is involved as an intermediate and that breakdown 
of this intermediate to form DHM becomes rate limiting. However, at low buffer 
concentrations, the dissociation of the iodosulfonium ion-iodide complex must 
be slow with respect to reduction (to form Met back) and ring closure (leading to 
DHM formation) (56). 
112 
 
Scheme 4.1: Young’s mechanism which supports evidence of base catalysis 
involvement in production of DHM 
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 In 1976, a little over 30 years after DHM was first discovered by Lavine 
(44), Glass and Duchek verified the structure of DHM through X-ray 
crystallography (42). They concluded that the sulfur atom of DHM was trivalent 
and that the geometry around the nitrogen is sp3 hybridized, indicating a single 
bond between the sulfur and nitrogen. Based on information obtained, Glass 
and Duchek concluded that the structure originally assigned by Lavine in 1945 
(44) was indeed correct (42).  
 With limited studies appearing in literature, methods previously used to 
quantify DHM formation are limited. Determination of the presence of DHM has 
been reported by two methods: 1) indirectly through addition of iodide and acid 
and subsequently quantifying amount of iodine liberated (58-59) or 2) directly 
through 1H NMR (39-40). Fortunately DHM has a distinctive –+S-CH3 NMR 
chemical shift from that of Met (–S-CH3) and MetO (–S(O)-CH3), allowing direct 
determination of the presence of DHM. In addition to the chemical shift, DHM 
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shows up as two distinctive peaks, due to the two diastereomers formed (39-
40). 
Only two papers have been found that discuss reactions of DHM (43,51). 
In a detailed study by Lambeth (43), DHM has been shown to be reduced by 
thiols (DTT: dithiothreitol, TNB: thionitrobenzoate, TNP: thionitrophyridine), a 
reaction that is accelerated many-fold by buffers. Reduction of DHM by the thiol 
requires a 1:2 ratio; a disulfide is produced from the thiol (scheme 4.2) (43). The 
rate constant for reduction of DHM by DTT, for example, is 0.3 M-1s-1 (0.1 M 
phosphate, pH = 7). Lambeth concluded that reduction of DHM by biologically 
relevant thiols, such as Cys and glutathione, may limit the lifetime of DHM and 
therefore it’s biological importance (43). Young and Briedis, just ten years after 
the study by Lambeth (43), followed up on this statement and investigated the 
reduction of DHM by glutathione (GSH). The rate constant for the reduction of 
DHM by GSH was found to be 0.305 M-1min-1. Thus in the presence of 
physiological concentrations of GSH, Young and Briedis estimated the half-life 
of DHM be from 33-330 mins. The authors conclude by stating “a compound 
with a half-life ranging between 0.5-5 hours is a prime candidate for in vivo 
functions, suggesting that the possibility that DHM may exist as a natural 
product should be re-examined (51).” 
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Scheme 4.2: Lambeth’s proposed mechanism for the reduction of DHM by 
thiols 
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 In literature, DHM formation is most often produced from oxidation of Met 
by iodine, a two electron process (38-40,42-45). However, DHM has been 
shown to form in other reactions as well. Chloramine-B oxidation of a small 
peptide containing a N-terminal Met has been shown to form DHM (40). The 
photo-oxidation of Met by singlet oxygen produces a persulfoxide intermediate 
that ring closes forming DHM (47,55). Fenton reagents have been found to form 
DHM, a reaction involving two sequential one-electron steps. These reactions 
occur when reactive radicals such as hydroxyl and halogen radicals oxidize Met 
to a sulfide radical cation (40,54), stabilized intramolecularly via a three electron 
S-N bond (50). Without a reaction partner, this intermediate decomposes 
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rapidly on the microsecond timescale. In order for DHM to be produced from the 
sulfide radical cation, the one-electron oxidized intermediate must be trapped 
before it can decompose. The most efficient trapping agents are radicals, such 
as superoxide. Reaction of superoxide with the sulfide radical cation forms 
sulfoxide, not DHM. However, triplet oxygen (3O2) can react with the 
intermediate to form DHM. Despite this information, it is not known if these two 
sequential one-electron steps to produce DHM are kinetically competent with 
the two electron oxidants (27). That being said, there are no reports of DHM 
production in proteins upon reaction with either one or two electron oxidants. 
 
4.2 Experimental methods 
4.2.1 Materials 
All chemicals were A.C.S certified grade or better and were used without 
further purification. 18.2 MΩ•cm water, obtained from a Millipore Milli-Q A10 
ultrapure water purification system, was used for all experiments. Unless 
otherwise noted, all solutions contained 0.1 M phosphate buffer at pH 7.4, 
which was prepared from NaH2PO4•H2O and Na2HPO4 (used as received from 
Mallinckrodt). Deuterium oxide (99.9%) and Acetonitrile-d3 were obtained from 
Cambridge Isotope Laboratories. Ub from bovine erythrocyte (≥98% by SDS-
PAGE, essentially salt-free, lyophilized powder), chloramine-T hydrate (98%), 
DL-methionine (>99%), taurine (99%), anti-inflammatory peptide 1 (antiflammin-
1), H2O2 (30 wt %), urea, calcium chloride (powder >97%), and bromine were all 
obtained from Sigma-Aldrich. N-acetyl-L-methionine (>99%) was obtained from 
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Fluka. Sodium iodide, sodium bromide, and sodium nitrite were obtained from 
EMD Chemicals. Iodine was obtained from Fisher Scientific. DSS (sodium 2,2-
dimethyl-2-silapentane-5-sulfonate) was obtained from TCI chemicals. 
Sequencing grade trypsin (SA>18,900 units/mg) was obtained from Promega. 
The N-terminal hexapeptide NH2-Met-Gln-Ile-Phe-Val-Lys-COOH (Ub1-6), 
purity >95%, was synthesized by the Molecular Biology Proteomic Facility at the 
University of Oklahoma Health Science Center. pH/pD was adjusted with 
NaOH, NaOD, HCl, or DCl as required. 
  
4.2.2 Sample preparation 
4.2.2.1 Preparation of oxidant stock solutions 
The concentration of H2O2 in stock solutions was determined 
spectrophotometrically at 240 nm (ε240 = 43.6 M-1cm-1) (60). Stock solutions of 
NaOCl were prepared by sparging Cl2 into a 2.1 M solution of NaOH. The 
sparging was stopped when the [OCl-] achieved ca. 0.99 M (pH > 12), as 
determined spectrophotometrically at 292 nm (ε292 = 350 M-1cm-1) (61). Stock 
solutions of NaOBr were prepared by two methods. In both cases, the solutions 
of OBr- were standardized spectrophotometrically at 329 nm (ε329= 332 M-1cm-1) 
(61). The first method consisted of adding a 5-fold excess of NaBr to a solution 
of NaOCl. This reaction mixture was stored in the dark for 5 min before 
determining its concentration spectrophotometrically. The second method 
consisted of adding Br2 to an ice-cold solution of NaOH. All solutions of OBr- 
were kept at 0 °C and used within two hours of thei r preparations to minimize 
117 
 
errors due to decomposition (62). Stock solutions of ONOO- were prepared by a 
method adapted from Koppenol et al. (63) Briefly, ice-cold solutions of NaNO2 in 
water and H2O2 in 1 M HCl were rapidly combined with a hand-mixer 
(comprised of two Hamilton syringes and a T-mixer). The effluent of the hand-
mixer was added directly into a stirring solution of 1.1 M NaOH. The 
concentration of ONOO- was determined spectrophotometrically (ε302 = 1670 M-
1cm-1) (64). Aqueous I3- stock solutions were prepared by addition of I2 to a 
stirring solution of 10-fold excess NaI. After all the I2 dissolved, the 
concentration of I3- was determined spectrophotometrically (ε353 = 26,400 M-
1cm-1) (65). Taurine monohaloamine (TauX, X = Cl or Br)  and dihaloamine 
(TauX2, X = Cl or Br) stock solutions were prepared by methods similar to 
Thomas et al. (66). Briefly, TauX (X = Cl or Br) was prepared by drop-wise 
addition of the hypohalite solution (OBr- was prepared by the Br2/NaOH method 
as described previously) into an equimolar amount of vortexed taurine in 0.1 M 
NaOH. TauX2 (X = Cl or Br) was prepared by drop-wise addition of the 
hypohalite solution to a vortexed taurine (half molar equivalent) in water. 
Immediately after mixing, the pH was lowered to pH < 5 by addition of HCl, in 
order to encourage the disproportionation of TauX to TauX2. After 30 min in the 
dark, the concentrations of the haloamines were determined 
spectrophotometrically: ε(TauCl)252 = 429 M-1cm-1 (66), ε(TauCl2)300 =  
370 M-1cm-1 (66), ε(TauBr)288 = 430 M-1cm-1 (67), and ε(TauBr2)336 =  
371 M-1cm-1 (67). OSCN- was generated by the LPO-catalyzed oxidation of 
SCN- by H2O2 at pH 7.4 (68). The SCN- and LPO were incubated in a 0.1 M 
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phosphate buffer at 20 °C, and the reaction was ini tiated by the addition of 
H2O2. The concentration of OSCN- was determined spectrophotometrically at 
376 nm (ε376 = 26.5 M-1cm-1) (68). 
 
4.2.2.2 Reaction of free methionine with oxidants 
A 75 mM stock solution of Met was prepared in 0.5 M phosphate buffer, 
pH = 7.4. While vortexing, 400 µL of the oxidant (diluted to the desired 
concentration with water prior to the reaction) was added drop-wise to 400 µL of 
the Met solution. After a period of time (< 10 min for halogenating reagents and 
ca. 3 h for ONOO-, OSCN-, and H2O2), 200 µL of D2O (20% deuterium to lock 
and shim) containing DSS (the NMR internal standard) was added. The final pH 
of the solutions was between 7.4-7.6. 
 
4.2.2.3 Reaction of antiflammin-1 and Ub1-6 with oxidants 
Stock solutions of the peptides were prepared by dissolving the 
lyophilized peptide in a 50/50 mixture of water and deuterated acetonitrile-d3. 
The peptides were further diluted (to achieve a peptide concentration ca. 100 
µM) by addition of a 0.1 M deuterated phosphate buffer (pH 7.4), made by 
adding DCl to D2O solutions of anhydrous Na2HPO4. The formation of the 
sulfoxide derivative of the peptide was achieved by addition of excess H2O2 
(69). The DHM peptide derivative was obtained by reaction of ca. 10% molar 
excess of I3- over the peptide. 
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4.2.2.4 Reactions and digestion of ubiquitin 
Ubiquitin (Ub, 1.9 mg) was dissolved in 0.1 M phosphate buffer (pH 7.4, 
100 µL). This solution was subsequently divided into three parts, and equal 
volumes of water (a control), excess H2O2 in water, and 10 molar equivalents of 
HOCl in water (prepared by diluting a stock solution of NaOCl in 0.1 M NaOH) 
were added to each part, respectively. The resulting three solutions were 
placed in the dark for approximately 20 min before initiating the tryptic digestion. 
The method used for digestion of the modified Ub samples was adapted from 
Cox et al. (11). Briefly, a trypsin solution (7 µg enzyme in 310 µL of digestive 
buffer consisting of 50 mM Tris-Cl at pH = 7.9, 6.5 M urea, and 10 mM CaCl2) 
was added to each of the Ub samples (650 µg Ub in 33 µL 0.1 M PBS at pH 
7.4). After this first addition of the trypsin, the samples were incubated in a 
water-shaking bath at 37 °C for 2-4 h; then a secon d trypsin solution (7 µg 
enzyme in 110 µL of digestive buffer) was added to each Ub sample. After the 
second aliquot of trypsin was added, the digestion was allowed to continue for 4 
h in a shaking water bath at 37 °C. The digested sa mples were divided into 50 
µL aliquots and stored at -20 °C until used. The LC  chromatograms of digested 
samples that were stored at -20 °C  for up to one month showed no changes. 
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4.2.3 pH measurements 
The [H+] of the buffered solutions were determined with an Orion Ion 
Analyzer EA920 using an Ag/AgCl combination pH electrode. pD 
measurements in D2O were made using the same pH electrode by adding 0.4 
units to the measurement (70). 
 
4.2.4 UV-vis spectroscopy 
Electronic spectra were measured using a HP 8452A diode array 
spectrophotometer with quartz cells calibrated for 1 mm, 2 mm, 1 cm, and 10 
cm path lengths at 20 °C. The 10 cm cell was used t o measure the 
concentration of OSCN- in stock solutions (vide infra). 
 
4.2.5 1H NMR measurements. 
For the studies involving the oxidation of free Met by various oxidants, 
spectra were recorded with a Varian Mercury VX-300 spectrometer at 20 oC. 
For the studies involving the oxidation of antiflammin-1 and Ub1-6, spectra were 
recorded with a Varian VNMRS-400 NMR spectrometer at 20 oC. The chemical 
shifts (ppm) were referenced to sodium 2,2-dimethyl-2-silapentane-5-sulfonate 
(DSS, δ = 0.015 ppm). The –S-CH3 groups of Met, MetO, and DHM have 
characteristic chemical shifts (40,49). Integration of the peaks corresponding to 
the -S-CH3 groups were used to determine the ratio of Met : MetO : DHM. 
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4.2.6 HSQC NMR measurements 
 
1H-13C heteronuclear HSQC experiments were performed on a Varian 
VNMRS 500 spectrometer at 20 °C. Ub samples were ra n for approximately 15 
h, nt = 160, ni = 256. Ub (3.5-4.0 mg) was dissolved in 500 µL of 0.1 M 
deuterated phosphate buffer (pH 7.0), made by adding DCl to D2O solutions of 
anhydrous Na2HPO4. While vortexing, 250 µL of oxidant solution was added, 
giving a final volume of 750 µL and protein concentration around 550-600 µM. 
Oxidants used were H2O2 (6 mM), chloramine-T (3.3 mM) in the presence of 
iodide (2.5 mM) (iodide was added to protein solution before addition of 
chloramine-T), and HOCl (5 mM) were all prepared by dilution of stock solutions 
with D2O to achieve desired concentration. Other samples were prepared but 
did not result in usable NMR data. These samples include chloramine-T and 
iodide at higher concentrations (20 mM and 2.5 mM respectively), modeled 
after a study done by Cox et al. (11), however the excess of chloramine-T 
produced a dominant peak around 2.4 ppm which left peaks due to Ub 
undetectable. Several attempts to decrease intensity of chloramine-T peak 
proved unsuccessful and include using ultra-filtration to separate the protein 
from remaining oxidant as well as reacting excess oxidant with either SCN- or 
TNB, however both methods did not diminish the dominating peak at 2.4 ppm. 
To overcome this problem, lower concentrations of chloramine-T was chosen 
(3.3 mM) as mentioned previously. Another unsuccessful reaction was reacting 
Ub with either two or ten equivalents of I3-. The resulting products gave 
successful NMR spectra, however this did not lead to oxidation of Met due to 
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triiodide being a weak oxidant (11). When reacting Ub with only two equivalents 
of HOCl, modification to the protein was observed (but not characterized), 
however no modification of the Met residue was observed (as indicated by no 
chemical shift in the –SCH3 peak). 
 
4.2.7 LC-MS of tryptic digested ubiquitin 
LC separation of the tryptic digests of native and oxidized Ub was 
performed using a BAS (Bioanalytical Systems Incorporated, West Lafeyette, 
IN) 200B HPLC equipped with a BAS Unijet reversed phase microbore column 
(ODS-18, 100 mm x 1 mm, 3 µm particle size) and a Unijet guard column 
(ODS-18, 10 mm x 1 mm, 3 µm particle size). Mobile phase A consisted of 
0.05% TFA and 0.05% TEA in deionized water. Mobile phase B consisted of 
0.05% TFA and 0.05% TEA in 40% acetonitrile. These mobile phase solutions 
were filtered and vacuum-degassed prior to use. A binary gradient was applied 
as follows: 0-2 min, 90% solvent A and 10% solvent B; 2-28 min, linear gradient 
to 30% solvent A and 70% solvent B; 28-35 min, linear gradient to 100% 
solvent B; 35-65 min, 100% solvent B; 65-75 min, linear gradient to return the 
mobile phase to 90% solvent A and 10% solvent B, which was maintained for 
an additional 32 min before injecting the next sample. The microbore column 
eluent was split (zero dead volume T) to a BAS UV-116A UV-visible detector 
set at 205 nm (6 µL/min final flow rate) and to a Micromass/Waters (Bedford, 
MA) Q-Tof-1 Mass Spectrometer operating in ESI (+) mode (13 µL/min final flow 
rate). The MS operating conditions were as follows: capillary voltage, 3.0 kV; 
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cone voltage ramp, 10-85 V; source block temperature, 120 °C; desolvation 
temperature, 150 °C; and desolvation gas flow rate,  200 L/hr. 
 
4.3  Results and discussion 
4.3.1 Oxidation of free methionine 
As mentioned previously, the –S-CH3 group has a distinctive 1H-NMR for 
Met (Figure 4.1, A), MetO (Figure 4.1, B), and the two optical isomers of DHM 
(Figure 4.1, C) (40,49). A representative 1H NMR spectrum is given in Figure 
4.1. As shown in Figure 4.1, the –S-CH3 group of Met has a chemical shift 
~2.14 ppm, MetO ~2.76 ppm, and DHM at 2.84 and 2.85 ppm. 
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Figure 4.1: Representative 1H NMR spectrum of the –S-CH3 region of free Met 
derivatives obtained from the reaction of 30 mM Met with 25 mM halogenating 
agent in 0.2 M phosphate buffer, pH = 7.4-7.6. This spectrum was obtained 
from the oxidation of Met with HOCl at pH = 7.5, 20 °C. The labeled resonances 
are S-CH3 of Met (A), MetO (B), and DHM (C). Inset: expansion of chemical 
shift range from 2.74 to 2.86 ppm, showing the two peaks of the isomers of 
DHM. 
 
  
22.22.42.62.83
Chemical Shift (ppm)
A
B
C
2.742.762.782.82.822.842.86
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Table 4.1: Product distribution (%) for the reaction of various oxidants with Met 
to give MetO and DHMa. Conditions: 25 mM oxidant and 30 mM Met at pH = 7.4 
(0.2 M PBS) and 20 °C. aThe oxidant was added to Met dropwise while 
vortexing. bPrior to its addition to Met, HOBr was generated in situ by addition of 
HOCl to Br- or by addition of Br2 to base, followed by neutralization. cI- was 
added to Met prior to the  addition of chloramine-T. 
Oxidanta MetO DHM 
H2O2 100 0 
ONOO- 100 0 
OSCN- 0 0 
Average (Non-X+) 100 0 
HOCl 56 44 
TauCl 56 44 
TauCl2 57 43 
Chloramine-T 58 42 
Average (Cl+) 57 43 
HOBr (HOCl/Br-)b 26 74 
HOBr (Br2/NaOH)b 22 78 
TauBr 23 77 
TauBr2 24 76 
Average (Br+) 24 76 
I3- 3 97 
I- + chloramine-T (5:1)c 10 90 
Average (I+) 6 94 
 
Using the distinctive chemical shifts and proton integration (of peaks 
described in figure 4.1), the ratio of MetO:DHM was determined for the 
oxidation of Met with various 2 electron oxidants (table 4.1). Examination of 
data (table 4.1) shows that the percentage of MetO to DHM formed is 
dependent on the type of oxidation that is occurring rather than the rate at 
which the reaction is occurring. To better explain this, rate constants for a few of 
the reactions are listed in table 4.2. 
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Table 4.2: Comparison of ratio  MetO:DHM and rate constants for oxidation of 
Met by various oxidants (pH = 7, 20 °C) (29, 48, 58 , 78-81) 
Oxidant Percent  MetO:DHM k (M-1s-1) Met + Oxidant 
H2O2 100:0 1.0x10-2 
ONOO- 100:0 1.81x101 
HOCl 56:44 3.8x107 
TauCl 56:44 3.9x101 
HOBr (HOCl/Br-) 26:74 3.5x106 
TauBr 23:77 ~102-103 
I3- 3:97 6.5x105 
 
 
Further examination of table 4.2 shows that there is not an apparent 
correlation between ratios of MetO:DHM formed and rate constant, rather a 
trend is observed for ratio of MetO:DHM and type of oxidant, [i.e. oxidation 
through an O-atom transfer (e.g. H2O2 and ONOO-) or Cl+ transfer (e.g. HOCl or 
TauCl)]. If the oxidants are grouped together by type of halogen, there seems to 
be a trend in how much DHM is produced. All of the chlorinating agents gave 
approximately equimolar amounts of MetO and DHM (42-44% DHM); the 
brominating agents produced higher yields of DHM (74-78% DHM); the 
iodinating agents gave nearly stoichiometric yields of DHM (90-97% DHM) 
(table 4.1). Formation of MetO versus DHM is a competition between 
intramolecular nucleophilic attack of the amine on a sulfonium intermediate to 
give DHM, or alternatively hydrolysis of the sulfonium intermediate to give MetO 
(scheme 4.3) (27). The percentage of DHM formed is related to the type of 
halosulfonium that is formed, whether it is a chlorosulfonium, bromosulfonium, 
or iodosulfonium species. Comparing analogous halosulfonium species, the 
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stability towards hydrolysis is I > Br > Cl (71-77), which reflects the trend 
observed in the yields of DHM. The more stable the halosulfonium intermediate 
is to hydrolysis, the greater the chance there is for intramolecular ring closure 
and formation of DHM, versus the hydrolysis to form MetO. 
 
Scheme 4.3: Schematic Branching Mechanisms via a Common Sulfenyl Halide 
Intermediate that Yield S-N and S-O Derivatives 
+ HOXδ+Sδ- N
-OH-
Sδ+ N
Xδ-
+S N
-X-
-X-
OH-
Sδ+ N
Xδ-
S N
O
Intramolecular 
Ring Closure
Hydrolysis
 
 
4.3.2 Oxidation of methionine containing peptides 
Formation of DHM, as mentioned previously, is only possible when the 
amine is available, and as a consequence only N-terminal Met of peptides and 
proteins can form DHM. For comparison with the free amino acid, two small 
peptides were oxidized to test for DHM formation at the N-terminal Met. The two 
chosen peptides are antiflammin-1 (anti-inflammatory peptide 1), with the 
sequence Met-Gln-Met-Lys-Lys-Val-Leu-Asp-Ser, and Ub1-6 with the sequence 
of Met-Gln-Ile-Phe-Val-Lys. Antiflammin-1 was picked due to the presence of 
both a terminal Met and internal Met. Both peptides were oxidized with H2O2, to 
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form the sulfoxide derivative of the peptide. In addition, peptides were oxidized 
with I3-, forming the DHM derivative of the peptide. DHM and MetO were 
quantified by examining the NMR spectra of the peptides. Figure 4.2 shows the 
results of the oxidation of antiiflammin-1.  
As observed previously with free Met, the –S-CH3 groups of the Met 
residue in the peptide (figure 4.2) has a characteristic chemical shift, with the 
sulfide ~2.1 ppm, sulfoxide ~2.7 ppm, and DHM moiety at 2.84 and 2.85 ppm. 
From this information, we are able to identify the modifications of antiflammin-1 
when it is oxidized. Unmodified peptide, Met-Gln-Met-Lys-Lys-Val-Leu-Asp-Ser, 
contains two Mets that have chemical shifts of 2.12 and 2.13 ppm (figure 4.2, 
bottom). Oxidation of antiflammin-1 with a small excess of H2O2 forms the 
corresponding sulfoxides, MetO-Gln-MetO-Lys-Lys-Val-Leu-Asp-Ser, as 
indicated by the shifts of the two new sets of –S-CH3’s (figure 4.2, middle). 
Oxidation of the peptide with an excess of I3- formed DHM-Gln-MetO-Lys-Lys-
Val-Leu-Asp-Ser (figure 4.2, top), as evidenced by the two new peaks which 
have chemical shifts corresponding the N-terminal Met being converted to a 
DHM derivative and the internal Met being oxidized to a sulfoxide. 
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Figure 4.2: 1H NMR spectra of antiflammin-1 (30 µM) in 0.1 M pD PBS (pH = 
7.4): native (bottom), oxidized with 10% molar excess of H2O2 (middle), and 
oxidized with 10% molar excess I3- (top). Note that the triplet at 2.9 ppm is due 
to internal standard DSS. The labeled resonances are S-CH3 of Met (A), MetO 
(B), and DHM (C). 
22.22.42.62.83
Chemical Shift (ppm)
ABC
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Figure 4.3: (Expansion of Figure 4.2) 1H NMR spectra of antiflammin-1 (30 µM) 
in 0.1 M pD PBS (pH = 7.4): peptide oxidized with 10% molar excess of H2O2 
(bottom), and oxidized with 10% molar excess I3- (top). Note that the triplet 
above 2.9 ppm is due to internal standard DSS, used for normalization of 
chemical shifts. 
 
  
2.752.82.852.92.95
Chemical Shift (ppm)
MetODHM
DSS
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Figure 4.3 shows an expansion of figure 4.2, focusing on the multiple 
peaks due to the diastereomers that are formed from oxidization of Met to DHM, 
which is diasterotopic at the sulfur. 
Similar results were seen for Ub1-6, however, this small peptide, with the 
sequence of Met-Gln-Ile-Phe-Val-Lys, only contains one Met, which is at the N-
terminus. The NMR spectrum of the Ub1-6 oxidation product is shown in figure 
4.4. Oxidation of Ub1-6 with H2O2 shows the formation of the sulfoxide (MetO-
Gln-Ile-Phe-Val-Lys), while oxidation by I3- shows the formation of DHM (DHM-
Gln-Ile-Phe-Val-Lys), both evidenced by the characteristic chemical shifts. 
Similar to the free amino acid Met, N-terminal Met (having the amine available 
for intramolecular ring closure) is oxidized by I3- to form the DHM derivative. 
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Figure 4.4:  1H NMR spectra of hexapeptide Ub1-6 (40 µM) in 0.1 M in PBS (pD 
7.4): native peptide (bottom), oxidized with 10% molar excess of H2O2 (middle), 
and oxidized with 10% molar excess I3- (top). The labeled resonances are S-
CH3 of Met (A), MetO (B), and DHM (C). (Note that the triplet above 2.9 ppm is 
due to internal standard DSS, and that the middle spectrum, still shows the 
presence of unoxidized Met. This is attributed to the slow oxidation of Met by 
H2O2 and not allowing the sample react long enough before collecting data.) 
2.22.42.62.83
Chemical Shift (ppm)
ABC
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4.3.3 Oxidation of Met-1 in ubiquitin 
Ub, a highly conserved 8.5 kDa eukaryotic regulatory protein, containing 
76 amino acids (82), was selected for investigation of whether DHM is formed in 
proteins because it contains only one Met (at the N-terminus) and no Cys 
residues (a competitive target of hypohalites) (83). 
 
4.3.3.1 HSQC of oxidized ubiquitin 
As previously shown, different oxidants produce a different amount of 
DHM. In order to show that DHM is formed in proteins, I3- was chosen for the 
oxidation of Ub (to optimize chances for formation of DHM; oxidation of free Met 
by I3- formed nearly stoichiometric amounts of DHM). To avoid the possible 
conversion of DHM to MetO, which could happen during the process of 
preparing the oxidized protein for analysis (e.g. by digestion and amino acid 
analysis), NMR was chosen to analyze the intact oxidized protein. Ub has been 
previously studied by NMR (83-84). To avoid the need for large (mM) 
concentrations of protein, labeled protein is typically used (1H, 13C, and 15N ). 
Due to the high cost of labeled proteins, this was not appropriate for our 
experiments. 1H (1D) experiments proved unsuccessful, the spectra of Ub and 
Ub oxidized with H2O2 showed no noticeable differences even after 556 
repetitive scans. Fortunately, HSQC (2D) experiments did prove successful. 
Figure 4.5 shows HSQC for Ub. 
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Figure 4.5: HSQC of 1 mM Ub in 0.1 M H2PO4 (pH = 7). (Box around 
approximate zoomed in region discussed further in figures 4.6-4.9.) 
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Though Ub is a small protein, the 2D NMR is still complicated, partially 
due to the protein being unlabeled. To try and simplify the analysis without 
doing extensive NMR experiments (such as other 2D experiments), the least 
complicated region, the methyl region, was focused on for the initial 
determination of Met modification (figure 4.6). Figure 4.6 shows that the CH3 of 
Met overlaps that of Ala28 (amino acids assigned with help from Marquardt et 
al. (85), who determined the chemical shift for all amino acid residues of Ub at 
pH = 6.6). For Ub, this peak integrates to 6 protons, as would be expected for 
the three protons of Ala28 and the three for Met1. When Ub is oxidized with 
H2O2, known to selectively oxidize Met to MetO (69), the following spectra 
(overlapped with figure 4.6 ) are observed (figure 4.7). 
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As can seen from the overlap of Ub and Ub oxidized with H2O2 (figure 
4.7), a few peaks have small shifts, but the noticeable difference is in the 
absence of the Met1 peak (inset, figure 4.7) in the oxidized Ub, and the 
presence of a new peak just below that labeled Val17 (presumed to be MetO). 
To test for formation of DHM, Ub was oxidized by triiodide. Ub oxidation by the 
iodine/triiodide system has been previously published (11,86-87). Cox et al. (86) 
report that oxidation of Ub with molecular iodine results in only the oxidation of 
Tyr59. Cox et al. (11) show that the oxidation of Ub with chloramine-T in the 
presence of iodide oxidizes three residues of Ub, Met-1, Tyr-59, and His-68. 
Cox et al. (11) oxidized Ub, enzymatically digested with trypsin, and initially 
analyzed using liquid chromatography (LC). After collecting the eluting peptide 
peaks, they digested the small fragments (using 6 M HCl, 110 °C, for 24 hrs), 
and used standard amino acid analysis to determine the modifications that 
occurred to Ub. Depending on the amount of iodide chosen, Tyr and His were 
either single or doubly iodinated, and Met was oxidized. The Met containing 
peptide, when oxidized, showed two distinctive peaks during LC, which authors 
assign to MetO and MetO2 (11). From experiments we performed with free Met, 
we know that strong oxidants, such as HOCl and performic acid (88), are 
needed to oxidize Met up to the sulfone, while weaker oxidants such as H2O2 
and triiodide only oxidize Met to the sulfoxide. Knowing this, we suspected that 
the two peaks observed by Cox et al. (11) were due to MetO and DHM, not the 
MetO2. Using the same conditions employed by Cox, we oxidized Ub and 
analyzed using HSQC. Unfortunately, the chloramine-T peak dominated the 
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spectrum and no protein peaks were identifiable. Using ultra-filtration, the 
oxidized protein was filtered to try and separate the protein from the 
chloramine-T peak, but was unsuccessful. With a lower concentration of 
chloramine-T, the chloramine-T was not dominating (figure 4.8). Figure 4.8 
shows the Met peak is indeed missing in the oxidized Ub, however, various 
other peaks have also shifted, making it difficult to determine which is the new 
Met peak without further experiments (note that in figure 4.8 the absence of the 
peak just below Val-17 which we believed was the MetO (figure 4.7). 
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Table 4.3: Rate constants for reaction of HOCl with amino acid residues in Ub 
Residue # residues in Ub a k (M-1s-1) 
His 1 1.0x105 
Lys 7 5.0x103 
Arg 4 26 
Asn 2 0.03 
Gln 6 0.03 
Cys 0 3.0x107 
Met 1 3.8x107 
Cystine 0 1.6x105 
Tyr 1 44 
Trp 0 1.1x104 
Terminal amine 1 1.0x105 
backbone 74 10 
a Modeled after table 4, reference 29 (note other amino acid residues contained 
in Ub have side chains which are no reactive with HOCl) 
 
Since the main goal of these experiments was to see qualitatively if DHM 
is formed in proteins, a different oxidant was tested. HOCl was chosen based 
on knowledge of the rate constants with the various residues of Ub (table 4.3). 
Table 4.3, modeled after a similar table by Pattison et al. (29) lists the residues 
of Ub that are reactive to HOCl as well as their predicted rate constants. Using 
this information, Met would be predicted to be amongst the first amino acid 
residue in Ub to react with HOCl. Experiments were performed to determine 
how many HOCl equivalents are needed to add to Ub in order for Met to be 
oxidized to MetO/DHM, without adding an unnecessary excess (HOCl is a more 
powerful oxidant than iodide/chloramine-T, which leaves more amino acid 
residues susceptible to oxidation). A large excess of HOCl would not be desired 
because the more HOCl added, the more amino acid residues would be 
modified as well as possibly over-oxidizing Met forming MetO2, making 
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interpretation of results more difficult. Though unexpected (from known rate 
constants), addition of 1, 2, or 5 molar equivalents of HOCl caused no 
modification to the Met residue. The addition of 10 molar equivalents of HOCl 
did result in Met oxidation (figure 4.9). The HSQC (figure 4.9), is quite 
complicated, but the Met peak has clearly disappeared. As seen previously with 
the chloramine-T/iodide system, oxidation of Ub with HOCl did not show a new 
peak near Val-17, as was seen in Ub oxidized with H2O2. Though these HSQC 
experiments did not conclusively show that DHM formed in the oxidation of Ub, 
it does show that the halide oxidized products of Ub are quite different from that 
of Ub oxidized with H2O2. 
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4.3.3.2 LC-UV and LC-MS of tryptic digested ubiquitin 
Using a procedure similar to Cox et al. (11), we oxidized Ub, carried out 
a tryptic digestion, and analyzed the peptides. Cox et al. (11) have shown that 
conditions needed to cleave the peptide bonds through digestion can cause 
modification of amino acids. We first needed to determine if DHM is stable 
enough to survive these conditions. We chose to analyze the peptides by LC-
MS. By knowing the mass of the peptides, we would be able to identify which 
peptides were modified and what products are formed. The enzyme trypsin 
cleaves peptide bonds at the carboxyl side of lysine or arginine, except when 
followed by proline. Complete tryptic digestion of Ub leaves the peptides listed 
in table 4.4. 
Table 4.4: Peptides of Ub after tryptic digestion 
Peptide Ub residues 
Met-Gln-Ile-Phe-Val-Lys 1-6 
Thr-Leu-Thr-Gly-Lys 7-11 
Thr-Ile-Thr-Leu-Glu-Val-Glu-Pro-Ser-Asp-Thr-Ile-Glu-Asn-Val-Lys 12-27 
Ala-Lys 28-29 
Ile-Gln-Asp-Lys 30-33 
Glu-Gly-Ile-Pro-Pro-Asp-Gln-Gln-Arg 34-42 
Leu-Ile-Phe-Ala-Gly-Lys 43-48 
Gln-Leu-Glu-Asp-Gly-Arg 49-54 
Thr-Leu-Ser-Asp-Tyr-Asn-Ile-Gln-Lys 55-63 
Glu-Ser-Thr-Leu-His-Leu-Val-Leu-Arg 64-72 
Leu-Arg-Gly-Gly 73-76 
 
After developing the LC instrumental conditions needed to separate the 
various peptides, the LC was coupled to the MS, allowing for simultaneous 
detection of eluting peptides by both LC-UV (at 205 nm) and LC-MS. Figure 
4.10 shows representative chromatograms from both detection methods. 
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Figure 4.10: Representative MS (solid) and UV (dotted) chromatograms of 
digested Ub. The scale of the MS chromatogram is shifted by 1.8 min to 
normalize the two chromatograms. The following peptides from the digested Ub 
have been assigned (based on observed m/z): A: Leu-Arg-Gly-Gly (73-76); B: 
Thr-Leu-Thr-Gly-Lys (7-11); C: Gln-Leu-Glu-Asp-Gly-Arg (49-54); D: Thr-Leu-
Ser-Asp-Tyr-Asn-Ile-Gln-Lys (55-63); E: Leu-Ile-Phe-Ala-Gly-Lys (43-48); F: 
Met-Gln-Ile-Phe-Val-Lys (1-6); G: Glu-Ser-Thr-Leu-His-Leu-Val-Leu-Arg (64-
72); H: Thr-Ile-Thr-Leu-Glu-Val-Glu-Pro-Ser-Asp-Thr-Ile-Glu-Asn-Val-Lys (12-
27). A-G were identified by m/z of (M+H)1+ and H was identified as (M+H)2+. 
Unidentified peaks may be due to autodigestion of trypsin. Inset: expansion of 
the chromatograms between 45 and 65 min. 
48 52 56 60 64
0 8 16 24 32 40 48 56 64
Time (min)
E F G,H
A B C D
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As can be seen from comparing UV and MS chromatograms (figure 
4.10), some peaks are detectable by one method and not the other, as is 
expected for the two different detection techniques. A UV peak (A, absorbance) 
is detectable depending on two variables, molar absorptivity (ε), and 
concentration (c), as determined by Beer’s law (A = ε*b*c; b is path-length of 
observation cell which can sometimes be varied between experiments, but not 
between analytes in the same sample). Besides illustrating representative 
chromatograms, figure 4.10 also identifies some of the digested peptides, 
determined by m/z from MS chromatogram. Knowing which peak is due to the 
Met-containing peptide allows us to determine what the product is when it is 
oxidized. 
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Figure 4.11: LC-MS-ESI+ chromatogram of digested Ub. Inset: MS spectrum of 
native hexapeptide Ub1-6, eluted at 55 min (*). The theoretical monoisotopic 
mass is 764.4. The observed mass is 764.4 + H+. 
 
Figure 4.11 illustrates the chromatogram and MS spectrum of the 
unmodified peptide. The peak which has a retention time around 55 mins has a 
m/z of 765.4 assigned as Met-Gln-Ile-Phe-Val-Lys, which is the mass of the 
peptide N-terminal peptide (764.4) + a hydrogen. Because the MS are taken in 
positive mode, peaks will be M + H+. Ub oxidized with H2O2 and digested is 
represented in figure 4.12. 
760 765 770 775M/Z
40 45 50 55 60 65
Time (min)
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Figure 4.12: LC-MS-ESI+ chromatogram of digested Ub that was oxidized with 
10% molar excess of H2O2.  Inset: MS spectrum of MetO derivative of the 
hexapeptide Ub1-6, eluted at 47.4 min (*). The theoretical monoisotopic mass is 
780.4. The observed mass is 780.3 + H+. 
 
Comparing figures 4.11 and 4.12, in Ub oxidized with H2O2, the Met peak 
disappears and a new peak with a retention time around 47 mins is observed. 
The MS spectrum of this peptide gives a m/z of 780.3 + H+, which is expected 
for the addition of a oxygen to the Met peptide (764.4+16) + H+ forming MetO-
Gln-Ile-Phe-Val-Lys. 
775 780 785 790M/Z
40 45 50 55 60 65
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Figure 4.13: LC-MS-ESI+ chromatogram of digested Ub that was oxidized with 
10 molar equivalents of HOCl.  Inset (left): MS of MetO derivative of the 
hexapeptide Ub1-6, eluted at 49.0 min (**). The theoretical monoisotopic mass 
is 780.4. The observed mass is 780.4 + H+. Inset (right): MS of DHM derivative 
of the hexapeptide Ub1-6, eluted at 51.5 min (*). The theoretical monoisotopic 
mass is 762.4. The observed mass is 762.4 + H+. 
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Oxidation of Ub with ten molar equivalents of HOCl led to modifications 
of the Met peptide (figure 4.13). A peak was observed with retention time 
around 49 min, with m/z of 780.4 + H+ and another with retention time around 
51.5 min, with m/z of 762.4 + H+ (or the Met peptide, 764.4 - 2 hydrogens, as 
would be expected for the DHM moiety). One modification of the Met-Gln-Ile-
Phe-Val-Lys (observed 764.4 + H+, figure 4.11) was its conversion to the 
sulfoxide, MetO-Gln-Ile-Phe-Val-Lys (observed 780.4 + H+, figure 4.13 left 
inset), evidenced using a sample of Ub that was selectively oxidized by H2O2 to 
MetO (figure 4.12). The other modification was attributed to the DHM derivative 
DHM-Gln-Ile-Phe-Val-Lys (observed 762.4 + H+, figure 4.13 right inset). 
Confirmation of the DHM derivatized peptide was achieved by independent 
synthesis of the hexapeptide, Met-Gln-Ile-Phe-Val-Lys and oxidation with a 
small excess of I3- followed by 1H NMR of the synthesized DHM-Gln-Ile-Phe-
Val-Lys which had the characteristic pattern of the two diastereomeric methyl 
groups of DHM, figure 4.4, top). The MS spectrum of DHM-Gln-Ile-Phe-Val-Lys 
was achieved by direct injection of the peptide onto the MS and compared to 
that of the DHM containing peptide from the tryptic digest of oxidized Ub 
analyzed by LC-MS (figure 4.14). Comparing the spectra in figure 4.14, there 
are small differences in the two which we attribute to the different methods of 
preparation (top spectrum: peptide oxidized with excess I3-, which may not be a 
clean reaction, and injected into MS without any cleanup; bottom spectrum: 
peptide eluted from LC into the MS).   
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Figure 4.14: Comparison of MS spectra of the DHM derivative of the Ub1-6 
hexapeptide, top: prepared from addition of a small excess of I3- to Ub1-6 and 
directly injected into the mass spectrometer, and bottom: LC-MS of peak with 
retention time of 51.5 min (*figure 4.13) from the tryptic digest of Ub oxidized 
with 10 molar equivalents of HOCl. The theoretical monoisotopic mass of  
DHM-Gln-Ile-Phe-Val-Lys is 762.4, observed mass is 762.4 + H+ (*). 
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To further confirm that the DHM derivative formed, the tryptic digest of 
Ub treated with 10 molar equivalents of HOCl (analyzed by LC-UV) was spiked 
with an authentic sample of DHM-Gln-Ile-Phe-Val-Lys. The spiking of the 
enzymatically digested oxidized Ub sample was qualitative, not quantitative, so 
the concentration of the peptides separated using LC-UV was approximately 
known, and spiked with the DHM hexapeptide sample (synthesized using a 
10% excess of I3-) that was about two and a half times its concentration. The 
authentic DHM hexapeptide exhibited the same chromatographic retention time 
as the corresponding hexapeptide in the tryptic digest of oxidized Ub (figure 
4.15). The peak, which has been identified using MS, having a LC-UV retention 
time around 51.5 mins, increases with addition of DHM-Gln-Ile-Phe-Val-Lys. In 
addition, other peaks change as well. For example, the peak around 47 mins, 
assigned to the peptide fragment Thr-Leu-Ser-Asp-Tyr-Asn-Ile-Gln-Lys (figure 
4.10), disappears and two peaks, around 59 mins and 65.5 mins appear along 
with peak around 57 mins increasing slightly. The two new peaks are 
associated with single and double iodination of the tyrosine containing peptide 
(peak that increased in intensity at 57 min was not assigned to the digested Ub, 
but a product of autodigestion of the trypsin). 
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Figure 4.15: LC-UV (205 nm) of Ub oxidized with 10 molar equivalents of HOCl 
and subsequently digested using trypsin (solid line). Same sample spiked with 
an authentic sample of the DHM derivative of Ub1-6 (prepared in 0.1 M 
phosphate buffer by adding a 10% molar excess of I3-; the product was 
characterized by 1H NMR) in order to verify retention time. 
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4.4 Summary and conclusions 
 Oxidation of Met, which has a free amine, can form either MetO or DHM. 
Different oxidants form different percentages of DHM. Two electron oxidants 
that react through oxygen transfer do not produce DHM, while halogenating 
species (but not the pseudohypohalous acid HOSCN) which react through a 
halide cation (X+, where X = I, Br, or Cl) transfer, produce a significant amount 
of DHM. The halogenating agents can be grouped by the yields of DHM they 
produce; chlorinating agents produce around 43% DHM, brominating agents 
approximately 75%, and iodinating agents close to 100% DHM. Assuming that 
the oxidation of Met by halogens initially produces a halosulfonium intermediate 
(either hydrolyzes to give MetO or goes through intramolecular nucleophilic 
attack of the amine on this sulfonium intermediate to give DHM) the percent 
yield of DHM is related to the type of intermediate formed. The relative order of 
stability towards hydrolysis is expected to be I > Br > Cl, which reflects the 
trends observed in the yields of DHM relative to MetO. The data shown 
demonstrates that when the amine is available, DHM forms in the free amino 
acid, small peptides, and the small protein Ub. The experiments in which the 
small peptide Antiflammin-1 (contains two Met, one at the N-terminus having 
the amine available, and one within the peptide that has the amine tied up in an 
amide bond) is oxidized confirms what has been previously mentioned in 
literature, that an amine has to be within close proximity to the sulfonium 
intermediate to form DHM; amide nitrogen atoms are apparently not sufficiently 
nucleophilic to form isothiazolidinium rings due to the electronic conjugation 
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with an adjacent carbonyl (89). Because the start codon for eukaryotic protein 
synthesis encodes Met (90), mammalian proteins are produced in vivo with Met 
at the N-terminus. As a consequence of post-translational modifications, 
roughly 40% of the N-terminal Met residues are cleaved, but the majority 
remains after protein processing (91). Ub was chosen to investigate whether 
DHM can be formed in proteins because it contains only one Met (at the N-
terminus) and no Cys residues (a competitive target of HOCl) (83). The results 
from the Ub studies suggest the N-terminal Met residues of protein yield DHM 
derivatives when reacted with electrophilic halogenating agents, while 
producing just the corresponding sulfoxide when reacting with non-halogenating 
oxidants such as H2O2 and peroxynitrite. This along with the high kinetic stability 
of DHM at neutral pH, which in the absence of catalysts has a half life of over 
600 days (58), shows the high potential for DHM as a biomarker of protein 
oxidation by halogenating agents. 
 
 
 
 
 
 
 
 
 
156 
 
4.5 Future experiments 
• Test other oxidants for ability to form DHM 
o Test both one electron and two electron oxidants (e.g. radicals) to 
expand the library of oxidants for %DHM vs. %MetO formed 
• Stability tests of DHM-proteins 
o pH and temperature profile to determine what conditions a    
DHM-protein can survive (e.g. digestion conditions) 
• Develop method to quantify the amount of DHM formed in proteins 
o Isotopically label protein so can use 2D-NMR more efficiently 
o Develop antibody which recognizes the DHM moiety 
• Test other proteins which contain N-terminal Met to determine if DHM 
forms 
• Look for DHM-proteins in vivo 
157 
 
4.6 References 
 (1) Hawkins, C. L.; Pattison, D. I.; Davies, M. J. "Hypochlorite-induced 
oxidation of amino acids, peptides and proteins." Amino Acids 2003, 25, 259-
274. 
 (2) Dean, R. T.; Fu, S. L.; Stocker, R.; Davies, M. J. "Biochemistry 
and pathology of radical-mediated protein oxidation." Biochemical Journal 1997, 
324, 1-18. 
 (3) Hawkins, C. L.; Morgan, P. E.; Davies, M. J. "Quantification of 
protein modification by oxidants." Free Radical Biology and Medicine 2009, 46, 
965-988. 
 (4) Davies, M. J. "The oxidative environment and protein damage." 
Biochimica Et Biophysica Acta-Proteins and Proteomics 2005, 1703, 93-109. 
 (5) In NDRL/NIST Solution Kinetics Database on the Web; Notre 
Dame University: Notre Dame, Indiana; Vol. 2009. 
 (6) Issaq, H. J.; Van, Q. N.; Waybright, T. J.; Muschik, G. M.; 
Veenstra, T. D. "Analytical and statistical approaches to metabolomics 
research." Journal of Separation Science 2009, 32, 2183-2199. 
 (7) Ptolemy, A. S.; Lee, R.; Britz-Mckibbin, P. "Strategies for 
comprehensive analysis of amino acid biomarkers of oxidative stress." Amino 
Acids 2007, 33, 3-18. 
 (8) Clarke, A. P.; Jandik, P.; Rocklin, R. D.; Liu, Y.; Avdalovic, N. "An 
integrated amperometry waveform for the direct, sensitive detection of amino 
acids and amino sugars following anion-exchange chromatography." Analytical 
Chemistry 1999, 71, 2774-2781. 
 (9) Chiou, S. H.; Wang, K. T. "Simplified protein hydrolysis with 
methanesulphonic acid at elevated-temperature for the complete amino-acid 
analysis of proteins." Journal of Chromatography 1988, 448, 404-410. 
 (10) Schoneich, C.; Sharov, V. S. "Mass spectrometry of protein 
modifications by reactive oxygen and nitrogen species." Free Radical Biology 
and Medicine 2006, 41, 1507-1520. 
 (11) Cox, M. J.; Shapira, R.; Wilkinson, K. D. "Tryptic peptide mapping 
of ubiquitin and derivatives using reverse-phase high performance liquid 
chromatography." Analytical Biochemistry 1986, 154, 345-52. 
 (12) Baldwin, A. J.; Kay, L. E. "Nmr spectroscopy brings invisible 
protein states into focus." Nature Chemical Biology 2009, 5, 808-814. 
158 
 
 (13) Saeed, S.; Gillies, D.; Wagner, G.; Howell, N. K. "Esr and nmr 
spectroscopy studies on protein oxidation and formation of dityrosine in 
emulsions containing oxidised methyl linoleate." Food and Chemical Toxicology 
2006, 44, 1385-1392. 
 (14) Gianazza, E.; Crawford, J.; Miller, I. "Detecting oxidative post-
translational modifications in proteins." Amino Acids 2007, 33, 51-56. 
 (15) Winterbourn, C. C.; Kettle, A. J. "Biomarkers of myeloperoxidase-
derived hypochlorous acid." Free Radical Biology and Medicine 2000, 29, 403-
409. 
 (16) Fialkow, L.; Wang, Y.; Downey, G. P. "Reactive oxygen and 
nitrogen species as signaling molecules regulating neutrophil function." Free 
Radical Biology and Medicine 2007, 42, 153-164. 
 (17) Winterbourn, C. C. "Biological reactivity and biomarkers of the 
neutrophil oxidant, hypochlorous acid." Toxicology 2002, 181-182, 223-227. 
 (18) Pattison, D. I.; Davies, M. J. "Reactions of myeloperoxidase-
derived oxidants with biological substrates: Gaining chemical insight into human 
inflammatory diseases." Current Medicinal Chemistry 2006, 13, 3271-3290. 
 (19) Lau, D.; Baldus, S. "Myeloperoxidase and its contributory role in 
inflammatory vascular disease." Pharmacology & Therapeutics 2006, 111, 16-
26. 
 (20) Davies, M. J.; Hawkins, C. L.; Pattison, D. I.; Rees, M. D. 
"Mammalian heme peroxidases: From molecular mechanisms to health 
implications." Antioxidants & Redox Signaling 2008, 10, 1199-1234. 
 (21) Nicholls, S. J.; Hazen, S. L. "Myeloperoxidase and cardiovascular 
disease." Arteriosclerosis Thrombosis and Vascular Biology 2005, 25, 1102-
1111. 
 (22) Ogino, K.; Wang, D. H. "Biomarkers of oxidative/nitrosative stress: 
An approach to disease prevention." Acta Medica Okayama 2007, 61, 181-189. 
 (23) Tsukahara, H. "Biomarkers for oxidative stress: Clinical 
application in pediatric medicine." Current Medicinal Chemistry 2007, 14, 339-
351. 
 (24) Wu, A. H. B. "Novel biomarkers of cardiovascular disease: 
Myeloperoxidase for acute and/or chronic heart failure?" Clinical Chemistry 
2009, 55, 12-14. 
159 
 
 (25) Loria, V.; Dato, I.; Graziani, F.; Biasucci, L. M. "Myeloperoxidase: 
A new biomarker of inflammation in ischemic heart disease and acute coronary 
syndromes." Mediators of Inflammation 2008. 
 (26) Malle, E.; Furtmuller, P. G.; Sattler, W.; Obinger, C. 
"Myeloperoxidase: A target for new drug development?" British Journal of 
Pharmacology 2007, 152, 838-854. 
 (27) Beal Jennifer, L.; Foster Steven, B.; Ashby Michael, T. 
"Hypochlorous acid reacts with the n-terminal methionines of proteins to give 
dehydromethionine, a potential biomarker for neutrophil-induced oxidative 
stress." Biochemistry 2009, 48, 11142-8. 
 (28) Harwood, D. T.; Nimmo, S. L.; Kettle, A. J.; Winterbourn, C. C.; 
Ashby, M. T. "Molecular structure and dynamic properties of a sulfonamide 
derivative of glutathione that is produced under conditions of oxidative stress by 
hypochlorous acid." Chemical Research in Toxicology 2008, 21, 1011-1016. 
 (29) Pattison, D. I.; Davies, M. J. "Absolute rate constants for the 
reaction of hypochlorous acid with protein side chains and peptide bonds." 
Chemical Research in Toxicology 2001, 14, 1453-1464. 
 (30) Cuq, J. L.; Aymard, C.; Cheftel, C. "Effects of hypochlorite 
treatments on a methionyl peptide." Food Chemistry 1977, 2, 309-14. 
 (31) Drozdz, R.; Naskalski, J. W.; Sznajd, J. "Oxidation of amino acids 
and peptides in reaction with myeloperoxidase, chloride and hydrogen 
peroxide." Biochimica et Biophysica Acta, Protein Structure and Molecular 
Enzymology 1988, 957, 47-52. 
 (32) Maier, K. L.; Matejkova, E.; Hinze, H.; Leuschel, L.; Weber, H.; 
Beck-Speier, I. "Different selectivities of oxidants during oxidation of methionine 
residues in the alpha -1-proteinase inhibitor." FEBS Letters 1989, 250, 221-6. 
 (33) Sharov, V. S.; Schoneich, C. "Diastereoselective protein 
methionine oxidation by reactive oxygen species and diastereoselective repair 
by methionine sulfoxide reductase." Free Radical Biology & Medicine 2000, 29, 
986-994. 
 (34) Khor, H. K.; Fisher, M. T.; Schoeneich, C. "Potential role of 
methionine sulfoxide in the inactivation of the chaperone groel by hypochlorous 
acid (hocl) and peroxynitrite (onoo-)." Journal of Biological Chemistry 2004, 
279, 19486-19493. 
 (35) Shao, B.; Belaaouaj, A.; Verlinde, C. L. M. J.; Fu, X.; Heinecke, J. 
W. "Methionine sulfoxide and proteolytic cleavage contribute to the inactivation 
of cathepsin g by hypochlorous acid: An oxidative mechanism for regulation of 
160 
 
serine proteinases by myeloperoxidase." Journal of Biological Chemistry 2005, 
280, 29311-29321. 
 (36) Pattison, D. I.; Hawkins, C. L.; Davies, M. J. "Hypochlorous acid-
mediated protein oxidation: How important are chloramine transfer reactions 
and protein tertiary structure?" Biochemistry 2007, 46, 9853-9864. 
 (37) Pattison, D. I.; Hawkins, C. L.; Davies, M. J. "What are the plasma 
targets of the oxidant hypochlorous acid? A kinetic modeling approach." 
Chemical Research in Toxicology 2009, 22, 807-817. 
 (38) Billington, D. C.; Golding, B. T. "Proton exchange in 
dehydromethionine; synthesis of l-methionine-methyl-2h3." Tetrahedron Letters 
1979, 2937-8. 
 (39) Billington, D. C.; Golding, B. T. "Aspects of the chemistry of 
dehydromethionine." Journal of the Chemical Society, Perkin Transactions 1 
Organic and Bio-Organic Chemistry (1972-1999) 1982, 1283-90. 
 (40) Fruttero, R.; Amiconi, G.; Ascoli, F.; Bolegnesi, M.; Ascenzi, P. 
"Identification of l-methionine oxidation products in tripeptides, in met-
enkephalin and in the bovine basic pancreatic trypsin inhibitor: 1h and 13c nmr 
study." Biochemistry and Molecular Biology International 1995, 35, 861-74. 
 (41) Gensch, K. H.; Higuchi, T. "Kinetic investigation of the reversible 
reaction between methionine and iodine. Improved iodometric determination of 
methionine." Journal of Pharmaceutical Sciences 1967, 56, 177-84. 
 (42) Glass, R. S.; Duchek, J. R. "The structure of dehydromethionine. 
An azasulfonium salt." Journal of the American Chemical Society 1976, 98, 
965-9. 
 (43) Lambeth, D. O. "Reduction of dehydromethionine by thiols. 
Kinetics and mechanism." Journal of the American Chemical Society 1978, 100, 
4808-13. 
 (44) Lavine, T. F. "Dehydromethionine, a new methionine derivative." 
Federation Proceedings 1945, 4, 96-96. 
 (45) Swank, D. W.; Lambeth, D. O. "Formation and properties of the 
azasulfonium functionality in dehydromethionine and other isothiazolidinium 
salts." Federation Proceedings 1981, 40, 1683-1683. 
 (46) Lavine, T. F.; (Lankenau Hospital). US, 1949. 
 (47) Weil, L.; Gordon, W. G.; Buchert, A. R. "Photooxidation of amino 
acids in the presence of methylene blue." Archives of Biochemistry and 
Biophysics 1951, 33, 90-109. 
161 
 
 (48) Sysak, P. K.; Foote, C. S.; Ching, T.-Y. "Chemistry of singlet 
oxygen. Xxv. Photooxygenation of methionine." Photochemistry and 
Photobiology 1977, 26, 19-27. 
 (49) Lambeth, D. O.; Swank, D. W. "Oxidative cyclization of 3-
(amino)thioethers to form s-substituted isothiazolidinium salts." Journal of 
Organic Chemistry 1979, 44, 2632-6. 
 (50) Asmus, K. D.; Goebl, M.; Hiller, K. O.; Mahling, S.; Moenig, J. 
"Sulfur-nitrogen and sulfur-oxygen three-electron-bonded radicals and radical 
cations in aqueous solutions." Journal of the Chemical Society, Perkin 
Transactions 2: Physical Organic Chemistry (1972-1999) 1985, 641-6. 
 (51) Young, P. R.; Briedis, A. V. "Kinetics and mechanism of the 
glutathione-dependent reduction of dehydromethionine." Biochimica et 
Biophysica Acta, General Subjects 1988, 967, 318-21. 
 (52) Alks, V.; Keith, D. D.; Sufrin, J. R. "Synthesis of the constrained l-
methionine analog, (z)-l-2-amino-4-(methylthio)-3-butenoic acid." Synthesis 
1992, 623-5. 
 (53) Schoneich, C. "Diastereoselectivity and neighboring group effects 
in the oxidation of methionine-containing peptides." Book of Abstracts, 211th 
ACS National Meeting, New Orleans, LA, March 24-28 1996, BTEC-013. 
 (54) Hong, J. Y.; Schoneich, C. "The metal-catalyzed oxidation of 
methionine in peptides by fenton systems involves two consecutive one-
electron oxidation processes." Free Radical Biology and Medicine 2001, 31, 
1432-1441. 
 (55) Miller, B. L.; Kuczera, K.; Schoneich, C. "One-electron 
photooxidation of n-methionyl peptides. Mechanism of sulfoxide and 
azasulfonium diastereomer formation through reaction of sulfide radical cation 
complexes with oxygen or superoxide." Journal of the American Chemical 
Society 1998, 120, 3345-3356. 
 (56) Young, P. R.; Hsieh, L. S. "General base catalysis and evidence 
for a sulfurane intermediate in iodine oxidation of methionine." Journal of the 
American Chemical Society 1978, 100, 7121-7122. 
 (57) Lavine, T. F. "An iodometric determination of methionine." Journal 
of Biological Chemistry 1943, 151, 281-297. 
 (58) Gensch, K. H.; Higuchi, T. "Kinetic investigation of reversible 
reaction between methionine and iodine - improved iodometric determination of 
methionine." Journal of Pharmaceutical Sciences 1967, 56, 177-&. 
162 
 
 (59) Peskin, A. V.; Turner, R.; Maghzal, G. J.; Winterbourn, C. C.; 
Kettle, A. J. "Oxidation of methionine to dehydromethionine by reactive halogen 
species generated by neutrophils." Biochemistry 2009, 48, 10175-10182. 
 (60) Beers, R. F.; Sizer, I. W. "A spectrophotometric method for 
measuring the breakdown of hydrogen peroxide by catalase." Journal of 
Biological Chemistry 1952, 195, 133-140. 
 (61) Anbar, M.; Dostrovsky, I. "Ultra-violet absorption spectra of some 
organic hypohalites." Journal of the Chemical Society 1954, 1105-1108. 
 (62) Nagy, P.; Beal, J. L.; Ashby, M. T. "Thiocyanate is an efficient 
endogenous scavenger of the phagocytic killing agent hypobromous acid." 
Chemical Research in Toxicology 2006, 19, 587-593. 
 (63) Koppenol, W. H.; Kissner, R.; Beckman, J. S. "Syntheses of 
peroxynitrite: To go with the flow or on solid grounds?" Methods in Enzymology 
1996, 269, 296-302. 
 (64) Romero, N.; Radi, R.; Linares, E.; Augusto, O.; Detweiler, C. D.; 
Mason, R. P.; Denicola, A. "Reaction of human hemoglobin with peroxynitrite 
isomerization to nitrate and secondary formation of protein radicals." Journal of 
Biological Chemistry 2003, 278, 44049-44057. 
 (65) Awtrey, A. D.; Connick, R. E. "The absorption spectra of i-2,i-3-,i-, 
io3-,s4o6 and s2o3= heat of the reaction i-3-=i-2+i." Journal of the American 
Chemical Society 1951, 73, 1842-1843. 
 (66) Thomas, E. L.; Grisham, M. B.; Jefferson, M. M. "Preparation and 
characterization of chloramines." Methods in Enzymology 1986, 132, 569-85. 
 (67) Thomas, E. L.; Bozeman, P. M.; Jefferson, M. M.; King, C. C. 
"Oxidation of bromide by the human leukocyte enzymes myeloperoxidase and 
eosinophil peroxidase: Formation of bromamines." Journal of Biological 
Chemistry 1995, 270, 2906-2913. 
 (68) Nagy, P.; Alguindigue Susan, S.; Ashby Michael, T. 
"Lactoperoxidase-catalyzed oxidation of thiocyanate by hydrogen peroxide: A 
reinvestigation of hypothiocyanite by nuclear magnetic resonance and optical 
spectroscopy." Biochemistry 2006, 45, 12610-6. 
 (69) Simpson, R. J. In Proteins and proteomics: A laboratory manual; 
Cold Spring Harbor: New York, 2002, p 370. 
 (70) Glasoe, P. K.; Long, F. A. "Use of glass electrodes to measure 
acidities in deuterium oxide." Journal of Physical Chemistry 1960, 64, 188-90. 
163 
 
 (71) Wilson, G. E., Jr. "Fragmentations of halosulfonium salts and 
related reactions. Role of sulfenyl intermediates." Quarterly Reports on Sulfur 
Chemistry 1967, 2, 313-17. 
 (72) Wilson, G. E., Jr. "Structure and reactivity of halosulfonium salts." 
Tetrahedron 1982, 38, 2597-625. 
 (73) Wilson, G. E., Jr.; Huang, M. G. "Sulfonium salts. Iv. Cleavage--
alpha -substitution competition of dibenzylhalosulfonium salts." Journal of 
Organic Chemistry 1970, 35, 3002-7. 
 (74) Allegra, G.; Wilson, G. E., Jr.; Benedetti, E.; Pedone, C.; Albert, R. 
"Structure of a halosulfonium salt. The 1:1 adduct of thiophane with bromine." 
Journal of the American Chemical Society 1970, 92, 4002-7. 
 (75) Minkwitz, R.; Gerhard, V.; Preut, H. "Crystal structure of 
chlorodimethylsulfonium(1+) hexafluoroantimonate(1-) and comparing interionic 
effects in halosulfonium hexafluorometallates." Zeitschrift fuer Anorganische 
und Allgemeine Chemie 1991, 596, 99-105. 
 (76) Minkwitz, R.; Werner, A. "Chemistry of sulfur halides. 25. 
Methyl(trifluoromethyl)halosulfonium salts. Halogen = f, cl, br, i." Zeitschrift fuer 
Naturforschung, B Chemical Sciences 1988, 43, 403-11. 
 (77) Armesto, X. L.; Canle L, M.; Fernandez, M. I.; Garcia, M. V.; 
Santaballa, J. A. "First steps in the oxidation of sulfur-containing amino acids by 
hypohalogenation: Very fast generation of intermediate sulfenyl halides and 
halosulfonium cations." Tetrahedron 2000, 56, 1103-1109. 
 (78) Pryor, W. A.; Jin, X.; Squadrito, G. L. "One-electron and 2-electron 
oxidations of methionine by peroxynitrite." Proceedings of the National 
Academy of Sciences of the United States of America 1994, 91, 11173-11177. 
 (79) Peskin, A. V.; Winterbourn, C. C. "Kinetics of the reactions of 
hypochlorous acid and amino acid chloramines with thiols, methionine, and 
ascorbate." Free Radical Biology and Medicine 2001, 30, 572-579. 
 (80) Pattison, D. I.; Davies, M. J. "Kinetic analysis of the reactions of 
hypobromous acid with protein components: Implications for cellular damage 
and use of 3-bromotyrosine as a marker of oxidative stress." Biochemistry 
2004, 43, 4799-4809. 
 (81) Prutz, W. A.; Kissner, R.; Nauser, T.; Koppenol, W. H. "On the 
oxidation of cytochrome c by hypohalous acids." Archives of Biochemistry and 
Biophysics 2001, 389, 110-122. 
 (82) Hershko, A.; Ciechanover, A. "The ubiquitin system." Annual 
Review of Biochemistry 1998, 67, 425-479. 
164 
 
 (83) Vijaykumar, S.; Bugg, C. E.; Cook, W. J. "Structure of ubiquitin 
refined at 1.8 a resolution." Journal of Molecular Biology 1987, 194, 531-544. 
 (84) Bamezai, S.; Banez, M. A.; Breslow, E. "Structural and functional 
changes associated with modification of the ubiquitin methionine." Biochemistry 
1990, 29, 5389-96. 
 (85) Cornilescu, G.; Marquardt, J. L.; Ottiger, M.; Bax, A. "Validation of 
protein structure from anisotropic carbonyl chemical shifts in a dilute liquid 
crystalline phase." Journal of the American Chemical Society 1998, 120, 6836-
6837. 
 (86) Cox, M. J.; Haas, A. L.; Wilkinson, K. D. "Role of ubiquitin 
conformations in the specificity of protein-degradation - iodinated derivatives 
with altered conformations and activities." Archives of Biochemistry and 
Biophysics 1986, 250, 400-409. 
 (87) Pickart, C. M.; Haldeman, M. T.; Kasperek, E. M.; Chen, Z. J. 
"Iodination of tyrosine-59 of ubiquitin selectively blocks ubiquitins acceptor 
activity in diubiquitin synthesis catalyzed by e2(25k)." Journal of Biological 
Chemistry 1992, 267, 14418-14423. 
 (88) Neumann, N. P.; Stein, W. H.; Moore, S. "Modification of 
methionine residues in ribonuclease." Biochemistry 1962, 1, 68-&. 
 (89) Chesnut, D. B. "The electron localization function signature of the 
amide bond exhibits nitrogen lone pair character." Journal of Physical 
Chemistry A 2000, 104, 7635-7638. 
 (90) Kozak, M. "Initiation of translation in prokaryotes and eukaryotes." 
Gene 1999, 234, 187-208. 
 (91) Bradshaw, R. A.; Hope, C. J.; Yi, E.; Walker, K. W. "Co- and 
posttranslational processing: The removal of methionine." Enzymes (3rd 
Edition) 2002, 22, 387-420, 505-508. 
 
  
 
  
165 
 
Chapter 5: Concluding Remarks and Future Experiments 
5.1 Summary of findings 
The rate constant for the oxidation of SCN- by HOCl at neutral pH was 
measured. Using competition kinetics, we obtain a rate constant of 
approximately 2x107 M-1s-1, remarkably comparable to that reported in literature 
which had been extrapolated from alkaline conditions (2.3x107 M-1s-1). The 
reaction of HSA with HOCl also was studied. Though an appropriate model 
could not be found to accurately fit the data, a stoichiometry of 7:1 was 
observed which supports predictions that the one Cys and six Met groups of 
HSA are the most reactive. These experiments give insight into the importance 
of fitting the complete data set (not just the 50% inhibition point) as well as 
consideration of stoichiometry (i.e. rate law) when trying to accurately fit 
competition reaction data. Though just briefly studied, HSA experiments 
demonstrate potential problems when homogenous reaction conditions are not 
obtained, causing reproducibility problems. 
The rate constant for the reaction of HOCl with four thioethers (Met, MetO, 
DNPMet, and TNBMe) was measured at neutral pH. The reactions studied did 
not show definitive evidence for the formation of a chlorosulfonium ion 
intermediate. However, the observed product, DHM, formed in the reaction of 
Met with HOCl, gives insight into the identity of the intermediate. Due to the 
hypothesized method by which DHM is formed, from intramolecular attack 
followed by ring closure, a halosulfonium intermediate can account for the 
formation of the DHM product. In addition, the thioether reactions studied 
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allowed us to estimate the half life for an intermediate of 100 ms or less 
(assuming εReactant ≈ εIntermediate and kformation of intermediate < 10 * kintermediate reacting). 
With a half-life of 100 ms, an intermediate should be long enough lived to be 
studied using stopped-flow instrumentation. 
DHM was found to form when free Met, peptides containing an N-terminus 
Met, and a protein containing an N-terminus Met, were oxidized by 
halogenating agents. For free Met, the oxidants can be grouped by the yields of 
DHM they produce, where chlorinating agents produce around 43% DHM, 
brominating agents approximately 75%, and iodinating agents close to 100% 
DHM. Most importantly, oxidation of Ub by HOCl formed DHM-Ub. Ease of 
formation of the DHM moiety in proteins along with its high stability at neutral 
pH shows the high potential for DHM as a biomarker of protein oxidation by 
halogenating agents. 
  
5.2 Recommended future studies 
The IT method for measuring rate constants is a promising technique; 
however, more studies need to be performed to validate the method to show its 
usefulness for a variety of reactions, not just fast reactions that we have 
examined. In addition, a model needs to be developed that is appropriate for 
the oxidation of HSA. This may need additional studies such as experiments in 
which certain reactive groups on HSA are blocked (e.g. Cys group) to help 
make the reaction and subsequent interpretation less complex. Additionally, a 
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smaller protein could be examined, one which has fewer reactive groups than 
HSA .  
Additional studies need to be performed on the oxidation of thioethers to find 
definitive evidence for a halosulfonium ion intermediate. Due to the high molar 
absorptivity and difference in reactant and product absorbance spectra, TNBMe 
system showed the most promise of the four thioethers studied. pH studies of 
the reaction of TNBMe and HOCl need to be performed, in particular under 
acidic conditions in which hydrolysis of an intermediate would be slower, 
possibly allowing a buildup of an intermediate to be observed. Other thioethers 
need to be studied, in particular ones which have high molar absorptivities so 
the kinetics can be monitored directly instead of by competition methods. The 
reaction of thioethers with HOBr is worth examining since the rate of reaction is 
slower (relative to HOCl) and the hydrolysis of a bromosulfonium intermediate 
may also be slower, possibly allowing an intermediate to buildup.    
Additional experiments are needed to study the formation of DHM in 
proteins. The work described in this dissertation is just the beginning of these 
studies. A method is needed to quantify the amount of DHM formed in proteins. 
In addition other oxidants need to be tested for their ability to form DHM-
proteins. One possibility to allow detection of DHM-derivatized proteins in 
complex physiologic fluids may be to create an antibody which recognizes the 
DHM moiety, making it possible to isolate or fluorescently tag any DHM formed. 
 
168 
 
Appendices 
 
Appendix A: Data for the reaction of HOCl (1 mM) with mixtures of MCD (1 
mM) and SCN- (0-4.6 mM) at pH 7.4, 0.1 M phosphate and 0.1 M NaCl. All 
samples had a varied amount of SCN- added to MCD (1 mM). The first data 
point (listed as 0 mM SCN-) is the 0% reaction data point (no HOCl added so 
100% of the MCD is remaining). The second data point is the 100% reaction 
data point (no SCN- added, only a reaction between the MCD and HOCl) 
Column Heading Brief Description 
[SCN-] mM amount of SCN- added to the sample 
A290 measured absorbance at 290 nm 
Dilution 
factor 
correction 
calculation of absorbance if consider dilution factor (e.g. the sample which contained 
4.58 mM SCN- was diluted by a factor of two before measuring absorbance spectrum 
(to keep absorbance within instrumental limitations), so the measured absorbance of 
0.829 was multiplied by two giving 1.658) 
Ascatt absorbance due to scattering (absorbance at 600 nm) 
∆A change in absorbance (Dilution factor correction - absorbance scattering) 
Corrected A 
∆A - correction factor (for this sample set its 0.017) calculated from the absorbance 
observed from the reaction of MCD and HOCl without any SCN- present (believed to 
be due to the buffer present in the sample) 
%MCD 
% MCD remaining, calculated from Corrected A (for each sample point) divided by 
Corrected A for 0% reaction (first data point in table), multiplied by 100 
Stoichiometry 
calculated using the following equation stoichiometry =  ( [HOCl]initial – ([MCD]initial – 
[MCD]final) ) / SCN-initial 
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[SCN- ] 
mM A290 
Dilution factor 
correction Ascatt ∆A 
Corrected 
A %MCD Stoichiometry 
0.00 0.865 1.730 0.002 1.729 1.712 100.0 
0.00 0.022 0.022 0.004 0.017 0.000 0.0 
0.06 0.187 0.187 0.006 0.181 0.164 9.6 1.7 
0.11 0.449 0.449 0.004 0.445 0.427 25.0 2.4 
0.23 0.758 0.758 0.004 0.753 0.736 43.0 2.1 
0.34 0.505 1.011 0.005 1.006 0.989 57.8 1.9 
0.46 0.553 1.105 0.004 1.101 1.084 63.3 1.6 
0.57 0.584 1.168 0.005 1.163 1.146 67.0 1.3 
0.69 0.634 1.268 0.002 1.266 1.249 73.0 1.2 
0.80 0.652 1.303 0.002 1.301 1.283 75.0 1.0 
0.92 0.684 1.368 0.002 1.365 1.348 78.7 1.0 
1.03 0.699 1.399 0.002 1.397 1.380 80.6 0.9 
1.14 0.720 1.440 0.001 1.439 1.421 83.0 0.9 
1.43 0.765 1.530 0.007 1.523 1.506 88.0 1.0 
1.72 0.766 1.532 0.000 1.532 1.515 88.5 1.0 
2.00 0.778 1.555 0.003 1.552 1.535 89.7 1.0 
2.29 0.793 1.586 0.000 1.586 1.569 91.6 1.0 
2.57 0.801 1.601 0.002 1.599 1.582 92.4 1.0 
2.86 0.803 1.606 0.002 1.604 1.587 92.7 1.0 
3.15 0.808 1.616 0.001 1.615 1.598 93.3 1.0 
3.43 0.815 1.631 0.001 1.629 1.612 94.2 1.0 
3.72 0.824 1.648 0.001 1.647 1.630 95.2 1.0 
4.00 0.830 1.660 0.003 1.657 1.640 95.8 1.0 
4.29 0.826 1.652 0.001 1.651 1.634 95.4 1.0 
4.58 0.829 1.658 0.001 1.657 1.640 95.8 1.0 
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Appendix B: C++ code for computing the constants using experimental data 
for the reaction of HOCl (1 mM) with mixtures of MCD (1 mM) and SCN- (0-4.6 
mM) at pH 7.4 in 0.1 M phosphate and 0.1 M NaCl. 
#include  <stdio.h> 
#include  <math.h> 
#include  <stdlib.h> 
 
FILE *pStream; 
 
main() 
{ 
 int i,xsteps; 
 double h, incamt,dampfac, MCD, MCDint, MCDold, X, Xint, Xold, 
HOClint, HOCltotal, kMCDeff, kXeff, H, Ka; 
 double calMCD[23],kXcalc[23]; 
 double expMCD[23] = {9.6, 25.0, 43.0, 57.8, 63.3, 67.0, 73.0, 75.0, 78.7, 
80.6, 83.0, 88.0, 88.5, 89.7, 91.6, 92.4, 92.7,           
                 93.3, 94.2, 95.2, 95.8, 95.4, 95.8}; 
 double expX[23] = {0.06e-3, 0.11e-3, 0.23e-3, 0.34e-3, 0.46e-3, 0.57e-3, 
0.69e-3, 0.80e-3, 0.92e-3, 1.03e-3, 1.14e-3,  
                 1.43e-3, 1.72e-3, 2.00e-3, 2.29e-3, 2.57e-3, 2.86e-3, 3.15e-3, 3.43e-
3, 3.72e-3, 4.00e-3, 4.29e-3, 4.58e-3}; 
 double stoich[23] = {1.7, 2.4, 2.1 ,1.9 ,1.6 ,1.3 ,1.2 ,1.0 ,1.0 ,0.9 ,0.9 ,1.0 
,1.0 ,1.0 ,1.0 ,1.0 ,1.0 ,1.0 , 1.0, 1.0, 1.0, 1.0,  
                 1.0}; 
 
  pStream = fopen("test21.txt", "w+" ); 
    fprintf(pStream,"i\texpX\texpMCD\tcalMCD\tkXcalc\n"); 
  
 xsteps = 23; 
 dampfac = 0.1; 
 h = 0.00001; 
 kMCDeff = 4.0e6; /* an experimental value; kMCDeff*[HOCl]T = 
kMCD*[HOCl] */ 
 MCDint = 0.001; 
 HOClint = 0.001;  /* this is the [HOCl]T = [HOCl] + [OCl-] */ 
 H = 3.98e-8;    /* pH = 7.4 */ 
 Ka = 3.98e-8;   /* pKa of HOCl is 7.4 */ 
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 for (i = 0; i < xsteps; ++i) {  
  Xint = expX[i]; 
  X=Xint; 
  kXeff = 5.0e5;  /* a starting estimate */ 
  calMCD[i] = expMCD[i]*2.0; /* give calMCD something to start with 
*/ 
  while (fabs((calMCD[i] - expMCD[i])/expMCD[i]) > 0.001 && X != 
0.0) { /* until calMCD is within 99.9% expMCD */ 
   incamt = dampfac*fabs((expMCD[i] - 
calMCD[i])/expMCD[i]); /* dampen the increment as calMCD  
                                                 approached expMCD */ 
   if (expMCD[i] > calMCD[i]) 
    kXeff = kXeff + kXeff*incamt;  
   else 
    kXeff = kXeff - kXeff*incamt; 
//  printf("i = %2d\tincamt = %.2e \n", i, incamt); 
   MCD=MCDint; 
   X=Xint; 
   HOCltotal = HOClint; 
   while (HOCltotal > HOClint/100.0) {   /* until 99.9% HOCl 
reacts */ 
    MCDold = MCD; 
    MCD = MCD - h*kMCDeff*MCD*HOCltotal; 
    Xold = X; 
    X = X - h*kXeff*X*HOCltotal/stoich[i]; 
    if (X < 0.0) X = 0.0; 
    HOCltotal = HOCltotal - 
h*kMCDeff*MCDold*HOCltotal - h*kXeff*Xold*HOCltotal; 
//    printf("flag1: MCD = %.2e X = %.2e HOCl = %.2e kX 
= %.2e\n", MCD, X, HOCltotal, kXeff); 
   };  
//   kXcalc[i] = stoich[i]*kXeff*(Ka+H)/H; /* convert kXeff to kX 
and save in case this is the right one */ 
   kXcalc[i] = kXeff*(Ka+H)/H; /* convert kXeff to kX and save 
in case this is the right one */ 
   calMCD[i] = 100.0*MCD/MCDint; /* save percent MCD in 
case this is the right one */ 
  }; 
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  fprintf(pStream,"%2d\t%.2e\t%.1f\t%.1f\t%.2e\n", i, expX[i], 
expMCD[i], calMCD[i], kXcalc[i]); 
 }; 
 fclose (pStream); 
} 
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Appendix C: C++ code used to fit the experimental data (using a defined rate 
constant for kSCN) for the reaction of HOCl (1 mM) with mixtures of MCD (1 mM) 
and SCN- (0-4.6 mM) at pH 7.4 in 0.1 M phosphate and 0.1 M NaCl. First loop 
calculates %MCD remaining when no stoichiometry of the reaction is taken into 
account, the second loop calculates %MCD remaining when the stoichiometry 
of the reaction is considered. The program uses kx : kXO : kXO2= 1.0 : 0.1 : 0.4 
and kSCN = kX = 1.9x107 M-1s-1 to fit the data, which was found to give a good fit. 
#include  <stdio.h> 
#include  <math.h> 
#include  <stdlib.h> 
 
FILE *pStream; 
 
main() 
{ 
 int i,xsteps; 
 double h, MCD, MCDint, MCDold, X, Xint, Xfinal, Xold, XO, XOold, XOO, 
XOOold, HOClint, HOCltotal, kMCDeff, kXeff, Ka, H, kOscale,  
                   kOOscale; 
 double calMCD[100]; 
 
  pStream = fopen("test23.txt", "w+" ); 
    fprintf(pStream,"i\tXint\tcalMCD\n"); 
  
 xsteps = 100; 
 Xfinal = 0.0036; 
 
 h = 0.00001; 
 
 kMCDeff = 4.0e6;  
 kXeff = 1.9e7; 
 kOscale = 0.1; 
 kOOscale = 0.4; 
 
 MCDint = 0.001; 
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 HOClint = 0.001; 
 
 for (i = 0; i < xsteps; ++i) {  
 
  Xint = i*Xfinal/100.0; 
   ;   
  MCD=MCDint; 
  X=Xint; 
  XO=0.0; 
  XOO=0.0; 
  HOCltotal = HOClint; 
 
  while (HOCltotal > HOClint/100.0) {   /* until 99% HOCl reacts */ 
    MCDold = MCD; 
    MCD = MCD - h*kMCDeff*MCD*HOCltotal; 
    Xold = X; 
    X = X - h*kXeff*X*HOCltotal; 
    if (X < 0.0) {X = 0.0; printf("Error: X underflow for 
datapoint %2d\n", i);}; 
    HOCltotal = HOCltotal - 
h*kMCDeff*MCDold*HOCltotal - h*kXeff*Xold*HOCltotal; 
  };  
   
  calMCD[i] = 100.0*MCD/MCDint; /* save percent MCD in case this 
is the right one */ 
  fprintf(pStream,"%2d\t%.2e\t%.1f\n", i, Xint, calMCD[i]); 
 }; 
 for (i = 0; i < xsteps; ++i) {  
 
  Xint = i*Xfinal/100.0; 
   ;   
  MCD=MCDint; 
  X=Xint; 
  XO=0.0; 
  XOO=0.0; 
  HOCltotal = HOClint; 
 
  while (HOCltotal > HOClint/100.0) {   /* until 99% HOCl reacts */ 
    MCDold = MCD; 
    MCD = MCD - h*kMCDeff*MCD*HOCltotal; 
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    Xold = X; 
    X = X - h*kXeff*X*HOCltotal; 
    if (X < 0.0) {X = 0.0; printf("Error: X underflow for 
datapoint %2d\n", i);}; 
    XOold = XO; 
    XO = XO + h*kXeff*X*HOCltotal - 
h*kXeff*kOscale*XO*HOCltotal; 
    if (XO < 0.0) {XO = 0.0; printf("Error: XO underflow 
for datapoint %2d\n", i);}; 
    XOOold = XOO; 
    XOO = XOO + h*kXeff*kOscale*XO*HOCltotal - 
h*kXeff*kOOscale*XOO*HOCltotal; 
    if (XOO < 0.0) {XOO = 0.0; printf("Error: XOO 
underflow for datapoint %2d\n", i);}; 
    HOCltotal = HOCltotal - 
h*kMCDeff*MCDold*HOCltotal - h*kXeff*Xold*HOCltotal –  
                                                                          
h*kXeff*kOscale*XOold*HOCltotal- h*kXeff*kOOscale*XOold*HOCltotal; 
  };  
   
  calMCD[i] = 100.0*MCD/MCDint; /* save percent MCD in case this 
is the right one */ 
  fprintf(pStream,"%2d\t%.2e\t%.1f\n", i, Xint, calMCD[i]); 
 }; 
 fclose (pStream); 
} 
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Appendix D: Results obtained from the code listed in appendix C. The left 
column is the result when no stoichiometry is taken into consideration (first “for” 
loop in code), while right column is the result when stoichiometry is taken into 
account (second “for” loop in code). Listed is the increment number i (code 
incremented for 99 points), the concentration of X initial used, and the resulting 
MCD calculated. 
i    Xint 
      
MCDcalc i    Xint 
      
MCDcalc 
0 0.00E+00 1.0 0 0.00E+00 1.0 
1 3.60E-05 4.6 1 3.60E-05 13.3 
2 7.20E-05 8.2 2 7.20E-05 22.0 
3 1.08E-04 11.8 3 1.08E-04 29.1 
4 1.44E-04 15.4 4 1.44E-04 35.0 
5 1.80E-04 19.0 5 1.80E-04 40.1 
6 2.16E-04 22.6 6 2.16E-04 44.6 
7 2.52E-04 26.2 7 2.52E-04 48.4 
8 2.88E-04 29.7 8 2.88E-04 51.9 
9 3.24E-04 33.3 9 3.24E-04 55.0 
10 3.60E-04 36.7 10 3.60E-04 57.7 
11 3.96E-04 40.1 11 3.96E-04 60.2 
12 4.32E-04 43.5 12 4.32E-04 62.4 
13 4.68E-04 46.7 13 4.68E-04 64.4 
14 5.04E-04 49.7 14 5.04E-04 66.3 
15 5.40E-04 52.7 15 5.40E-04 67.9 
16 5.76E-04 55.4 16 5.76E-04 69.5 
17 6.12E-04 58.0 17 6.12E-04 70.9 
18 6.48E-04 60.3 18 6.48E-04 72.2 
19 6.84E-04 62.5 19 6.84E-04 73.4 
20 7.20E-04 64.6 20 7.20E-04 74.5 
21 7.56E-04 66.4 21 7.56E-04 75.5 
22 7.92E-04 68.2 22 7.92E-04 76.4 
23 8.28E-04 69.7 23 8.28E-04 77.3 
24 8.64E-04 71.2 24 8.64E-04 78.1 
25 9.00E-04 72.5 25 9.00E-04 78.9 
26 9.36E-04 73.7 26 9.36E-04 79.6 
27 9.72E-04 74.9 27 9.72E-04 80.3 
28 1.01E-03 75.9 28 1.01E-03 80.9 
29 1.04E-03 76.8 29 1.04E-03 81.5 
30 1.08E-03 77.7 30 1.08E-03 82.1 
31 1.12E-03 78.6 31 1.12E-03 82.6 
32 1.15E-03 79.3 32 1.15E-03 83.1 
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33 1.19E-03 80.1 33 1.19E-03 83.6 
34 1.22E-03 80.8 34 1.22E-03 84.0 
35 1.26E-03 81.4 35 1.26E-03 84.4 
36 1.30E-03 82.0 36 1.30E-03 84.8 
37 1.33E-03 82.6 37 1.33E-03 85.2 
38 1.37E-03 83.1 38 1.37E-03 85.6 
39 1.40E-03 83.6 39 1.40E-03 85.9 
40 1.44E-03 84.0 40 1.44E-03 86.3 
41 1.48E-03 84.5 41 1.48E-03 86.6 
42 1.51E-03 84.9 42 1.51E-03 86.9 
43 1.55E-03 85.3 43 1.55E-03 87.2 
44 1.58E-03 85.7 44 1.58E-03 87.5 
45 1.62E-03 86.0 45 1.62E-03 87.7 
46 1.66E-03 86.4 46 1.66E-03 88.0 
47 1.69E-03 86.7 47 1.69E-03 88.2 
48 1.73E-03 87.0 48 1.73E-03 88.4 
49 1.76E-03 87.3 49 1.76E-03 88.7 
50 1.80E-03 87.6 50 1.80E-03 88.9 
51 1.84E-03 87.9 51 1.84E-03 89.1 
52 1.87E-03 88.1 52 1.87E-03 89.3 
53 1.91E-03 88.4 53 1.91E-03 89.5 
54 1.94E-03 88.6 54 1.94E-03 89.7 
55 1.98E-03 88.9 55 1.98E-03 89.9 
56 2.02E-03 89.1 56 2.02E-03 90.1 
57 2.05E-03 89.3 57 2.05E-03 90.2 
58 2.09E-03 89.5 58 2.09E-03 90.4 
59 2.12E-03 89.7 59 2.12E-03 90.6 
60 2.16E-03 89.9 60 2.16E-03 90.7 
61 2.20E-03 90.1 61 2.20E-03 90.8 
62 2.23E-03 90.2 62 2.23E-03 91.0 
63 2.27E-03 90.4 63 2.27E-03 91.1 
64 2.30E-03 90.6 64 2.30E-03 91.3 
65 2.34E-03 90.7 65 2.34E-03 91.4 
66 2.38E-03 90.9 66 2.38E-03 91.5 
67 2.41E-03 91.0 67 2.41E-03 91.6 
68 2.45E-03 91.2 68 2.45E-03 91.8 
69 2.48E-03 91.3 69 2.48E-03 91.9 
70 2.52E-03 91.5 70 2.52E-03 92.0 
71 2.56E-03 91.6 71 2.56E-03 92.1 
72 2.59E-03 91.7 72 2.59E-03 92.2 
73 2.63E-03 91.9 73 2.63E-03 92.3 
74 2.66E-03 92.0 74 2.66E-03 92.4 
75 2.70E-03 92.1 75 2.70E-03 92.5 
76 2.74E-03 92.2 76 2.74E-03 92.6 
77 2.77E-03 92.3 77 2.77E-03 92.7 
78 2.81E-03 92.4 78 2.81E-03 92.8 
79 2.84E-03 92.5 79 2.84E-03 92.9 
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80 2.88E-03 92.6 80 2.88E-03 93.0 
81 2.92E-03 92.7 81 2.92E-03 93.1 
82 2.95E-03 92.8 82 2.95E-03 93.1 
83 2.99E-03 92.9 83 2.99E-03 93.3 
84 3.02E-03 93.0 84 3.02E-03 93.3 
85 3.06E-03 93.1 85 3.06E-03 93.4 
86 3.10E-03 93.2 86 3.10E-03 93.5 
87 3.13E-03 93.3 87 3.13E-03 93.5 
88 3.17E-03 93.4 88 3.17E-03 93.6 
89 3.20E-03 93.4 89 3.20E-03 93.7 
90 3.24E-03 93.5 90 3.24E-03 93.8 
91 3.28E-03 93.6 91 3.28E-03 93.8 
92 3.31E-03 93.7 92 3.31E-03 93.9 
93 3.35E-03 93.8 93 3.35E-03 94.0 
94 3.38E-03 93.8 94 3.38E-03 94.0 
95 3.42E-03 93.9 95 3.42E-03 94.1 
96 3.46E-03 94.0 96 3.46E-03 94.2 
97 3.49E-03 94.0 97 3.49E-03 94.2 
98 3.53E-03 94.1 98 3.53E-03 94.3 
99 3.56E-03 94.1 99 3.56E-03 94.3 
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Appendix E: Complete data set for the reaction of HOCl (100 µM) with 
mixtures of MCD (100 µM) and HSA (0-61 µM) at pH 7.4, 0.1 M phosphate and 
0.1 M NaCl. All samples have a varied amount of HSA added to MCD (100 µM). 
The first data point (listed as 0 µM HSA) is the 0% reaction data point, it’s a 
sample with no HOCl added, so 100% of the MCD is remaining. The second 
data point is the 100% reaction data point, (no HSA added, only a reaction 
between the MCD and HOCl). 
 
Column Heading Brief Description 
[HSA] mg/ml amount of HSA in the sample 
[HSA] µM amount of HSA in sample calculated in µM 
A290 measured absorbance at 290 nm 
With dilution factor calculation of absorbance if consider dilution factor 
Ascatt absorbance due to scattering (absorbance at 600 nm) 
∆A change in absorbance (Dilution factor correction - absorbance scattering) 
Corrected A 
∆A - correction factor (for this sample set its 0.01449) calculated from the 
absorbance observed from the reaction of MCD and HOCl without any HSA present 
(believed to be due to the buffer present in the sample) 
%MCD 
% MCD remaining, calculated from Corrected A (for each sample point) divided by 
Corrected A for 0% reaction (first data point in table), multiplied by 100 
Stoichiometry 
calculated using the following equation stoichiometry =  ( [HOCl]initial – ([MCD]initial – 
[MCD]final) ) / HSAinitial 
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[HSA] 
mg/m
l 
[HSA
] µM A290 
With 
dilution 
factor Ascatt ∆A 
Corrected 
A %MCD Stoichiometry 
0.00 0.00 -0.01317 -0.01317 -0.02766 0.01449 0 0.00 
0.00 0.00 0.68469 2.73876 -0.01334 2.7521 2.73761 100.00 1.0 
0.11 1.67 0.29002 0.29002 -0.02853 0.31855 0.30406 11.11 6.7 
0.22 3.34 0.54091 0.54091 -0.02525 0.56616 0.55167 20.15 6.0 
0.44 6.68 0.45613 0.91226 -0.02568 0.93794 0.92345 33.73 5.1 
0.67 10.02 0.55273 1.10546 -0.02621 1.13167 1.11718 40.81 4.1 
1.00 15.03 0.70438 1.40876 -0.02629 1.43505 1.42056 51.89 3.5 
1.20 18.03 0.38281 1.53124 -0.02609 1.55733 1.54284 56.36 3.1 
1.42 21.37 0.41104 1.64416 -0.0235 1.66766 1.65317 60.39 2.8 
1.60 24.04 0.43607 1.74428 -0.02516 1.76944 1.75495 64.11 2.7 
1.82 27.38 0.4518 1.8072 -0.02644 1.83364 1.81915 66.45 2.4 
2.00 30.06 0.47392 1.89568 -0.02545 1.92113 1.90664 69.65 2.3 
2.22 33.39 0.50488 2.01952 -0.02467 2.04419 2.0297 74.14 2.2 
2.40 36.07 0.52174 2.08696 -0.0174 2.10436 2.08987 76.34 2.1 
2.62 39.41 0.53693 2.14772 -0.02174 2.16946 2.15497 78.72 2.0 
2.80 42.08 0.561 2.244 -0.01987 2.26387 2.24938 82.17 2.0 
3.02 45.42 0.57115 2.2846 -0.02356 2.30816 2.29367 83.78 1.8 
2.89 43.41 0.56792 2.27168 -0.023 2.29468 2.28019 83.29 1.9 
3.42 51.43 0.62387 2.49548 -0.01431 2.50979 2.4953 91.15 1.8 
4.08 61.45 0.67221 2.68884 -0.01588 2.70472 2.69023 98.27 1.6 
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Appendix F: C++ code for computing the rate constant for the reaction of HOCl 
(100 µM) with mixtures of MCD (100 µM) and HSA (0-61 µM) at pH 7.4 in 0.1 M 
phosphate and 0.1 M NaCl. 
#include  <stdio.h> 
#include  <math.h> 
#include  <stdlib.h> 
 
FILE *pStream; 
 
int main() 
{ 
 int i,xsteps; 
 double h, incamt,dampfac, MCD, MCDint, MCDold, X, Xint, Xold, 
HOClint, HOCltotal, kMCDeff, kXeff, H, Ka; 
 double calMCD[18],kXcalc[18]; 
 double expMCD[18] = {11.1, 20.1, 33.7, 40.8, 51.9, 56.4, 60.4, 64.1, 
66.4, 69.7, 74.1, 76.3, 78.7, 82.2, 83.8, 83.3, 91.2,  
                 98.3}; 
 double expX[18] = {1.67e-6, 3.34e-6, 6.68e-6, 1.00e-5, 1.50e-5, 1.80e-5, 
2.14e-5, 2.40e-5, 2.74e-5, 3.01e-5, 3.34e-5,  
                 3.61e-5, 3.94e-5, 4.21e-5, 4.54e-5, 4.34e-5, 5.14e-5, 6.15e-5}; 
 double stoich[18] = {6.7, 6.0, 5.1, 4.1, 3.5, 3.1, 2.8, 2.7, 2.4, 2.3, 2.2, 2.1, 
2.0, 2.0, 1.8, 1.9, 1.8, 1.6}; 
 
  pStream = fopen("testhsa.txt", "w+" ); 
    fprintf(pStream,"i\texpX\texpMCD\tcalMCD\tkXcalc\n"); 
  
 xsteps = 18; 
 i=0; 
 dampfac = 0.1; 
 h = 0.00001; 
 kMCDeff = 4.0e6; /* an experimental value; kMCDeff*[HOCl]T = 
kMCD*[HOCl] */ 
 MCDint = 0.0001; 
 HOClint = 0.0001;  /* this is the [HOCl]T = [HOCl] + [OCl-] */ 
 H = 3.98e-8;    /* pH = 7.4 */ 
 Ka = 3.98e-8;   /* pKa of HOCl is 7.4 */ 
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 for (i = 0; i < xsteps; ++i) {  
  Xint = expX[i]; 
  X=Xint; 
  kXeff = 5.0e5;  /* a starting estimate */ 
  calMCD[i] = expMCD[i]*2.0; /* give calMCD something to start with 
*/ 
  while (fabs((calMCD[i] - expMCD[i])/expMCD[i]) > 0.001 && X != 
0.0) { /* until calMCD is within 99.9% expMCD */ 
   incamt = dampfac*fabs((expMCD[i] - 
calMCD[i])/expMCD[i]); /* dampen the increment as calMCD  
                                                 approached expMCD */ 
   if (expMCD[i] > calMCD[i]) 
    kXeff = kXeff + kXeff*incamt;  
   else 
    kXeff = kXeff - kXeff*incamt; 
//  printf("i = %2d\tincamt = %.2e \n", i, incamt); 
   MCD=MCDint; 
   X=Xint; 
   HOCltotal = HOClint; 
   while (HOCltotal > HOClint/100.0) {   /* until 99.9% HOCl 
reacts */ 
    MCDold = MCD; 
    MCD = MCD - h*kMCDeff*MCD*HOCltotal; 
    Xold = X; 
    X = X - h*kXeff*X*HOCltotal/stoich[i]; 
    if (X < 0.0) X = 0.0; 
    HOCltotal = HOCltotal - 
h*kMCDeff*MCDold*HOCltotal - h*kXeff*Xold*HOCltotal; 
//    printf("flag1: MCD = %.2e X = %.2e HOCl = %.2e kX 
= %.2e\n", MCD, X, HOCltotal, kXeff); 
   };  
//   kXcalc[i] = stoich[i]*kXeff*(Ka+H)/H; /* convert kXeff to kX 
and save in case this is the right one */ 
   kXcalc[i] = kXeff*(Ka+H)/H; /* convert kXeff to kX and save 
in case this is the right one */ 
   calMCD[i] = 100.0*MCD/MCDint; /* save percent MCD in 
case this is the right one */ 
  }; 
  fprintf(pStream,"%2d\t%.2e\t%.1f\t%.1f\t%.2e\n", i, expX[i], 
expMCD[i], calMCD[i], kXcalc[i]); 
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 }; 
 fclose (pStream); 
} 
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Appendix G: C++ code used to simulate the data for the reaction of HOCl (1 
mM) with mixtures of MCD (1 mM) and Sulfite (0-250 µM) 
Clear[percentMCD, kMCD,kSO3,h,nsteps,]; 
xsteps=100; (* should equal nsteps *) 
SO30=0.000010; (* start [SO3]=10uM *) 
Do[{ 
      
Clear[MCD,SO3,HOCl,n,MCDdata,SO3data,HOCldata,MCDPlot,SO3Plot,HOCl
Plot]; 
      kMCD=3.6*10^6; 
      kSO3=7.6*10^8; 
      totaltime=0.001000; (* 1000usec *) 
      h=0.000010; (* every 10usec *) 
      MCD[0]=0.001000; (* 1mM *) 
      SO3[0]=SO30*(x+1); (* increase [SO3] by 10uM each time *) 
      HOCl[0]=0.001000;(* 1mM *) 
      nsteps = Round[totaltime/h]; (* so this does it every 10 *) 
      n=1; 
      While[HOCl[n-1]>HOCl[0]/10000, (* react until 99.99% initial, since /100 
would be 99% *) 
          { 
            MCD[n] =MCD[n-1] - h*kMCD*MCD[n-1]*HOCl[n-1], 
            SO3[n] = SO3[n-1] - h*kSO3*SO3[n-1]*HOCl[n-1], 
            HOCl[n] =HOCl[n-1] - h*kMCD*MCD[n-1]*HOCl[n-1]- h*kSO3*SO3[n-
1]*HOCl[n-1], 
            n=n+1 
            }] //N; 
      percentMCD[x]= 100*MCD[n-1]/MCD[0]//N; 
      }, 
    {x,0,xsteps-1}] //N; 
percentdata = Table[{SO30*(n+1),percentMCD[n]}, {n, 0, xsteps-1}] 
percentPlot=ListPlot[percentdata,Frame -> True, PlotStyle-> 
{RGBColor[1,0,0],PointSize[0.02]},PlotLabel="Percent MCD vs. 
[SO3]",PlotRange=All]; 
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Appendix H: Simulated data for the competition reaction of MCD/Sulfite with 
HOCl, comparing [MCD]=100 µM (circle) versus [MCD]=200 µM (diamonds). 
 
 
 
Sodium sulfite reacts with HOCl with a rate constant around 109 M-1s-1 
(Fogelman et al. “Hypochlorite and Hypochlorous Acid Reactions with Sulfite,” 
Inorganic Chemistry, 28 (6) 986-993, 1989) much faster than the rate constant 
of 106 M-1s-1 for HOCl with MCD. When the rate constant of the inhibitor (sulfite 
in this particular example) is orders of magnitude faster than the competitor (or 
vice versa), HOCl gets used up by the faster reacting species, and then any 
HOCl that remains reacts with the slower reacting species, making it non-
competitive. Take the following example, X (inhibitor) and Y (competitor, 
remains constant) compete for reaction with Z. X and Z react with a rate 
constant of 109 M-1s-1 and Y and Z react with a rate constant of 106 M-1s-1. Since 
X reacts orders of magnitude faster than Y, any X that is present (up to the 
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amount of Z available) will react, and then any Z remaining will react with Y. 
When X and Y are not competitive, a plot of X versus %Z remaining yields a 
graph which fits to a linear equation (y=mx+b). When X and Y are competitive 
(i.e. have similar rate constants), there is typically some curvature/non-linearity 
to the fit. This curvature can be modified by changing experimental conditions 
such as the concentration of the competitor (i.e. MCD). The curvature and 
shape of the fit, as well as investigating how experimental conditions change 
the fit, can both provide valuable insight into the reaction.    
 
